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Abstract 
 
Neurons within the peripheral nervous system (PNS) have a remarkable ability to repair 
themselves after injury; however, neurons within the central nervous system (CNS) do not 
spontaneously regenerate. Therefore, understanding the molecular elements responsible for 
successful regenerative response in the PNS can help us to establish basic principles and 
strategies for promoting regeneration in CNS structures such as the spinal cord. Nerve 
repair in the PNS has been suggested to be in part due to the involvement of intrinsic 
molecules such as transcription factors. In this thesis, I am focusing on the C/EBP family of 
transcription factors and their potential role in axonal regeneration after PNS injury. I 
examined the expression of different C/EBP members in PNS after injury after, using the 
sciatic nerve crush injury model I found that C/EBPδ mRNA is upregulated 4, 24 and 72 
hours in dorsal root ganglia (DRG) following injury, whereas C/EBPβ and C/EBPγ 
expression is transiently upregulated by 4 hours resuming background levels after 72 hours. 
Conversely, C/EBPα and C/EBPε did not show upregulation following injury. In order to 
determine the function of C/EBPs in axonal growth in an in vitro system I used the ND7/23 
cell line where I found that upon neurite growth induced by cyclic adenosine 
monophosphate (cAMP), the mRNA levels of C/EBPβ and C/EBPδ were upregulated. 
Furthermore, the conditional expression of a C/EBP total inhibitor or a C/EBPδ antisense 
construct decreases neurite elongation in vitro. Additionally, I found that 24 hours after 
treatment of ND7/23 cells with trichostatin A (TSA) C/EBPδ expression is elevated. 
Subsequently, I found that in DRG cultures from C/EBPδ knock-out animals, the lack of 
C/EBPδ affects the intrinsic growth capacity of dorsal root ganglion neurons which show a 
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drastically reduced axonal growth in vitro. To address the role of C/EBPδ in vivo, 
peripheral nerve repair was assessed in transgenic C/EBPδ knock-out animals following 
sciatic nerve crush. C/EBPδ knock-outs show, by immunostaining, impaired nerve 
regeneration 3 days and 14 days after sciatic nerve injury. Furthermore, functional recovery 
and morphometric analysis indicate that nerve regeneration is delayed in C/EBPδ deficient 
animals. These data demonstrate that the C/EBPδ gene is involved in neuronal repair after 
peripheral nerve injury. 
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Chapter 1 – Introduction 
After injury in the central nervous system (CNS) injured axons usually fail to regenerate, 
whereas following injury to the mature peripheral nervous system (PNS) damage axons 
regenerate successfully if not to appropriate targets. Two main complications have been 
identified to account for this poor regeneration in the mature CNS.  One is unfavourable 
glial environment for axonal growth, characterised by the presence of myelin debris, glial 
scar, cavitation and lack of facilitatory molecules (Bradbury et al., 2002; Silver and Miller, 
2004; Fawcett, 2006). The other is failure of damaged CNS neurons to initiate a programme 
of gene expression which is beneficial for axon regeneration (Bomze et al., 2001; Woolf, 
2001). Accumulating evidence indicates that overcoming the inhibitory signals is beneficial 
but must be combined with activation of the intrinsic growth state of neurons to achieve 
successful axon regeneration (Schnell et al., 1994; Fischer et al., 2001; Fischer et al., 2000). 
Key molecules for orchestrating the changes in gene expression that increase the intrinsic 
growth state of peripherally injured sensory neurons necessary for regenerating an axon are 
transcription factors. Therefore, the objective of this project is to examine the CAAT 
enhancing binding protein (C/EBP) family of transcription factors‘ potential role in axonal 
regeneration after PNS injury. Specifically, my work aims to addresses the effect of 
C/EBPδ during nerve regeneration. 
 
1. 1 The peripheral nerve anatomy 
The peripheral nerve is composed of connective tissue and neural components. The 
smallest functional units in the peripheral nerve are the nerve fibres which can be either 
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unmyelinated or myelinated (Flores et al., 2000). While unmyelinated fibres are composed 
of several axons, enveloped as a group by a single Schwann cell, myelinated fibres consist 
of a single axon, enveloped individually by a single Schwann cell. The length of an axon 
covered by a single Schwann cell is called an internode and the short distance between 
Schwann cells processes, in which the axon is not myelinated, is known as the node of 
Ranvier.    
The connective tissue structures of the peripheral nerve are composed of three 
distinct sheaths: endoneurium, perineurium, and epineurium, from innermost to outermost, 
respectively (Fig. 1). These three structures form a framework that organizes and protects 
the nerve fibres and axons (Flores et al., 2000). The epineurium made up the connective 
tissue that surrounds the entire nerve trunk. The perineurium is the middle-level connective 
tissue sheath around the nerve fibres, and it made up of concentrically arranged, more 
compact cellular layers. The innermost sheath surrounding the Schwann cells and 
individual fascicles of longitudinally running nerve fibres is the endoneurium.  
 
 
Fig. 1 Peripheral nerve fibre components. From International review of neurobiology, volume 87.  
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1.2.1 Effects of peripheral axotomy  
The study of peripheral nerve regeneration potential has been reported since ancient times 
(Naff and Ecklund, 2001). However, it is only since the second half of nineteenth century 
that a body of literature on nerve regeneration and nerve repair strategies began to 
accumulate, starting with the milestone observations of Augustus Waller in 1850, reprinted 
in (Stoll et al., 2002).  
In his influential paper entitled ―Experiments on the section of the glossopharyngeal 
and hypoglossal nerves of the frog, and observations of the alterations produced thereby in 
the structure of their primitive fibres‖ and without the advantage of staining techniques that 
were later developed by Golgi, Cajal, and others, Waller described for the first time the 
progressive disorganization of the axons which occurs downstream to nerve transection and 
which also involved the myelin sheaths. This sequence of pathological changes leading to 
axonal degeneration distal to the site of the lesion is today known as Wallerian 
degeneration (Fig. 2), a complex process which is crucial for subsequent regeneration of 
axons. In mammals, Wallerian degeneration is fast in the PNS, taking about 7–14 days 
(Griffin et al., 1992; George and Griffin, 1994). The complex histological changes during 
Wallerian degeneration involve several cell types: neurons, monocyte lineage cells, 
myelinating and non-myelinating Schwann cells (Vargas and Barres, 2007). 
 
The neuronal response induced by peripheral axotomy of adult PNS neurons has 
been intensively investigated. Early experiments showed that axotomy changed the cell 
morphology, the status of metabolism in the nerve cell bodies and axonal transport 
(Grafstein, 1975). First, axotomy divides the axon into a proximal segment that remains 
attached to the cell body and a distal segment that has lost that attachment. Because the 
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capacity for protein synthesis is largely restricted to the cell body, axotomy dooms the 
distal segment. Additionally, glial cells that ensheath the distal segment are also affected. 
The myelin sheath, which requires axonal contact for its maintenance as well as genesis 
becomes fragmented and is eventually enveloped, along with axonal debris, by phagocytic 
cells. 
 
1.2.2. The distal segment 
In Wallerian degeneration the primary histological change involves physical fragmentation 
of both axons and myelin, a process that begins promptly after nerve injury. Within hours 
after transection, the axon membrane fuses and seals the ends. Disintegration of the axons 
starts within the first days. The first stages of this process are characterized by a granular 
disintegration of axoplasmic microtubules and neurofilaments due to proteolysis 
(Schlaepfer, 1977).  Ultrastructurally, both neurotubules and neurofilaments become 
disarrayed, and axonal contour becomes irregular, due to varicose swellings. By 48 to 96 
hours post injury, axonal continuity is lost and conduction of impulses is no longer 
possible. Myelin disintegration lags slightly behind that of axons but is advanced by 36 to 
48 hours. Myelin debris is cleared rapidly and efficiently in the PNS of mammals over the 
course of 7–14 days (Griffin et al., 1992; George and Griffin, 1994). However, in humans, 
myelin debris is still present years after degeneration of CNS axons (Buss et al., 2004; 
Becerra et al., 1995).  
Myelinating Schwann cells respond rapidly to axonal injury, prior to the 
degeneration of the axon. ErbB2 receptors located in Schwann cells microvilli are 
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transiently activated within minutes following axotomy (Guertin et al., 2005). Schwann 
cells play a key role in both the breakdown of the myelin sheath and the clearance of its 
debris. Schwann cells decrease their synthesis of myelin lipids within the first 12 h after 
axotomy (White et al., 1989) and halt their production of myelin proteins within 48 h 
(Trapp et al., 1988). Following peripheral nerve injury, Schwann cells degrade their own 
myelin, they phagocyte extracellular myelin debris, and they pump myelin debris into the 
extracellular space for phagocytosis by macrophages (Hirata et al., 1999). During the first 
few days following injury, Schwann cells clear myelin debris in the absence of 
macrophages to promote fast clearance of nerve debris in the PNS (Stoll et al., 1989; Perry 
et al., 1995).  
Following axon degeneration, around 3 days after nerve injury, Schwann cells start 
proliferating organizing themselves into columns, forming bands of Büngner as guideposts 
for new sprouting axons during regeneration. Interestingly, Schwann cells in contact with 
injured axons enter the cell cycle, whereas myelinating Schwann cells in contact with intact 
axons do not enter the cell cycle (Murinson et al., 2005).  Not only Schwann cells but also 
perineural satellite cells which surround nerve cell bodies in sensory and autonomic 
ganglia, proliferate within a few days after peripheral axon injury. Satellite cells have little 
cytoplasm with their flattened nuclei closely appose neurons and their processes are 
involved in metabolic interactions with the neuron (Lu and Richardson, 1991). 
Interestingly, blocking the satellite cells proliferation does not impede peripheral 
regeneration (Lu and Richardson, 1991). In cases where the axonal injury results in a 
significant amount of nerve cell death in the affected ganglia, the subsequent phagocytosis 
of neuronal debris is also carried out by satellite cells. Additionally, satellite cells are 
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known to provide trophic molecules such as CNTF to support neurons and protect them 
from injury.  
In the PNS, Schwann cells release a wide variety of chemokines and cytokines after 
injury; a number of these recruit macrophages to the degenerating nerve (Shamash et al., 
2002). Schwann cells secrete leukemia inhibitor factor (LIF) which attracts macrophages in 
vitro (Tofaris et al., 2002). Additionally, LIF and tumor necrosis factor-α (TNFα) induce 
production of macrophage chemoattractant protein-1 (MCP-1) by Schwann cells (Subang 
and Richardson, 1999). Macrophages are recruited from the circulation into the 
degenerating sciatic nerve by 3 days post axotomy (Perry et al., 1987) also as a result of 
local bleeding and migration of monocytes through the blood vessel endothelium. 
Macrophage numbers peak between 14 and 21 days after axotomy in the PNS (Avellino et 
al., 1995).  Macrophages in the PNS mediate the final phase of myelin debris removal in 
the distal nerve stump. Post injury, macrophages enter the endoneural tubes at 5 days, and 
by 7 days post injury numerous macrophages are found within the basal laminar tubes 
(Griffin et al., 1992). 
 
1.2.3 The proximal segment and the cell body 
The proximal portion of the neuron also suffers the effect of a nerve lesion. In some cases 
the neuron dies by apoptosis, probably due to restriction in the supply of target derived 
trophic factors or due to calcium influx when the axonal membrane is disrupted. In those 
neurons that are not killed immediately by the lesion, there is a well described set of 
changes that occur, many of which are associated with re-initiating synthesis of the proteins 
that are needed for axon growth and regeneration. In terms of anatomical appearance of the 
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neuron, these changes take the form of chromatolysis: Within 6 hours of the injury, the cell 
body swells, the nucleus migrates to the periphery of the cell and Nissl granules and the 
rough endoplasmatic reticulum becomes fragmented (Lieberman, 1971).  
Metabolic changes also accompany chromatolysis, including overall increases in 
protein and RNA synthesis as well as changes in the pattern of genes that the neuron 
expresses. The neurons switch from a signaling mode to a growing mode and the increased 
RNA synthesis implies some alteration of gene expression. Protein synthesis is upregulated 
together with increased proteolysis in parallel with an increase of production of material 
required for restitution of the axon and a decreased production of material associated with 
synaptic transmission. Lipid synthesis is also significantly increased, possibly 
corresponding to the stimulated synthesis of membranous components of the nerve cell.  
There may be a decreased axonal transport of transmitter-associated materials 1-2 
days after axotomy, followed by an increased axonal transport of protein after initiation of 
axon regeneration (Grafstein, 1975). Changes within nerve cell body are prerequisite for 
sustained axonal regeneration. The detailed molecular mechanisms have been further 
explored in recent studies which aim to elucidate a specific growth programme 
characterized by expression of a series of regeneration-associated genes (Snider et al., 
2002; Smith and Skene, 1997; Aubert et al., 1995).  
Axotomy also affects postsynaptic neurons. When axotomy disrupts the major 
inputs to a cell, as happens in denervated muscle, the consequences are severe. Usually the 
target atrophies and sometimes dies. When targets are only partially denervated their 
responses are more subtle. Axotomy affects also inputs to the injured neuron. Frequently, 
synaptic terminals withdraw from neuronal cell bodies or dendrites of chromatolytic 
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neurons and are replaced by the processes of glial cells, Schwann cells in the PNS and 
microglia or astrocytes in the CNS. This process is called synaptic stripping, depresses 
synaptic function and can impair recovery of function. 
 
Fig. 2 Wallerian degeneration. A) A normal neuron with a normal functional axon. B)  After axotomy the 
nerve terminals of the injured neuron fail rapidly (1). The distal stump, separeted from the cell body, 
undergoes Wallerian degeneration (2). Myelin degenerates (3) phagocytic cells invade (4). The cell body 
undergoes chromatolysis , in which the nucleus moves to an eccentric position (5). Presynaptic terminals on 
the chromatolytic neuron withdraw and are enwrapped by glial proccesses (6). The inputs to and targets of the 
injured neuron can atrophy and even degenerate (7,8). From Principles of  neural science 4
th
 edition by 
Kandel, Schwartz and Jessell. 
 
1.3 Differences between the peripheral and the central nervous system following nerve 
injury 
Brain and spinal injuries are one of the largest single causes of severe disability and loss of 
working days in the United Kingdom. Worldwide over a half million people each year 
suffer from brain damage and spinal cord injuries and the UK contributes a 1000 of   those 
cases. The majority of patients affected by nerve injury are young adult males, who 
represent around 70% of all the cases.  
The aetiology of nerve injury varies substantially among different countries. 
However, motor vehicle accidents are the most frequently implicated factor, followed by 
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falls and sport injuries. In most cases injury to the spinal cord is not fatal and life 
expectancy is not shorted when compared to the normal population. However, many people 
become disabled due to full or partial paralysis below the level of injury, resulting in a 
radical and sudden change in their way of life and becoming in numerous cases dependant 
on the help of others. Spinal cord injuries present serious consequences for the affected 
individual and despite major progress in the field cannot yet be repaired.  
 Most of the harmful outcome of spinal cord injury results from damage to axons 
that due to their length are in a more vulnerable position than other cell components. 
Injuries to axons in both the central nervous system (CNS) and peripheral nervous system 
(PNS) of mammals result
 
in axonal degeneration distal to the site of the lesion: a process 
known as Wallerian degeneration. Although neurons within the PNS have a remarkable 
ability to repair themselves after injury neurons within the central nervous system CNS do 
not spontaneously regenerate. To some extent the difference in regenerative potential 
between the PNS and CNS can in part be due to the permissive environment in the PNS, in 
which axons regenerate. This permissive environment consists of Schwann cells and their 
basal laminae, fibroblasts, collagen, and macrophages (Fawcett and Keynes, 1990; Fawcett 
and Keynes, 1986). Of all these components Schwann cells are essential for axonal 
regeneration (Hall, 1986). This is shown by the decrease of axonal growth when viable 
Schwann cells are absent from the area of injury (Smith and Stevenson, 1988). In the PNS, 
Schwann cells and macrophages are key players in Wallerian degeneration. Their main role 
is to pave the way to a permissive environment for axonal growth by helping eliminate the 
damaged and degenerated axons and myelin debris, also by secreting a diversity of 
proteins, including neurotrophic factors such as nerve growth factor (NGF) and brain 
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derived neurotrophic factor (BDNF) which are involved in axonal regeneration (Heumann 
et al., 1987; Acheson et al., 1991). 
  In the PNS, Schwann cells release a wide variety of chemokines and cytokines after 
injury; a number of these recruit macrophages to the degenerating nerve (Shamash et al., 
2002). Schwann cells secrete leukemia inhibitor factor (LIF) which attracts macrophages in 
vitro (Tofaris et al., 2002). Additionally, LIF and tumor necrosis factor-α (TNFα) induce 
production of macrophage chemoattractant protein-1 (MCP-1) by Schwann cells (Subang 
and Richardson, 1999). As previously mentioned, during the first few days post injury, 
Schwann cells clear myelin debris in the absence of macrophages to promote fast clearance 
of nerve debris in the PNS (Perry et al., 1995). Thereafter, macrophages are recruited from 
the circulation into the degenerating sciatic nerve by 3 days post axotomy (Perry et al., 
1987; Stoll et al., 1989), and macrophage numbers peak between 14 and 21 days after 
axotomy in the PNS (Avellino et al., 1995). Macrophages in the PNS mediate the final 
phase of myelin debris removal in the distal nerve stump. Post injury, macrophages enter 
the endoneural tubes at 5 days, and by 7 days post injury numerous macrophages are found 
within the basal laminar tubes  (Griffin et al., 1992). 
Conversely in the CNS, most macrophages present in the white matter early post 
injury are the resident microglia. Microglia numbers rise in response to injury 2–3 days 
later than do macrophages in PNS injury (Lawson et al., 1994). After DRG rhizotomy, it 
takes almost two weeks for microglia to express immunoreactivity for ED-1, a marker for 
activated macrophages (George and Griffin, 1994). Nonetheless these microglia clear 
disintegrating myelin only extremely slowly (Aldskogius, 1974). Another important 
difference in the response of the PNS and the CNS to injury is that the blood brain barrier is 
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disrupted at the site of injury but not along the entire length of the distal nerve tract as 
occurs in the PNS. The absence of blood brain barrier opening post injury may limit the 
infiltration of macrophages into degenerating CNS tracks (George and Griffin, 1994). 
In addition to the environmental factors exerting a positive effect on the 
regenerative capacity of neuronal axons in the PNS, it appears that intrinsic factors also 
play a pivotal role in regeneration. However, the molecular identity of such factors is far 
from known.  
In contrast to the PNS, axons injured inside CNS tracts normally fail to regenerate, 
independent of whether their cell bodies are located inside or outside the CNS. There is a 
wealth of data indicating that the CNS environment is inhibitory to axonal regeneration, 
particularly the non permissive environment generated by the scarring process that occurs 
around all CNS injuries, most predominant in the spinal cord (Fawcett and Asher, 1999). 
Additionally, the inhospitable glial environment of the CNS composed of astrocytes and 
oligodendrocytes results in CNS axons growing defectively (Fawcett et al., 1989a; Fawcett 
et al., 1989b). Consequently, it is becoming apparent that successful neuronal regeneration 
depends on signaling events and processes representing an interplay of inhibitory growth 
signals in the environment and the intrinsic growth capacity of the damaged neuron. 
Below I shall review the diverse inhibitory and permissive factors that exert 
different roles, both intrinsically and extrinsically, in the process of regeneration in the 
central and peripheral nervous system.  
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1.4 Inhibitory factors  
The inability of axons to regenerate after injury to the adult CNS could be the consequence 
of several factors including the formation of a glial scar, the absence of neurotrophic 
factors, the intrinsically reduced capacity for growth, or the presence of growth inhibitory 
molecules. There are several inhibitory molecules present in the injured CNS which gives 
rise to a less favourable environment for axonal regeneration, limiting the axon‘s ability to 
sprout,  growth, reach its target and restore functional synapses. Consequently injury to the 
CNS is in general irreparable. Axon inhibitory molecules can be categorized in different 
groups such as myelin associated molecules, components of the extracellular matrix and 
inhibitory molecules released by the glial scar.  
The myelin sheath is a membranous extension which encircles an axon in a 
multilayered concentric fashion. Myelin is composed of approximately 80% lipid and 20% 
protein. Some of the proteins that make up myelin are myelin basic protein (MBP), myelin 
oligodendrocyte glycoprotein (MOG), and proteolipid protein (PLP). Myelin serves as an 
electrical insulator which increases the speed of conducted action potential impulses via a 
process called saltatory conduction. In the PNS, myelin is produced by Schwann cells with 
a single Schwann cell myelinating a single axonal segment. In the CNS, however, 
myelination is performed by oligodendrocytes which send out projections that upon contact 
with an axon begin the new process of membrane extension and axonal envelopment. In the 
CNS a single oligodendrocyte can myelinate many axons. In both systems myelin is crucial 
for accurate signal propagation.  
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During the myelination process changes occur in the expression of myelin membrane 
proteins. The final phase of myelination also correlates with an abrupt drop in axonal 
sprouting and growth (Savio and Schwab, 1990; Kapfhammer and Schwab, 1994a; 
Kapfhammer and Schwab, 1994b). This loss of growth potential may be attributed to the 
expression of the myelin associated inhibitors of regeneration. Since these myelinated 
axons have already reached their targets prior to the end of the myelination process, it is 
believed that the myelin associated inhibitors may act to prevent unintentional sprouting 
and improper synapse formation. While this blockage of axonal growth by the inhibitors is 
essential following the end of development, it also has the adverse effect of blocking any 
efforts by damaged adult axons to regenerate after injury.   
 
1.4.1 Myelin associated molecules 
1.4.1.1 Nogo 
Studies performed by Schwab and co-workers during the mid-late 1980s examined CNS 
myelin‘s inhibitory properties and found that the main inhibitory components were 
membrane bound and associated with the protein fraction of CNS myelin. Subsequently, 
the inhibitory components of myelin were biochemically separated in sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) as 35-and 250 kDa proteins 
called initially neurite growth inhibitor NI-35 and NI-250. Interestingly, it has been shown 
that treatment of axons with NI-250 in vitro causes a rapid and large increase in growth 
cone calcium, which in turn leads to growth cone collapse (Bandtlow et al., 1993; Schwab 
et al., 1993). Furthermore, the application of the monoclonal antibody IN-1 raised against a 
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NI-35 and NI-250 showed a reduced inhibitory activity of myelin in vitro (Caroni and 
Schwab, 1988). The IN-1 antibody was then instrumental in the characterization and 
protein sequencing of its target antigen, which led to the cloning of what is today known as 
Nogo (Chen et al., 2000a; GrandPre et al., 2000; Prinjha et al., 2000).  
There are three Nogo isoforms, Nogo-A, -B and –C, encoded from a single gene by 
alternative splicing. The three Nogo isoforms contain a 66 amino acid extracellular region 
(Nogo-66) which displays neuron-specific growth inhibitory activity in vitro (GrandPre et 
al., 2000; GrandPre et al., 2002). During development Nogo-A mRNA is highly expressed 
in the ventral spinal cord, DRG and autonomic ganglia of both humans and rodents. In the 
adult, Nogo-A (in addition to the spinal cord and ganglia), is also highly expressed in 
oligodendrocytes and motor neurons. However, it is not expressed in astrocytes or Schwann 
cells (Josephson et al., 2001). Schwab and colleagues demonstrated that Nogo-A expressed 
mainly by oligodendrocytes is highly inhibitory for axonal growth (Savio and Schwab, 
1989; Savio and Schwab, 1989; GrandPre et al., 2000; Caroni et al., 1988).  
Several knock-out models targeting the three different isoforms have been generated 
but at the present there is a lack of consensus on the effect of the Nogo deletion. 
Regeneration studies performed on these animals have shown limited axonal repair (Kim et 
al., 2003; Zheng et al., 2003; Simonen et al., 2003). It has been shown that neutralization of 
Nogo-A inhibitory
 
activity with the IN-1 antibody permits some axons to regenerate. 
Curiously, this effect on regeneration was shown initially to be limited since only 5-10% of 
the axons regenerate (Schnell and Schwab, 1990; Bregman et al., 1995). Furthermore, the 
humanized anti-Nogo antibody promotes axonal sprouting and functional recovery 
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following unilateral transection of the cervical spinal cord in macaque monkeys (Freund et 
al., 2006; Freund et al., 2007).  
  
1.4.1.2 Myelin associated glycoprotein 
Another inhibitory molecule is the myelin associated glycoprotein (MAG) that is expressed 
in myelin forming cells, oligodendrocytes in the CNS and Schwann cells in the PNS. MAG 
appears to play a major role in myelination, it has the ability to inhibit the growth of many 
but not all types of axons and like Nogo, it is capable of causing growth cone collapse 
(Mukhopadhyay et al., 1994). MAG is a bifunctional protein that intriguingly can promote 
or inhibit neurite outgrowth depending on the neuronal age (Mukhopadhyay et al., 1994; 
Sheng et al., 1989; Turnley and Bartlett, 1998). For instance, it has been demonstrated that 
during development MAG does not impede axonal growth. While at a later stage, the 
neuron‘s response to the activity of MAG changes giving rise to an inhibitory reaction 
(DeBellard et al., 1996). Additionally, the effect of MAG on the growth cone depends on 
the level of cyclic adenosine monophosphate (cAMP). MAG is inhibitory when cAMP is 
low, normally in adult neurons, but it allows growth when cAMP is high, which is the case 
of young neurons (Cai et al., 2002; Cai et al., 2001; Cai et al., 1999) .  
In an effort to further elucidate the role of MAG in the inhibition of axonal 
regeneration, MAG knock-out mice have been generated. Myelin purified from these 
animals exhibits a reduced ability to inhibit axonal growth from primary neurons in vitro 
(Li et al., 1996; Shen et al., 1998). Additionally, MAG knock-out mice were cross-bred 
with Wld
s
 mice that have a delayed lesion-induced myelin degeneration following 
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peripheral nerve injury and which show impaired axonal regeneration (Brown et al., 1991). 
After peripheral nerve injury, analysis of MAG deficient/Wld
s
 mice revealed that the 
number of regrowing axons travelling along intact myelin sheaths doubled as compared to 
Wld
s
 mice expressing MAG, suggesting that the absence of MAG may contribute to the 
improved axonal regrowth in the double mutants (Schafer et al., 1996). The dramatic 
difference in the clearance of myelin debris could be attributed, at least in part, to the 
difference in regenerating ability seen between CNS and PNS neurons.   
 
1.4.1.3 Oligodendrocyte myelin glycoprotein 
Oligodendrocyte myelin glycoprotein (OMgp) is a 120 kDa highly glycosylated protein and  
the most recent myelin-associated molecule with inhibitory properties that has been 
identified (Kottis et al., 2002). OMgp has been found on neurons such as pyramidal cells in 
the hippocampus and cortical neurons (Mikol and Stefansson, 1988; Habib et al., 1998). 
OMgp is also expressed during fetal and post-natal brain development and its concentration 
peaks at the late stages of myelination (Mikol and Stefansson, 1988; Vourc'h et al., 2003a). 
OMgp induces growth cone collapse and inhibits axonal growth in vitro (Kottis et al., 2002; 
Wang et al., 2002b). OMgp contains a highly conserved leucine-rich repeat (LRR) domain 
which is required for proper receptor binding. Different studies have shown that the 
deletion of this LRR domain leads to a total loss of the OMgp inhibitory capacity in vitro 
(Vourc'h et al., 2003b).   
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1.4.2 Myelin inhibitor receptors  
Interestingly, Nogo, MAG and OMgp bind to the neuronal Nogo receptor (NgR) with high 
affinity (Fournier et al., 2001; Fournier et al., 2002; Wang et al., 2002b) see (Fig. 3). 
Binding requires the interaction with the p75 neurotrophin receptor (p75NTR) for 
mediation of the inhibitory signal (Wang et al., 2002a) that activates Rho-A, a GTPase 
member of the Rho family involved in growth cone collapse and the retraction
 
of neurites 
(Lehmann et al., 1999). Furthermore, inactivation of Rho-A with C3 enzyme can stimulate 
axonal outgrowth on MAG and myelin substrates (Lehmann et al., 1999). 
The expression pattern of NgR is consistent with a role in the inhibition of axonal 
regeneration. Transcripts are present mainly in the adult and maturing brain where NgR 
protein is found in many type of neurons but not in oligodendrocytes (Hunt et al., 2002) . 
Importantly, blocking studies on NgR and p75NTR independently have shown that the 
inhibitory effects of Nogo, MAG and OMgp can be reduced (Wang et al., 2002b; Wang et 
al., 2002a). Furthermore, NEP1-40, a peptide antagonist of NgR competes for binding of 
Nogo-66 to NgR (GrandPre et al., 2002). NEP1-40 which blocks Nogo, but not 
MAG/OMgp in vitro, has shown significant efficacy in promoting regeneration and 
recovery after experimental spinal cord injury (GrandPre et al., 2002).  
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Fig. 3 Nogo, MAG and OMgp all interact with Nogo receptor to bring about inhibition of neurite 
outgrowth: Modified from Filbin M, Nature Reviews Neuroscience 4, 703-713. NgR contains two regions of 
LRRs — a cluster of eight together, and a series closer to the carboxyl terminus. NgR interacts with p75NTR to 
transduce the inhibitory signal across the membrane. Nogo, Mag and OMgp all activate Rho to bring about 
inhibition. Mag has been shown to inactivate Rac, but it is not known whether this effect is required for 
inhibition.  
 
NgR does not possess intracellular signalling domains and therefore require co-receptors to 
transduce inhibitory activity. The low-affinity neurotrophic factor receptor, p75NTR, has 
been reported to transduce growth inhibitory signals through a membrane complex 
involving NgR1 (Wang et al., 2002a). During early development p75NTR is expressed in 
many types of cells within the CNS and PNS (Ryffel and Mihatsch, 1993). Injury to the 
nervous system induces p75NTR expression in many cells types.  
 
1.4.3 Components of the extracellular matrix 
The extracellular matrix represents the environment for numerous inhibitory molecules that 
exert their effect on axons during elongation processes immediately after injury. One of the 
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most prominent members in this category is Tenascin R, present in the basement membrane 
and in white matter. It is produced by astrocytes during development and with important 
roles in mediating axonal-glia interactions (Lochter et al., 1991; Faissner and Kruse, 1990). 
Tenascin R is upregulated after axonal injury (Laywell et al., 1992) and it has been shown 
to be inhibitory for axonal growth (Pesheva et al., 1989). 
Damage to the CNS results in an injury response mechanism that ultimately after 
several weeks results in the formation of a glial scar, this process is also known as gliosis. 
This glial scar formation represents a major obstacle to the regeneration of axons. Several 
studies indicate that glial scars can inhibit both axon growth and myelination. Throughout 
gliosis, different cell types become involved and recruited to the injury site at different time 
points presenting a variable environment for growing axons. This can be supportive during 
early stages post-injury or inhibitory by the end of the glial scar formation (Kreutzberg, 
1996). Initially, within hours after injury microglia cells and macrophages from the 
bloodstream will enter the CNS lesion and 3-5 days after injury oligodendrocyte precursors 
are recruited particularly to demyelinated areas of a CNS injury. These cells correspond to 
a major source of inhibition for axonal growth in the injured CNS since they express a wide 
variety of inhibitors such as NG2 proteoglycans (Dou and Levine, 1994),  neurocan (Asher 
et al., 2000) and versican (Asher et al., 2002). If the injury penetrates the meningeal surface 
of the brain or spinal cord, meningeal cells will migrate to the injury site immediately after 
oligodendrocyte precursor cells arrival. Meningeal cells have been described also as 
inhibitory since they produce the non-permissive molecules NG2 proteoglycan (Levine and 
Nishiyama, 1996) and tenascin (Faissner, 1997). 
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Ultimately, the glial scar‘s final organization consists principally of tightly packed and 
interconnected astrocytes which are also inhibitory to axon growth. Astrocytes and 
oligodendrocyte precursors account for the production of the inhibitory chondroitin 
sulphate proteoglycans (CS-PGs), neurocan, brevican, and NG2 (Rhodes and Fawcett, 
2004; Friedlander et al., 1994). Furthermore, it has also been suggested by electron 
microscopy studies that the structural organisation of the astrocyte processes are tightly 
interlinked, making the astrocytic scar impenetrable and physically impossible for axons to 
cross. CS-PGs consist of a core glycoprotein (neurocan, versican, NG2, brevican, 
phosphacan, aggecan and biglycan) attached to sulphated glycosaminoglycan (GAG) sugar 
chains. CS-PGs become highly upregulated in the CNS lesion site (Fitch and Silver, 1997; 
Snow et al., 1990). Interestingly it has been demonstrated that axonal re-growth in the 
injured CNS is prevented around the areas where CS-PG is expressed (Davies et al., 1997).  
Additionally CS-PGs have been implicated in axonal regenerative failure after 
injury in vitro (Niederost et al., 1999) and in vivo (Davies et al., 1999). A related series of 
observations showing the inhibitory effects of CS-PGs on axonal growth has been made 
during neuronal development where chondroitin sulphate GAGs (CS-GAG) function as 
repulsive cues for elongating axons (Kubota et al., 1999). Conversely, inhibition of CS-
PG‘s negative effect on axonal growth can be partially overcome by using chondroitinase, 
an enzyme that digests CS-GAG sulphate chains. This treatment on gliotic tissue in CNS 
lesions has been demonstrated to be favourable to some extent for axonal regeneration and 
recovery of function (Bradbury et al., 2002; Moon et al., 2001). However, this beneficial 
effect on axonal regeneration is not nearly equivalent with axonal regeneration observed in 
the PNS. Even though the mechanism by which CS-PGs exert their inhibitory action on 
37 
 
axonal growth is still not well understood, some indications demonstrate that GAG chains 
are responsible in great part for this effect which is dependent on GAGs sulfation pattern 
(Clement et al., 1998). In vitro studies indicate that if GAG sulfation is avoided then most 
of its inhibitory effect is reduced (Smith-Thomas et al., 1995). However, CS-PG protein 
cores are also involved in axonal growth inhibition. Interestingly, some evidence suggests 
that the growth inhibitory effects of CS-PGs in the glial scar appear to be mediated by 
activation of protein kinase C (PKC) and via a signalling pathway which, like NgR-
p75NTR pathway utilizes the small GTPase Rho and its downstream effector, ROCK 
(Dergham et al., 2002; Borisoff et al., 2003; Sivasankaran et al., 2004). Rho in its active 
form has a negative effect on the actin cytoskeleton, thereby inhibiting axonal elongation 
and mediating growth cone collapse (Borisoff et al., 2003). 
 
1.5 Neurotrophins and cytokines  
One common effect of axonal insult is the variation in the accessibility of target-derived 
neurotrophic growth factors. Following injury, the axotomized neurons lose connection 
with their targets and consequently they no longer receive any target-derived neurotrophic 
factors. Interestingly, Schwann cells in the peripheral damaged area continue making some 
of these factors. However, this compensatory production of neurotrophic factors is not 
sufficient to replace normal factors derived from their targets (Heumann et al., 1987). These 
neurotrophic factors include NGF, brain-derived neurotrophic factor (BDNF), 
neurotrophin-3 (NT-3) and neurotrophin 4/5 (NT 4/5). This group of neurotrophic factors 
exert their effects through binding specifically to tyrosine kinase receptors (trk). It is known 
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that NGF interacts with trkA, BDNF and NT 4/5 with trkB and NT-3 with trkC (Fig. 4). All 
these three high-affinity receptors are expressed within DRG (McMahon et al., 1994; 
Kashiba et al., 1995; Wright and Snider, 1995). Additionally, both NGF and its receptors 
are produced during development, adult life, and aging by many cell types in the CNS and 
PNS, immune and inflammatory system. In addition to trk A, B and C, a low affinity cell 
surface receptor, p75 neurotrophin receptor, binds and mediates the cellular response to 
NGF and BDNF (Lindsay, 1994; Chao and Hempstead, 1995; Friedman and Greene, 1999). 
During embryonic development sensory neurons require a sufficient supply of these factors 
in order to survive and maturate. However, after birth these factors are no longer needed for 
neuron survival.  
In vitro overnight treatment, ―priming‖, of neurons with NGF and BDNF is another 
way to increase cAMP levels. Neurotrophins can initiate an intracellular signalling cascade 
that prevents cAMP degradation. Neurotrophin binding to trk receptors leads to 
autophosphorylation of the receptor and activation of extracellular signal-regulated kinase 
(ERK) resulting in the inhibition of the phosphodiesterase (PDE4) (Kaplan and Miller, 
2000). As mentioned before, inhibition of phosphodiesterase leads to cAMP elevation by 
preventing its degradation. Subsequently, by blocking the activation of ERK, the improved 
regeneration observed after cAMP increase in vitro is abolished (Gao et al., 2003).    
NGF signalling has also been demonstrated to regulate the expression of CREB 
through the cAMP-PKA pathway (Finkbeiner, 2000) which has been previously reported to 
be involved in neuronal regeneration. Additionally it has been demonstrated in vitro that 
NGF expression by Schwann cells is upregulated by cytokines and other inflammatory 
mediators (Lindholm et al., 1987; Mirsky and Jessen, 1999). 
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In the adult nervous system neurotrophic factors are suggested to have a neuroprotective 
activity on severely injured or degenerating neurons. For instance, in adults, NGF 
expression is undetectable in Schwann cells, but after nerve insult, Schwann cells distinctly 
upregulate expression of NGF in vivo. Additionally, following nerve injury retrograde 
axonal transport of NGF is transiently downregulated 10-fold for nearly 48hrs (Raivich et 
al., 1991). NGF withdrawal induces axotomy-like effects in the uninjured, NGF sensitive 
sensory and sympathetic neurons, predominantly when it comes to the expression of 
transcription factors such as c-jun (Gold et al., 1993) and different neuropeptides including 
galanin, vasoactive intestinal peptide (VIP), substance P (SP), calcitonin gene-related 
peptide (CGRP) and neuropeptide Y (NPY) (Shadiack et al., 2001).  
However, unlike the traditional view of NGF effects in vitro and in developmental 
studies where treatment with NGF has been shown to promote neurite outgrowth (Levi-
Montalcini and Angeletti, 1968) the effects of NGF in vivo remains controversial. 
On one side intriguing observations suggest that treatment with NGF, NT-3, or glial 
cell derived neurotrophic factor (GDNF) can be successful in promoting sprouting of axons 
by regulating the intrinsic capacity of neuronal regeneration in the damaged spinal cord 
(Ramer et al., 2000). In addition, functional regeneration of chronically injured sensory 
afferents into adult spinal cord after neurotrophin gene therapy found that adenoviral gene 
transfer of NGF or FGF2 promoted functional regeneration of sensory axons into the spinal 
cord following dorsal root injury (Romero et al., 2001). Similarly, intrathecal 
administration of BDNF in conjunction with transplantation of embryonic spinal cord tissue 
into damaged spinal cord resulted in marked enhancement of axon growth from descending 
tracts beyond the lesion, leading to partial functional recovery (Coumans et al., 2001).  
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On the other hand, it has been shown that the application of NGF to axotomized neurons 
causes a delay in axonal regeneration (Hirata et al., 2002; Gold, 1997). Additionally, some 
experiments associate the NGF treatment with development of hypersensitivity to 
nociceptive stimuli in form of allodynia and hyperalgesia (Petty et al., 1994; Shu and 
Mendell, 1999). Interestingly, NGF deprivation by the use of specific antibodies prevents 
hyperalgesia (McMahon et al., 1995).  
These reports from different sources indicate that treatment with NGF although may 
be beneficial after nerve injury for the survival of neurons and sprouting of axons may have 
limited potential to translate into human trials due to its influence on pain. 
 
 
Fig. 4 The trk family of neurotrophins receptors: All neurotrophins bind to one or more receptor of the Trk 
protein family. (Tyrosine receptor kinase, TrkA, B, C) Trk receptors are a small subfamily consisting of three 
members out of the large superfamily of several hundred proteins with tyrosine kinase enzymatic activity that 
also includes receptors for epidermal growth factor (EGF), insulin, fibroblast growth factor (FGF), platelet 
derived growth factor (PDGF) and numerous other growth factors. The Trk receptor tyrosine kinases are 
characterized by a specific combination of structural motives: In their extracellular domains: three tandem 
repeat leucine-rich motives are flanked by two cysteine clusters. The main contacts between the Trk receptors 
and their ligands occur within two Ig-like C2 type domains. The protein sequences of the intracellular, 
enzymatically active, tyrosine kinase domains are highly conserved in the three receptors. The neurotrophins 
NGF, NT-3, BDNF and NT 4/5 bind to the Trk receptors with strong (thick arrows) and weak interactions 
(thin arrows). From (Dechant, 2001). 
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Interleukin – 6 (IL-6), LIF, ciliary neurotrophic factor (CNTF), cardiotrophin-1 (CT-1) are 
structurally and functionally related cytokines which have been defined as neuropoietic 
cytokines (Heinrich et al., 2003). Previously, it has been shown that neuropoietic cytokines 
promote survival of various populations of embryonic and newborn neurons, including 
sensory and motor neurons (Sendtner et al., 1996; Simon et al., 1995; Horton et al., 1998).   
Both LIF and IL-6 are strongly upregulated after sciatic nerve transection (Murphy 
et al., 1995) and some injury responses are lost in LIF -/- or IL-6 -/- mice (Kurek et al., 
1996; Zhong et al., 1999; Cafferty et al., 2004; Cafferty et al., 2001). For example, both LIF 
-/- and IL-6 -/- mice display reduced peripheral nerve regeneration (Zhong et al., 1999; 
Cafferty et al., 2001). Additionally, without IL-6 or LIF the intrinsic growth capacity of 
DRG neurons is significantly reduced in vitro and in vivo (Cafferty et al., 2004; Cafferty et 
al., 2001; Inserra et al., 2000).  
IL-6 upregulation following peripheral axotomy has been correlated with 
accelerated peripheral nerve regeneration (Hirota et al., 1996). Additionally, IL-6 
expression is also increased after CNS injury (Gadient and Otten, 1997), however, high 
levels of IL-6 could also exacerbate the inflammation that occurs after spinal cord injury 
and lead to increased cell death  (Gadient and Otten, 1997). 
CNTF is an abundant cytosolic molecule in myelinating Schwann cells of adult 
rodents and after nerve lesion CNTF mRNA and protein levels are reduced in distal regions 
of the sciatic nerve and then increase concomitantly with regeneration (Sendtner et al., 
1992b). In response to nerve injury, CNTF is transported axonally at an increased rate to 
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the neuronal cell body (Curtis et al., 1993). CNTF supports survival and/or differentiation 
of a variety of neuronal cell types including sensory, sympathetic, and motoneurons. Also, 
non-neuronal cells, such as oligodendrocytes, microglial cells, liver cells, and skeletal 
muscle cells, respond to exogenously administered CNTF, both in vitro and in vivo. Due to 
the fact that CNTF -/- mice appear remarkably normal and display only mild motor neuron 
problems and that the expression of CNTF is altered by nerve injury in the CNS or PNS, 
suggest that CNTF does not play a critical role in development of the nervous system but 
does play a role in the injury response of the nervous system (Ip, 1998; Seniuk et al., 1992; 
Sendtner et al., 1997; DeChiara et al., 1995). Additionally, in vivo, CNTF rescues several 
kinds of neurons from axotomy-induced death (Richardson, 1994). 
 
1.6 Intrinsic factors involved in axonal regeneration 
Axonal regeneration is influenced not only by inhibitory cues, but also by permissive 
neuronal factors such as second messengers, regeneration associated genes, transcription 
factors, growth associated proteins, cytoskeletal proteins, growth factor, their different 
receptors and cytokines. Therefore, the final outcome in nerve regeneration reflects an 
interaction between the growth ability of the neurons and different signalling pathways 
responsive to the non-permissive environment. These pathways are fully exemplified by 
regeneration of the somatosensory
 
system.  
Each segment of the spinal cord has a sensory dorsal root and motor ventral root 
(Fig. 5). The prime function of the spinal dorsal roots and their cranial equivalents is to 
serve as afferent conduits to the central nervous system. The primary afferent fibres are 
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sensory neuronal peripheral branches, which terminate in the skin or other peripheral 
tissues. Primary sensory neurons also have central branches, which end in the dorsal horn 
of the spinal cord. The cell bodies of the neurons that innervate the head and body areas are 
located in the trigeminal and dorsal root ganglia (DRG), respectively.  
Sensory axons have their cell bodies in the DRG, which have an axon which divides 
into two branches, the first targeting the PNS and another branch entering the CNS at the 
dorsal root entry zone (DREZ). Due to this particular anatomical organization of the DRG, 
it is possible to perform studies in order to directly compare CNS and PNS regeneration 
and also to determine whether it is the inability of the axon or the inhibitory surrounding of 
the CNS environment that inhibit regeneration. Nerve injury leads to a vigorous axonal 
regeneration when the injury is elicited in the peripheral branch; in contrast a nerve lesion 
on the central branch extending into the dorsal column of the spinal cord results in a failure 
in regeneration. Interestingly, if the peripheral
 
branch is injured at a time point before the 
central branch, regeneration of the central axons can be enhanced (Neumann and Woolf, 
1999; Richardson and Issa, 1984; Richardson and Verge, 1986). This effect is called the 
conditioning lesion.  
The capability of a conditioning peripheral lesion to induce regeneration of central 
dorsal column axons has previously been documented. The first studies described improved 
growth after a conditioning lesion of dorsal column axons into a peripheral nerve graft 
(Richardson and Issa, 1984). Recent studies have shown that a conditioning lesion can 
induce regeneration of dorsal column axons in the absence of a peripheral nerve graft 
(Neumann and Woolf, 1999).  
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Fig. 5 Anatomical organization of the spinal cord and the dorsal root ganglion: Red colour illustrates the 
sensory tract whereas blue colour illustrates the motor pathway.  Taken from McDonald J, Scientific 
American, September, 1999. 
 
1.6.1 Cyclic AMP 
The molecular mechanisms responsible for the conditional lesion effect were not well 
understood until it was discovered that the levels of a second messenger, cAMP become 
elevated following a conditioning lesion, allowing neurons to grow on MAG and myelin 
(Qiu et al., 2002; Neumann et al., 2002). Twenty four hours after a sciatic nerve injury, 
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cAMP levels in DRG neurons are upregulated three-fold. This effect depends on protein 
kinase A (PKA), a downstream effector of cAMP. By 1 week post lesion, cAMP levels in 
DRG neurons return to control, but growth on MAG/myelin improves and is now PKA 
independent. To address if the ability of mature DRG neurons to grow on MAG and myelin 
after a conditioning peripheral lesion is dependent on cAMP, an inhibitor of protein PKA, 
was injected into DRGs at the same time as the conditioning lesion. PKA inhibition blocks 
completely the improved growth on MAG and myelin 1 day later and attenuates growth 
after one week (Qiu et al., 2002). Additionally, dibutyryl cAMP (dbcAMP), a non-
hydrolyzable cAMP analogue, was injected into DRGs 1, 2 or 7 days before plating the 
neurons on myelin. The result showed that neurite outgrowth was significantly increased, 
demonstrating that cAMP has the capacity to mimic the conditioning lesion effect in vitro 
in a PKA-dependent manner that becomes PKA independent (Qiu et al., 2002; Neumann et 
al., 2002) see (Fig. 6). Additionally, administration of dbcAMP overcomes inhibition by 
MAG and myelin in different neuronal subtypes, including cerebellar, cortical, and 
hippocampal neurons (Cai et al., 1999).  
 The therapeutic potential of cAMP has also been assessed in studies of spinal cord 
injury. This has been done by elevating cAMP levels through the application of rolipram, a 
phosphodiesterase inhibitor that blocks cAMP degradation and induces an increase in 
cAMP levels in vitro and post-injury in vivo improving regeneration and functional 
recovery (Nikulina et al., 2004; Pearse et al., 2004). Rolipram treated animals also showed 
a decreased expression of glial fibrillary acidic protein (GFAP) indicating a reduced glial 
scarring (Nikulina et al., 2004). As mentioned before the glial scar is another major 
contributor to regenerative failure, forming both a physical and biochemical barrier to 
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regenerating axons. These results suggest that astrogliosis can be reduced through elevation 
of cAMP, which could enhance axonal regeneration by making the CNS environment more 
permissive. 
Rolipram has the added advantage of being able to cross the blood-brain barrier, 
which makes subcutaneous and oral administration possible (Krause and Kuhne, 1988) 
alleviating the need for invasive surgery that could cause further damage to the spinal cord. 
This makes Rolipram a logical attractive drug for potential therapeutic intervention. 
 
  Fig. 6 Elevation of cAMP mimics the effects of a peripheral conditioning lesion on dorsal column 
regeneration: From Filbin M, Nature Reviews Neuroscience 4, 703-713. 
In a conditioning lesion the peripheral branch of the DRG is lesioned 1, 2 or 7 days before carrying out the 
measurements as described. To elevate cAMP, dibutyryl cAMP (db-cAMP) was injected directly into the 
dorsal root ganglion cell bodies in the absence of a peripheral lesion, and the animals were left for 1, 2 or 7 
days before carrying out the assays/measurements as described. By day 7 cAMP-induced neurite outgrowth 
becomes PKA-independent post-lesion and post-injection. ArgI, Arginase I; CNS, central nervous system; 
MAG, myelin-associated glycoprotein; PKA, protein kinase A; PNS, peripheral nervous system. + indicates 
expression or regeneration relative to untreated/unlesioned. Control indicates background levels. 
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It has also been shown by other groups that the increase of cAMP levels is involved in a 
variety of neuronal processes including memory and learning (Alberini et al., 1995), 
neuronal survival (Hanson, Jr. et al., 1998),  neurite outgrowth (Kao et al., 2002), axonal 
regeneration (Teng and Tang, 2006), axonal growth cone turning and developmental 
guidance (Song et al., 1997). 
It is known that MAG can induce a low-level gradient of intracellular calcium 
within the growth cone leading to a repulsive turning response (Henley et al., 2004). 
Interestingly, by administration of cAMP analogues calcium levels can be further 
increased. This can subsequently convert MAG-mediated repulsion to attraction (Henley et 
al., 2004; Henley and Poo, 2004). 
It is normally accepted that embryonic neurons are capable of extending long axons, 
both during development or following axotomy at the embryonic stages. Consequently, 
cAMP studies have revealed that the cAMP levels of embryonic neurons are significantly 
higher than that of their adult counterparts, and that this elevation can account for the 
ability of these neurons to extend processes in the inhibitory CNS environment (Cai et al., 
2001). Furthermore, the loss of regenerative capacity which occurs postnatally correlates 
with a decrease in endogenous cAMP levels. Even in neuronal types which retain their 
regenerative abilities in the neonatal stages, cAMP levels appear to remain high until the 
developmental switch occurs (Cai et al., 2001).   
While cAMP has many different roles in a variety of signalling pathways in 
neuronal cells, the artificial increase of cAMP alone may not be a satisfactory therapeutic 
approach. Therefore, it is necessary to understand the entire complexity of the cAMP 
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signalling pathway; particularly the downstream effectors and cAMP-regulated genes that 
might mediate this improved regenerative capacity. Understanding these events may 
present yet another potential target for therapeutic intervention, which in combination with 
other approaches could hopefully encourage regeneration in adults.  
The intracellular second messenger cAMP is produced close to the cytoplasmic 
surface of the plasma membrane in response to a variety of extracellular
 
signals, including 
hormones, growth factors, and neurotransmitters. These signal molecules bind to a surface 
receptor to activate adenylyl cyclase through a trimeric stimulatory G protein. Active 
adenylyl cyclase catalyses the synthesis of cAMP from ATP, which upon formation binds 
to the regulatory subunits of PKA (Fig. 7). PKA is normally inactive as a tetrameric 
holoenzyme, consisting of two catalytic and two regulatory units (C2R2), with the 
regulatory units blocking the catalytic centres of the catalytic units.  cAMP binds to specific 
locations on the regulatory units of the protein kinase, and causes dissociation between the 
regulatory and catalytic subunits, thus activating the catalytic units and enabling them to 
phosphorylate substrate proteins. 
 The activated catalytic subunits of PKA are imported to the nucleus due to a 
putative nuclear localization signals in their amino acid sequence that facilitate passage 
through nuclear pores. In the nucleus, the activated kinase subunits phosphorylate cAMP 
response element binding protein (CREB) and other transcription factors. CREB binds to 
the 5′ untranslated regions of genes that contain a cAMP-response element (CRE) and, 
upon phosphorylation, initiates a cascade of gene expression. Normally the action of the 
kinase ceases when the cAMP is removed by enzymatic degradation by phosphodiesterase. 
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In the absence of cAMP, the catalytic subunits again become inhibited by re-association 
with regulatory subunits (Schwartz, 2001). 
It has been demonstrated that cAMP acts on the downstream effector PKA to 
mediate its biological function. A possible mechanism of cAMP-induced activation of PKA 
on the ability to overcome MAGs inhibitory effect on neurite outgrowth is the 
phosphorylation and the subsequent inhibition of Rho GTPase signalling pathway, which is 
involved in growth cone collapse (Lang et al., 1996; Lehmann et al., 1999).  
 
Fig. 7 cAMP signalling cascade leading to the activation of PKA: cAMP is a second messenger, used for 
intracellular signal transduction, such as neurotrophic factors, which cannot get through the cell membrane. 
cAMP is used by a major class of G proteins. cAMP is synthesised from adenosine triphosphate (ATP) by 
adenylyl cyclase which is embedded in the plasma membrane with the enzymatic activity in the cytoplasm. 
Adenylyl cyclase is activated by binding a subunit of the Gs G-protein (GTP-Gs). Protein kinase A (PKA), a 
cAMP-dependent kinase, is the main intracellular target of cAMP. Active PKA can further phosphorylate a 
number of proteins. Taken from Biology (Fifth Edition) by Campbell, Reece, and Mitchell. 
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Another signalling component that has been suggested to be involved in the regeneration 
promoting signal is the transcription factor CREB which is activated by elevated levels of 
cAMP (Lonze and Ginty, 2002). Indeed, recent evidence indicates that the phosphorylation 
and activation of CREB is a vital part of cAMP-mediated axonal growth (Gao et al., 2004). 
Upon treatment of cerebellar neurons with dbcAMP, CREB phosphorylation occurs within 
5 minutes, and peaks by 1 hour after treatment (Gao et al., 2004). CREB activity is essential 
for overcoming inhibition by MAG and myelin. Expression of dominant negative CREB in 
DRG and cerebellar neurons blocks the ability of dbcAMP to overcome inhibition, whereas 
constitutively active CREB promotes neurite outgrowth on MAG in the absence of elevated 
cAMP in vitro (Gao et al., 2004). Furthermore, adenoviruses expressing constitutively 
active CREB have been injected into DRG neurons of adult rats prior to a dorsal column 
lesion 4 days later. The results showed a significant regeneration of axons into the lesion 
site in animals expressing constitutively active CREB (Gao et al., 2004). These findings 
suggest that activation of CREB is sufficient to promote axonal regeneration, indicating 
that the activation of CREB by cAMP leads to the transcription of genes that are involved 
in overcoming myelin inhibition.  
  One cAMP regulated gene that has been involved in overcoming inhibition by 
myelin is arginase I (Arg I).  It has been shown that exogenous application of Arg I is 
neuroprotective against apoptosis-inducing stimuli in cortical neurons in vitro (Esch et al., 
1998). During post-natal development, Arg I expression level in DRG neurons drops 
spontaneously between P3 and P5 and remains
 
at a low level coinciding with cAMP decline 
and the onset of myelin inhibition (Cai et al., 2002). The elevation of cAMP leads to an 
upregulation of Arg I and the subsequent synthesis of polyamines, which overcome 
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inhibition of axonal regeneration by MAG/myelin (Fig. 8). Priming with polyamines and 
overexpression of Arg I using an adenoviral construct carrying
 
the Arg I cDNA can block 
MAG/myelin-induced inhibition of regeneration (Cai et al., 2002). Conversely, blocking 
Arg I/polyamines abrogate the cAMP mediated regenerative increase (Cai et al., 2002).  
 
Fig. 8 Possible cAMP pathways involved in axon regrowth and neuronal survival: Modified from (Cui 
and So, 2004). Elevation of cAMP can influence neuronal survival and axonal regrowth via multiple signaling 
cascades in the nervous system. The primary signaling transduction executor is PKA, which acts on various 
pathways, including MAPK/ERK upregulation of c-Jun, Rho inactivation by p75 translocation into lipid rafts 
and upregulation of CREB and Arginase I/polyamines. These actions result in enhanced neuronal survival and 
axon regrowth potential and/or overcome axon growth inhibition. 
 
1.6.2 Regeneration associated genes 
The ability of neurons to regenerate an axon after injury is determined by both the 
surrounding environment and factors intrinsic to the damaged neuron. It is known that 
different neurons respond in various ways to the same environment and that injury induces 
changes in the axonal growth capacity of an injured neuron. Presumably, this is attributable 
to the induction of neuronal regeneration associated genes by peripheral axotomy. 
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To elucidate which regulated genes are involved in axonal regeneration in vitro and in vivo 
functional examination as well as cellular localisation and distribution of gene products has 
been performed. The majority of these experiments have involved conditioned DRG 
neurons where the regenerative propensity of DRG neurons after peripheral nerve injury is 
associated with changes in expression of numerous genes. Here below I shall discussed four 
regeneration associated genes, which are upregulated following nerve axotomy (Bonilla et 
al., 2002; Mason et al., 2002; Skene and Willard, 1981; Livesey et al., 1997). 
   
 
1.6.2.1 GAP-43 and CAP-23 
One of the most prominent regeneration associated genes involved in axonal regeneration is 
the growth associated protein of 43kDa (GAP-43), an acidic membrane protein that, along 
with cytoskeleton-associated protein of 23 kDa (CAP-23) and MARCKS (myristoylated 
alanin-rich C kinase substrate), belong to the MARCKS family and code for components of 
the axonal growth cone which are major protein kinase C (PKC) substrates. These three 
molecules, sharing similar structural and functional features, can regulate actin dynamics 
through modulating the accessibility of phosphatidylinositol 4,5-bisphosphate (PIP2) at 
plasmalemma rafts (Laux et al., 2000). 
GAP-43 is expressed at high levels in both central and peripheral neurons in the 
embryo but levels decline with maturation and aging (Skene, 1989a; Biffo et al., 1990). 
GAP-43 is also highly expressed on the surface of the growth cones of growing and 
successfully regenerating axons and it is expressed at low levels in neuron cell bodies 
(Chong et al., 1994; Meiri et al., 1988).  
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Peripheral nerve injury induces robust re-expression of GAP-43 but this upregulation is 
only seen in CNS neurons when the axon is injured close to the cell body (Tetzlaff et al., 
1994). The upregulation of GAP-43 is associated with the activation of the interleukin-6 
(IL-6)/ glycoprotein 130 (gp130)/Janus kinase signalling cascade, whilst IL-6 induces 
GAP-43 in rat pheochromocytoma cells (PC12) (Marz et al., 1997). While null deletion of 
IL-6 or sustained perineural infusion of the Janus kinase (JAK) inhibitor AG490 blocks 
upregulation of GAP-43 and compromises neurite outgrowth in the PNS (Qiu et al., 2005; 
Cafferty et al., 2004). Overexpression of GAP-43 in adult neurons enhances nerve 
sprouting with growth cones (Caroni 1997). However, GAP-43 alone is not sufficient to 
elicit regeneration of CNS axons. These results can be interpreted to imply that GAP-43 is 
important in the generation of growth cones but this is not enough for a successful 
induction of nerve repair (Mason et al., 2000).  
CAP-23 also known as BASP1 and NAP-22 is expressed in several tissues but is 
particularly abundant in neurons during brain development, accounting for approximately 
0.5% of the total amount of brain protein. The expression of the protein is maintained in 
selected brain structures throughout adulthood (Mosevitsky et al., 1994; Carpenter et al., 
2004; Van den Bogaerdt et al., 2004) and up-regulation is observed in neurons during nerve 
regeneration (Mosevitsky, 2005). Furthermore, overexpression of CAP-23 in PC12E2 cells 
and primary hippocampal neurons stimulates neurite outgrowth in both cell types (Frey et 
al., 2000). Interestingly, GAP-43 co-expressed together with CAP-23 can induce axonal 
elongation by DRG neurons in vitro and it can enhance regeneration of central DRG axons 
into a peripheral nerve graft in adult mice after spinal cord injury in vivo(Bomze et al., 
2001).  This regenerating effect in the CNS is about one-third of what is normally seen with 
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a conditioning peripheral nerve injury (Bomze et al., 2001). In contrast, mice that are GAP-
43 deficient show defects in axonal pathfinding and suppression of GAP-43 expression via 
antisense oligonucleotides disrupt growth cone formation, spreading, branching and 
adhesion (Strittmatter et al., 1995; Aigner and Caroni, 1995).  
 
1.6.2.2 SPRR1A 
Small proline-rich repeat protein 1A (SPRR1A) is an 18kDa protein consisting of 30% 
proline
 
residues that belongs to the multigene SPRR family of keratinocyte differentiation 
markers which also include S100C and p21/wildtype p53 activator 1 (Gibbs et al., 1993; 
Starkey et al., 2009).  Neuronal expression of SPRR1A was first detected in a microarray 
analysis of genes induced during successful sciatic nerve regeneration in the mouse 
(Bonilla et al., 2002). Unlike GAP-43, which is expressed during development and 
constitutively by some cells in the adult (Skene, 1989b), there is no expression of SPRR1A 
during development or in naïve uninjured cells (Bonilla et al., 2002).  
SPRR1A induction is slightly upregulated in DRG neurons 1 day after peripheral 
sciatic nerve crush (Bonilla et al., 2002) and sciatic nerve transection (Starkey et al., 2009) 
but is drastically upregulated by 3-4 days, reaching maximal levels of expression at 7-14 
days. However, while SPRR1A expression was reduced to negligible levels by 30 days 
after sciatic crush injury, SPRR1A was still expressed by a significant proportion of DRG 
neurons following transection (Starkey et al., 2009; Bonilla et al., 2002). Although there is 
a minimal expression following injury to the centrally projecting branches of DRG neurons, 
SPRR1A expression has also been detected following peripheral sciatic nerve injury in the 
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spinal cord by 1 week and in the terminals of DRG neurons in the dorsal horn and in 
motoneurons in the ventral horn (Starkey et al., 2009). These observations are similar to 
GAP-43 expression in the adult rat following injury, where virtually all injured DRG 
neurons are known to upregulate GAP-43 following peripheral nerve injury, but levels do 
not change following injury to central DRG projections (Schreyer and Skene, 1993; 
Bradbury et al., 2002). By using double immunofluorescence to show the extent of co-
expression of SPRR1A with three markers for DRG subpopulation CGRP, IB4, and NF200, 
it was found that SPRR1A is expressed in all three DRG cell populations following either 
crush or transection of the sciatic nerve (Starkey et al., 2009).  
SPRR1A localizes selectively to filamentous actin (F-actin)-rich structures and not 
others. The selective localization suggests that SPRR1A stimulates axonal extension by 
regulating actin-based motility in growth cone ruffles. In ruffles but not stress fibres, 
SPRR1A is co-localized with one another and F-actin, indicating that these co-induced 
proteins co-ordinately modulate actin dynamics. Overexpression of SPRR1A can induce 
large increases in neurite outgrowth in adult DRG neurons, SPRR1A shifts adult sensory 
neurons from a branching to an elongating mode of growth, and blockade of SPRR1A 
decreases the outgrowth potential of preconditioned adult neurons (Bonilla et al., 2002). 
Previous work has shown that SPRR1A is regulated by the gp130 signalling 
pathway in the heart. SPRR1A is upregulated by cytokines such as LIF and CT-1 that act 
upon the receptor signalling subunit gp130 which transduces the signal through, janus 
kinases (JAKs) into 3 different pathways MAP kinases (MAPKs), signal transducers and 
activators of transcription 3 (STAT3), and phosphatidylinositol 3-kinase (PI-3K) pathways. 
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Additionally binding sites for C/EBP and c-Jun were identified in the SPRR1A promoter 
region (Pradervand et al., 2004) see (Fig. 9).  
 
 
Fig. 9 SPRR1A activation in the myocardium: In response to myocardial injuries, IL-6 cytokines are 
released and act on the surrounding cells (left panel). The binding of IL-6 cytokines (CT-1, LIF) to 
gp130/LIFR receptor complex activates STAT3, PI-3K, and MAPK signalling pathways (right panel). A 
MAPK signalling pathway activates the transcription factors C/EBPβ and (activator protein -1) AP-1. In turn, 
they bind to SPRR1A promoter and induce SPRR1A gene transcription. Taken from (Pradervand et al., 2004). 
 
1.6.2.3 Reg-2 
Regenerating protein 2 (Reg-2) is a 16kDa secreted protein that is expressed in a cytokine-
dependent manner in developing rat motor and sensory neurons. However, Reg-2 is 
normally not expressed in the adult rat central and peripheral nervous system. Following 
nerve axotomy, Reg-2 is expressed de novo within 24 hrs, in motoneurons, sympathetic 
neurons and DRG neurons. Reg-2 is upregulated in small IB4 positive DRG neurons 1 day 
after peripheral injury and its expression shifts from small neurons to medium-large (IB4 
negative) neurons 5-7 days later (Averill et al., 2002) . In addition, a recent study showed 
that in a mono-arthritis inflammation model, Reg-2 is selectively upregulated in IB4 
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positive DRG neurons and that Reg-2 expression in these cells might be induced by LIF 
treatment (Averill et al., 2008) . 
Reg-2 is axonally transported toward the injury site, it can act as a Schwann cell 
mitogen in vitro and its mitogenic capability can be enhanced by cAMP elevation (Livesey 
et al., 1997; Namikawa et al., 2005; Averill et al., 2008; Averill et al., 2002). The 
expression of Reg-2 in both sensory and motor neurons during development is driven by 
cytokines which include IL-6, CNTF, LIF and CT-1 (Livesey et al., 1997). These cytokines 
have been shown
 
to prevent motor neuron cell death that follows neonatal axotomy 
(Cheema et al., 1994; Sendtner et al., 1990; Pennica et al., 1996) 
 
and to prolong motor 
neuron survival in strains of mice that show
 
spontaneous motor neuron cell death (Sendtner 
et al., 1992a; Nishimune et al., 2000; Mitsumoto et al., 1994; Lindsay, 1996; Winter et al., 
1996; Bordet et al., 1999). 
  Reg-2 inhibition in motoneurons by using antisense adenovirus cancels the survival 
effect of CNTF on cultured motoneurons, indicating that Reg-2 expression is a required 
step in the CNTF survival pathway (Nishimune et al., 2000). Direct injection of Reg-2 
antibody into the crushed nerve significantly slowed regeneration of peripheral nerve after 
nerve crush (Livesey et al., 1997). 
 
1.6.3 Retrograde signals 
Activation of intrinsic growth capacity in neurons following injury allows regeneration to 
take place in the PNS. This event, truncated in the CNS is one of the mechanisms that 
contribute to the difference in the success of regeneration between the PNS and CNS.  
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Normally, the cell body of an injured neuron must collect accurate and timely information 
about the site and extent of axonal damage in order to boost its intrinsic growth capacity 
and successfully regenerate. Specific mechanisms must therefore exist to transmit such 
information along the length of the axon from the lesion site to the cell body. One 
postulated mechanism responsible for this event is the retrograde transport of injury signals 
where molecules activated at the injury site send information to the cell body giving rise to 
the upregulation of regeneration associated genes and thus increased growth capacity of the 
neuron. As previously mentioned a conditioning lesion to the peripheral branch prior to 
injury to the central branch promotes regeneration of central axons suggesting that 
retrograde injury signals travel from the peripheral injury site back to the cell body to 
increase the intrinsic growth capacity of the neuron. An increased intrinsic growth state 
may be one of the factors that could enable centrally injured axons to regenerate.  
There are various injury signals functioning in a temporal sequence, including the 
interruption of the normal supply of retrogradely transported target-derived factors and 
retrograde injury signals emanating from the injury site travelling back to the cell body, 
also known as positive injury signals. Target derived signals, also known as negative injury 
signals, such as the lack of retrogradely transported NGF. This type of signal represses the 
intrinsic neuronal growth activity during embryonic to adult transition, once a neuron is 
connected with its target allowing proper synaptic development.  
Positive injury signals triggered by axonal injury induces the local activation and 
retrograde transport of several mitogen activated kinases (MAPKs), including Erk (Perlson 
et al., 2005) , the c-Jun N-terminal kinase (JNK)(Cavalli et al., 2005). Inhibition of JNKs 
blocks neurite outgrowth in cultured adult neurons (Lindwall et al., 2004) and it has been 
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suggested that the activation of these kinases, in particular JNK and Erk and their 
interaction with the injury activates several downstream genes through the local release of 
cytokines which include LIF, IL-6, and CNTF.  
Among these downstream genes several transcription factors have been shown to 
become phosphorylated and localized in the nucleus following activation of the different 
MAP kinase pathways. These genes and others regeneration associated genes may be 
regulated by transcription factors playing a pivotal role in changing the expression of genes 
and proteins pattern in the injured neurons that might be associated with axonal 
regeneration.   
 
1.6.4 Transcription factors  
Regulation of mRNA gene expression belongs to one of the most complex types of control 
in eukaryotic genes, which can be regulated at several steps, including transcriptional 
initiation, elongation, mRNA processing, transport, translation, and stability. Perhaps, the 
most crucial control of regulation is at the level of transcriptional initiation (Maston et al., 
2006). Among the factors involved in the control of accurate transcription of protein coding 
genes by RNA polymerase II, transcription factors play a crucial role as a result of their 
interaction with regulatory sequences present in the promoter and enhancer regions of 
target genes.  Different types of transcription factors, characterized by different DNA 
binding domains, have been described, each associating with their own class of specific 
DNA sequences. Examples of transcription factor families include those containing a 
cysteine rich zinc finger, homeobox, helix-loop-helix and bZIP domains (Pabo CO, 1992). 
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Additionally to a sequence specific DNA binding domain, a traditional transcription factor 
also contains an activation domain necessary to promote transcription.  
The lack of CNS regeneration in adult mammals is largely attributable to the 
presence of an inhibitory environment. Another important factor is the absence or limited 
upregulation in the expression of transcription factors in injured CNS neurons in marked 
contrast to the robust increase found in neurons whose peripheral axons are injured (Plunet 
et al., 2002; Mason et al., 2003).  
Transcription factors are central to any coordinated molecular programme and 
several transcription factors are upregulated following peripheral nerve injury and during 
axonal regeneration, including c-Jun, c-Fos and the activator transcription factor (ATF) 
subfamily which are member of the AP-1 family of transcription factors. The transcription 
factors NFIL3/E4BP4, SYR-box containing gene 11 (S0X-11), signal transducer and 
activator of transcription-3 (STAT-3) and nuclear factor-κB (NF-κB), are also upregulated 
after nerve injury (Table 1).  
Table 1 Transcription factors up or down regulated after nerve injury 
Gene  Expression Reference 
ATF-3 ↑ (Seijffers et al., 2007) 
c-jun ↑ (Jenkins and Hunt, 1991) 
junD ↑ (Herdegen et al., 1991) 
NF-κB ↓ (Doyle and Hunt, 1997) 
 
↑ (Ma and Bisby, 1998) 
NFIL3/E4BP4 ↑ (Nilsson et al., 2005) 
p 202b ↑ (Nilsson et al., 2005) 
P311 ↑ (Fujitani et al., 2004) 
Sox11 ↑ (Boeshore et al., 2004) 
STAT-3 ↑ (Schwaiger et al., 2000) 
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1.6.4.1 C-jun 
Jun proteins in combination with Fos proteins, form the AP-1 early response family of 
transcription factors. The Fos proteins (c-Fos, FosB, Fra-1, Fra-2) can only heterodimerize 
with members of the Jun family whereas the Jun proteins (c-Jun, JunB, JunD) can both 
homo- and heterodimerize with Fos members to form transcriptionally active complexes 
(Jochum et al., 2001). Additionally Jun proteins can also heterodimerize with other 
transcription factors such as ATF, CREB (Hai et al., 1999) and C/EBP (Hsu et al., 1994). 
In different cell types, c-Jun has been shown to participate in regulation of the cell 
cycle, cellular differentiation, organogenesis, tumor transformation and apoptosis. c-Jun is 
activated through double phosphorylation by the c-Jun N-terminal kinases (JNK) pathway 
but has also a phosphorylation-independent function. c-Jun knockout is lethal, due to 
defects of the interventricular septum in the heart and incomplete separation of the aorta 
and the pulmonary artery. Additionally c-Jun deficient foetuses present abnormalities in the 
liver (Eferl et al., 1999). 
 c-Jun is expressed during neurogenesis and in the adult brain, it is highly expressed 
in regenerating PNS neurones; it promotes neuronal differentiation and neurite outgrowth. 
Axotomized retinal ganglion cells (RGCs) that regenerate through a peripheral nerve graft 
co-express c-Jun and the major growth-associated protein GAP-43 for several weeks 
(Herdegen et al., 1997). 
The expression of c-Jun is upregulated in fetal tissue transplanted into adult striatum 
for up to six months following grafting, and this upregulation correlates with the ongoing 
regenerative efforts of the grafted neurons (Aznar et al., 1995).  Conditioning ischemia 
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selectively induces c-Jun (but not JunB or c-Fos) in hippocampal CA1 neurons, and many 
of the cells positive for c-Jun not only survive the initial ischemia, but become protected 
from cell death following a subsequent ischemic insult (Sommer et al., 1995). After 
hypoglycemia, seriously damaged but surviving hippocampal neurons selectively express c-
Jun (Gass et al., 1995). 
By using cre/loxP technology, conditional mice lacking c-Jun in neuronal cells have 
been generated. They display slight defects during neurogenesis. However, after transection 
of the facial nerve, c-Jun deficient animals suffered from severe defect in the axonal 
response. Additionally c-Jun deficiency blocks post-traumatic neuronal cell death, but it 
leads to severe neuronal atrophy (De Felipe and Hunt, 1994; Raivich et al., 2004). 
 
1.6.4.2 STAT-3 
STAT-3 is a transcription factor phosphorylated by Janus kinases (JAKs) in response to 
cytokine activation of a cell surface receptor tyrosine kinase. Upon activation, STAT-3 
becomes dimerized and localized to the nucleus where it activates transcription of cytokine-
responsive genes (Ihle, 2001; Heinrich et al., 2003). It is known that JAK/STAT pathway is 
activated through neuropoietic cytokines signalling via gp130 receptor, which dimerises 
and associates with JAKs. JAKs phosphorylate gp130 and then recruit STAT-3, leading to 
tyrosine 705 phosphorylation, dimerization and nuclear translocation to initiate target gene 
transcription (Fig. 10).  
Immunohistochemical evidence indicates that in axotomized DRG neurons, STAT-
3 is phosphorylated and activated (Qiu et al., 2005). A conditioning lesion has been shown 
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to activate a robust neurite outgrowth of adult DRG neurons in vitro (Smith and Skene, 
1997).  Conversely, conditional knockout studies by using cre-mediated gene ablation
 
in 
motoneurons suggest that STAT-3 is involved in supporting survival of injured neurons and 
the lack of STAT-3 downregulates the expression of anti-apoptotic genes Reg-2 and Bcl-xl 
in axotomized motoneurons (Schweizer et al., 2002).  
In order to study signalling mediators that underlie regenerative axon growth in the 
conditional model, Snider and colleagues used chemical inhibitors in axotomized sensory 
neurons in vitro to block the activation of Erk
 
kinase (MEKK), phosphatidylinositol-3
 
kinase (PI3-K), and JAK signalling. The results indicated that unlike JAK, neither MEK
 
nor 
PI3-K inhibitors blocked elongation of adult sensory neurons
 
after a conditioning lesion, 
suggesting that JAK/STAT-3 signalling is required for the upregulation of gene expression
 
for cytoskeletal elements normally observed after axotomy (Liu and Snider, 2001). Similar 
results have shown that inhibition of JAK2 by continuous perineural infusion of inhibitor 
AG490 to the proximal nerve stump after nerve injury blocks STAT-3 phosphorylation, 
leading to a compromised neurite outgrowth in vitro and a diminished axonal regeneration 
of the dorsal column in
 
the adult spinal cord after a preconditioning sciatic nerve
 
transection 
(Qiu et al., 2005).  
Recently, it has been suggested that in response to the chronic insults
 
or stress of the 
pathogenesis of multiple sclerosis (MS), cortical
 
neurons of MS patients upregulate a 
CNTF-mediated neuroprotective signalling
 
pathway involving STAT-3 and B cell 
lymphoma leukaemia 2 protein (Bcl2). Induction of CNTF signalling, the phosphorylation 
of
 
STAT-3 and the expression of anti-apoptotic molecule, Bcl2, thus represents a 
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compensatory response to disease
 
pathogenesis and a potential therapeutic target in MS 
patients (Dutta et al., 2007). 
 
Fig. 10 STAT-3 activation pathway: IL-6 leads to dimerization of gp130 receptors. Associated JAKs 
become activated and phosphorylate the cytoplasmic part of gp130, thereby creating docking sites for STAT-
3. STAT-3 becomes phosphorylated form homo- or hetero-dimers and translocate into the nucleus, where 
they regulate gene transcription. Modified from Suzuki T, Nature Genetics 32, 166 – 174.  
 
1.6.4.3 CREB 
The regulation of cAMP has been shown to be crucial in nerve regeneration. Therefore, the 
regulation of gene transcription by cAMP has been studied extensively. Even though there 
may be several transcription factors capable of mediating this response, the most widely 
studied so far has been CREB. CREB belongs to the basic leucine zipper (bZIP) 
superfamily of transcription factors.  CREB binds to certain DNA sequences called cAMP 
response elements (CRE) and thereby increases or decreases the transcription, and thus the 
expression, of certain genes (Fig. 11). CREB is closely related in structure and function to 
cAMP response element modulator (CREM) and ATF-1. 
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CREB mediates the positive effects of cAMP on axonal regeneration (Lonze et al., 2002; 
Sheng et al., 1991) and it is also responsible for the mediation of neuronal survival 
responses to neurotrophins (Finkbeiner, 2000).  It is well-established that CREB has both 
constitutive and cAMP-inducible activities, with distinct domains within the protein 
contributing to these activities, like the palindromic binding site 5′-TGACGTCA-3′ for 
CRE. The cAMP-inducible activity of CREB is activated via phosphorylation of the 
specific serine residue ser133 by PKA, and the phosphorylated form of CREB then is able 
to bind the co-activator, CREB-binding protein (CBP) and recruit it to the promoter to 
provide further bridging to the pre-initiation complex (Mayr and Montminy, 2001) (Fig. 
11). 
CREB activity has also been implicated in learning, memory formation and synaptic 
plasticity in experiments using the marine snail Aplysia (Kandel, 2001). Related 
experiments in rodents indicate that CREB may be required for long-term memory 
(Bourtchuladze et al., 1994). Furthermore, previous studies found that inducible expression 
of a dominant inhibitor of all CREB family members in the dorsal hippocampus produces 
spatial memory deficits (Pittenger et al., 2002). Since the formation of long-term memory 
and axonal growth both require cellular changes, it is perhaps not unexpected to think that 
both processes would have overlapping requirements for diverse genes downstream of 
CREB. 
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Fig. 11 CREB activation pathway: CREB controls gene expression when cAMP levels increase. Genes 
activated by cyclic AMP possess an upstream cyclic AMP response element (CRE) that binds CREB protein.  
In the presence of cyclic AMP, cytoplasmic PKA is activated and its activated catalytic subunit then moves 
into the nucleus, where it catalyzes phosphorylation of the CREB protein, thereby stimulating its activation 
domain. The recruitment of the co-activator CREB-binding protein (CBP), allows CREB to regulate the 
transcription of certain genes. From The World of the Cell, 7th Edition, Chapter 23 by Wayne M. Becker, 
Lewis J. Kleinsmith, Jeff Hardin & Gregory P. Bertoni, 2009. 
 
1.6.4.4 ATF-3 
Activating transcription factor-3, is another important transcription factor upregulated in 
Schwann cells and injured DRG neurons after peripheral injury and is downregulated after 
reinnervation of peripheral targets (Seijffers et al., 2007). ATF-3 is induced in sensory 
neurons of large diameter after spinal cord injury (Huang et al., 2006). Upregulation after 
injury is preceded by phosphorylation of c-Jun and JNK activation (Pearson et al., 2003). 
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ATF-3 is normally induced by stress stimuli and cellular damage and has both apoptosis-
promoting and survival functions in different tissues (Allen-Jennings et al., 2001; Perez et 
al., 2001; Hartman et al., 2004).  In the nervous system, ATF-3 appears to have a survival 
role (Herdegen et al., 1997). After delivery to the hippocampus, ATF-3 protects CA3 
pyramidal neurons from kainic acid-induced apoptosis (Francis et al., 2004) and rescues 
neonatal superior cervical ganglion neurons from apoptosis due to NGF withdrawal 
(Nakagomi et al., 2003). In a transgenic animal model that constitutively expresses ATF-3 
in non-injured
 
adult DRG neurons; peripheral nerve regeneration
 
was enhanced in the 
transgenic mice to a level comparable to that produced by a preconditioning nerve injury 
(Seijffers et al., 2007). The expression
 
of some growth-associated genes, such as SPRR1A, 
but not others
 
like GAP-43, was upregulated in the non-injured neurons. However, even 
though ATF-3
 
increased DRG neurite elongation on permissive
 
substrates in vitro, it did not 
overcome the inhibitory effects of myelin
 
or promote central axonal regeneration in the 
spinal cord in
 
vivo (Seijffers et al., 2007).  
 
1.6.4.5 NF-κB 
The transcription NF-κB exists in all cell types and has been implicated in the early control 
of the neuronal response to injury and regeneration. NF-κB is present in the cytoplasm in 
an active form bound to its inhibitor IκB. Upon stimulation by an extracellular signal, NF-
κB is released from its inhibitor, translocates to the nucleus and participates in many 
regulatory processes.  
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NF-κB is active as early as 30 minutes after CNS injury, is still present at 72h, and is 
expressed by macrophages, microglia and neurons (Bethea et al., 1998). Activation of NF-
κB in neurons occurs in response to pro-inflammatory cytokines that are elevated after 
injury. NF-κB is also activated during the excitotoxin-induced apoptosis of striatal neurons 
(Qin et al., 1998). NF-κB can be activated by Rho (Montaner et al., 1999), raising the 
possibility that the abnormal Rho activation after spinal cord injury (Dubreuil et al., 2003; 
Madura et al., 2004) may lead to activation of NF-κB and neuronal death.  
The function of NF-κB in the nervous system remains unclear and its role in 
neuroprotection or neurodegeneration is open to debate. NF-κB in brain neurons promotes 
their death in an ischemia animal model (Herrmann et al., 2005), while neuron-restricted 
ablation of NF-κB driven gene expression increases neurodegeneration suggesting that NF-
κB expression in forebrain neurons is required for neuroprotection (Fridmacher et al., 
2003). Furthermore NF-κB expression studies in DRG neurons after peripheral nerve injury 
have shown that the activated form of NF-κB, the heterodimer p65, is expressed in a sub-
population (32%) of mixed diameter sensory neurons in L4 and L5 DRG, indicating that 
this transcription factor is involved in intracellular signalling in sensory neurons under 
physiological conditions. Four hours after crushing the sciatic nerve, ipsilateral p65 staining 
was abolished in a subgroup (60-70%) of these neurons. The contralateral side was 
unaffected by the injury and loss of NF-κB activity was not observed following sham 
surgery. Within 24 hrs of sciatic injury, ipsilateral p65 staining resumed control levels 
(Doyle and Hunt, 1997). This downregulation in the expression of NF-κB in DRG neurons 
after nerve injury contrasts with another study where  upregulation of NF-κB in DRG was 
observed  2 weeks following partial sciatic injuries, possibly in response to cytokines and 
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neurotrophins produced by endoneurial cells in the partially injured nerve during Wallerian 
degeneration (Ma and Bisby, 1998). More recently our group has shown that that NF-κB 
does not contribute to the intrinsic resistance of adult DRG neurons to apoptotic death after 
axotomy. Additionally, NF-κB is unlikely to have an involvement in DRG neurons 
processes such as axonal regeneration and neuropathic pain, which are responsive to nerve 
injury (Gushchina et al., 2009). NF-κB has been proposed to be important in the axonal 
growth of developing sensory neurons (Gallagher et al., 2007). However, it has also been 
suggested that axonal outgrowth is not mediated by NF-κB in adult DRG cultured neurons 
(Gushchina et al., 2009). These discrepancies could be explained by a recent study 
demonstrating that NF-κB can either stimulate or inhibit neurite growth in developing 
neurons depending on the phosphorylation status of p65 (Gutierrez et al., 2008). 
 
1.7 The CAAT enhancer binding protein family of transcription factors  
 The CAAT enhancing binding proteins (C/EBP) are a family of transcription factors 
consisting of six members α, β, γ, δ, ε and δ (genetic nomenclature CEBPA, CEBPB, 
CEBPG, CEBPD, CEBPE and CEBPZ, respectively) (Fig. 12). To avoid confusion since 
several independent groups have characterized and given C/EBPs different names, a 
systematic nomenclature was proposed by Steve MacKnight and colleagues, in which 
members are designated as C/EBP followed by a Greek letter indicating the chronological 
order of their discovery (Table 2). The C/EBPs have been involved in the regulation of 
multiple aspects of cell function including inflammation, differentiation, proliferation, 
stress response and neuronal development (Ramji and Foka, 2002). The C/EBPα gene was 
first cloned in 1988, in Steve McKnight‘s laboratory (Landschulz et al., 1988a) where 
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further studies led to the discovery of the leucine zipper as well as the basic helix loop helix 
groups of transcription factors (Landschulz et al., 1988b), and to the identification of an 
optimal canonical binding site, RTTGCGYAAY (R = A or G, and Y = C or T). The C-
terminal of the C/EBPs contains the bZIP domain, highly conserved among all the 
members of the family, which consists of a basic amino acid rich DNA binding region 
followed by a dimerization motif called the leucine zipper (Fig. 12). Due to high sequence 
identity of over 90% in the C- terminal 55-65 amino acid residues between the six members 
of the family, the C/EBPs can form homodimers and heterodimers in all possible 
interfamilial directions (Roman et al., 1990; Williams et al., 1991). Additionally, the 
C/EBPs can also give rise to protein-protein interactions with other bZIP and non-bZIP 
families of transcription factors. For instance, C/EBPs can bind to transcription factors of 
the NF-kB, CREB/ATF and AP-1 families (Vallejo et al., 1993; Vinson et al., 1993; 
Lekstrom-Himes and Xanthopoulos, 1998). Dimerization is a prerequisite for DNA binding 
and is mediated by the basic region  (Landschulz et al., 1988b). 
 Besides the vast number of possible heterodimer formations between the six 
different members of the family, the number of C/EBP proteins present in an organism may 
be even higher due to a leaky ribosomal scanning mechanism where different size 
polypeptides can be generated. Two isoforms of C/EBPα can be generated from its mRNA. 
The full-length protein is 42 kDa and contains three activation domains which mediate 
cooperative binding of C/EBPα to TATA box-binding protein and transcription factor IIB 
(TFIIB), two components of the RNA polymerase II basal transcriptional apparatus (Nerlov 
and Ziff, 1995). The second C/EBPα isoform is a shorter 30-kDa protein that retains its 
dimerization and DNA-binding domains; however, it possesses an altered transactivation 
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potential compared with the 42-kDa isoform (Fig. 12). C/EBPβ mRNA can produce at least 
three isoforms, 38 kDa (LAP*), 35 kDa (LAP) and 20 kDa (LIP), the last two being the 
most common. However, LIP, unlike LAP, does not contain any activation domain (Fig. 
12) (Descombes and Schibler, 1991). C/EBPε mRNA can generate at least four isoforms 
(32 kDa, 30 kDa, 27 kDa and 14 kDa), of which the 32 kDa has the highest activation 
potential and the 14 kDa the lowest since it lacks an intact transcriptional activation domain 
(Fig. 12) (Lekstrom-Himes, 2001; Yamanaka et al., 1997).  
In contrast to the C-terminal, the N-terminal does not share high sequence identity 
among the members of the C/EBP family; there is less than 20% homology, with the 
exception of three small subregions conserved in almost all the members but C/EBPγ (Fig. 
12) (Cooper et al., 1995). These regions are activation domains responsible for the 
interaction with the components of the basal transcription apparatus which can promote 
transcription, repression and autoregulatory function. (Johnson, 2005; Williamson et al., 
1998; Tang and Koeffler, 2001). Since C/EBPγ lacks the transcriptional activation domains 
present in all the other members, it acts as a transdominant negative regulator by forming 
inactive heterodimers with other members leading to the repression of gene transcription 
(Cooper et al., 1995). C/EBPε can generate 4 isoforms of 32 kDa, 30 kDa, 27 kDa and 14 
kDa with the first having the highest activation potential (Yamanaka et al., 1997; Lekstrom-
Himes, 2001). 
The functional properties of C/EBPs has been investigated extensively in the past 
years using different methods such as analysis of promoter regions of target genes, 
overexpression or inhibition, and studies on knock-out mice (Ramji and Foka, 2002). It has 
been demonstrated that C/EBPs are involved in a variety of different cellular events for 
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instance the control of cell differentiation especially during adipogenesis (Darlington et al., 
1998), and myeloid-cell differentiation and maturation (Yamanaka et al., 1998; Zhang et 
al., 1997). Furthermore, it has been determined that C/EBPs also have an important role in 
the response to inflammatory insult. C/EBPα, β and δ expression levels can be regulated by 
an array of different cytokines such as interleukin -1 and -6 and TNF-α (Poli, 1998; Poli, 
1998; Alam et al., 1992; Akira et al., 1990). In addition, numerous binding sites have 
recently been identified for several C/EBPs in regulatory regions of multiple genes 
involved in the inflammatory response, including those coding for cytokines and their 
receptors, acute-phase plasma proteins, and components of signal transduction pathways 
present in adipocytes, hepatocytes, myeloid cells and keratinocytes, among others (Ramji 
and Foka, 2002). 
 
Table 2 Nomenclature of C/EBP genes 
 
 
Gene Alternative name Source 
C/EBPα C/EBP, RcC/EBP-1 Rat, mouse, human, chicken, bovine, Xenopus 
laevis, Rana catesbeiana, fish 
C/EBPβ NF-IL6, IL-6DBP, LAP, 
CRP2, NF-M, AGP/EBP, 
ApC/EBP 
Rat, mouse, human, chicken, bovine, Xenopus 
laevis, Aplysia, fish 
C/EBPγ Ig/EBP-1 Rat, mouse, human, chicken, fish 
C/EBPδ NF-IL6b, CRP3, CELF, 
RcC/EBP2 
Rat, mouse, human, Rana catesbeiana, bovine, 
ovine, fish 
C/EBPε CRP-1 Rat, mouse, human, ovine, fish 
C/EBPδ CHOP-10, GADD153 Mouse, rat, human, hamster 
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Fig. 12 The C/EBP family of transcription factors: C/EBPα, β, γ, δ, ε, and δ and their different isoforms. 
The N-terminal consist of the activation domain (AD) represented in green and the negative regulatory 
domain (RD) shown in blue. The basic leucine zipper domain in the c-terminal consists of the basic region 
(red) and the leucine zipper domain (yellow with black lines). Taken from (Ramji and Foka, 2002). 
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1.7.1 Regulation of the C/EBP family 
The expression of the C/EBPs is regulated by the actions of a number of factors, including 
cytokines, mitogens, hormones, nutrients and agents that cause cellular stress (Table 3). 
The C/EBPs have been found to be regulated at a number of different levels, including gene 
transcription, translation, protein–protein interactions and phosphorylation-mediated 
changes in DNA- binding activity, activation potential and nuclear localization (Table 3). 
Additionally, there is a potential effect of tissue, cell and species specific differences in the 
mechanisms of regulation. For example, TNFα induces C/EBPβ mRNA expression in 
astrocytes and renal mesangial cells, but modulates nuclear–cytoplasmic translocation in 
hepatocytes (Yin et al., 1996; Buck et al., 2001; Cardinaux et al., 2000; Tengku-
Muhammad et al., 2000; Granger et al., 2000b).  
 
1.7.1.1 Transcriptional regulation 
Transcriptional regulation is the main point of control in the regulation of mRNA (Table 3). 
The promoter regions of C/EBPα, -β, -δ, -ε, -δ, have been analyzed. The role of the 
different sequence elements in the regulation of gene expression during adipogenesis, 
inflammation and hepatocyte proliferation is described below under global gene regulation, 
with other aspects addressed here. 
The proximal promoter region of the mouse C/EBPα gene was initially 
characterized and shown to contain potential binding sites for C/EBP, Sp1, nuclear factor 
(NF)-1, NF- Y, upstream stimulating factor (USF), basic transcription element-binding 
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protein (BTEB) and NF-kB (Christy et al., 1991; Flodby et al., 1993; Legraverend et al., 
1993). This promoter can be activated by C/EBPα and -β by specific binding to the C/EBP 
recognition sequence (Christy et al., 1991; Legraverend et al., 1993). The proximal 
promoter region of the rat and mouse C/EBPα gene are almost identical and can be auto-
activated through the C/EBP-binding site (Rana et al., 1995). However, the promoter 
regions of the human, chicken and Xenopus C/EBPα genes present only partial sequence 
identity with the mouse/rat promoter (Kockar et al., 2001; Timchenko et al., 1995). In the 
case of the human promoter, it lacks a C/EBP recognition sequence, due to a single base 
substitution but it can still be auto-activated, although only by C/EBPα (Timchenko et al., 
1995). All this evidence indicates that the C/EBPα gene is auto-activated in a species 
specific manner. 
The promoters of the mouse, rat, chicken and Xenopus laevis C/EBPβ genes which 
are also capable of autoregulation have been identified (Foka et al., 2001; Chang et al., 
1995; Niehof et al., 2001a; Mink et al., 1999). The transcription factor CREB also controls 
C/EBPβ expression by interacting with two sites near the TATA box called the cAMP-
response element (CRE) (Niehof et al., 1997). The CRE sequences are also required for the 
IL-6-mediated induction of C/EBPβ transcription during the acute-phase response (APR) 
through a signalling pathway involving tethering of STAT-3 to a DNA-bound complex 
(Niehof et al., 2001b), and in combination with an Sp1 site for the activation of gene 
transcription during macrophage differentiation (Berrier et al., 1998). 
C/EBPδ is expressed constitutively in osteoblasts, where it activates the synthesis of 
insulin-like growth factor I by the binding site for the runt domain factor 2 present in the 3´ 
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proximal region of the C/EBPδ gene promoter (McCarthy et al., 2000). The transcription of 
the C/EBPδ gene in growth-arrested mammary epithelial cells and in the mammary gland is 
activated by STAT3 which binds to a recognition sequence in the promoter region 
(Sabatakos et al., 1998). This STAT3 site is also required for the IL-6-mediated induction 
of C/EBPδ transcription in hepatocytes (Cantwell et al., 1998). Analysis of the mouse, rat 
and ovine C/EBPδ promoters suggests the potential existence of species-specific 
mechanisms for autoregulation (Davies et al., 2000; Yamada et al., 1998; O'Rourke et al., 
1999). 
The C/EBPε gene promoter is transcribed by two alternative promoters, Pα and Pβ, 
which contains no TATAAA box, but through a combination of differential splicing and 
alternative use of promoters generates four mRNA isoforms (Yamanaka et al., 1997). The 
promoter also contains a functional retinoic acid-responsive element that can be induced by 
the corresponding ligand (Park et al., 1999). 
 
1.7.1.2 Translational regulation 
A key aspect of translational control of C/EBPα and -β is the alternative use of initiation 
codons (Calkhoven et al., 2000). As mentioned previously, two distinct isoforms of 
C/EBPα, 42kDa and 30kDa, can be produced from a single mRNA (Ossipow et al., 1993; 
Lin et al., 1993). The 30kDa polypeptide as opposed to the 42kDa form has a lower 
transactivation potential and lacks antimitotic activity (Ossipow et al., 1993; Lin et al., 
1993). The ratio of the two isoforms changes during both adipocyte differentiation and 
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hepatocyte development (Ossipow et al., 1993; Lin et al., 1993). Similarly, the C/EBPβ 
ratio of the activator LAP form to the repressor LIP polypeptide has been shown to increase 
under a number of conditions, and such changes are likely to be functionally important 
(Descombes and Schibler, 1991). For example, LIP is elevated in breast cancer which is 
consistent with its ability to induce epithelial cell proliferation and the formation of 
mammary hyperplasia (Zahnow et al., 2001). The C/EBPα and C/EBPβ mRNA contains a 
conserved short upstream open reading frame (uORF) that is located seven bases from the 
initiation codon that specifies for the full-length protein (Calkhoven et al., 1994). 
Previously it has been shown that the integrity of the uORF is essential for the leaky 
ribosome scanning mechanism that leads to the production of different sized polypeptides 
(Calkhoven et al., 2000).  
 
1.7.1.3 Regulation by phosphorylation 
Phosphorylation plays a key role in the modulation of C/EBPβ function. C/EBPβ is 
normally repressed and negative regulatory regions mask its transactivation domains 
(Williams et al., 1995; Kowenz-Leutz et al., 1994). This repression is abolished by 
phosphorylation of the repression domain (Kowenz-Leutz et al., 1994). Transactivation of 
C/EBPβ can be induced by phosphorylation of Thr235 through a Ras/MAPK pathway (Zhu 
et al., 2002), by phosphorylation of  Ser
105
 via protein kinase C (PKC) (Trautwein et al., 
1993), and Ser
276
 by Ca
2+
/calmodulin-dependent protein kinase (Wegner et al., 1992). 
However, phosphorylation can also suppress the activation potential of C/EBPβ. For 
example, insulin inhibits transactivation by C/EBPβ via the PI 3-kinase pathway (Guo et 
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al., 2001). In contrast, the PKA-mediated in vitro phosphorylation of a region between 
Ser
173
 and Ser
223
, and Ser
240, suppresses C/EBPβ DNA-binding activity (Trautwein et al., 
1994). Similarly, a PKC-mediated phosphorylation of Ser
240
 leads to a decrease in DNA 
binding (Trautwein et al., 1994). On the other hand, phosphorylation of PKA in rat PC12 
cells results in the translocation of C/EBPβ into the nucleus, where it then activates the 
transcription of the c-fos gene (Metz and Ziff, 1991). Translocation of C/EBPβ in a 
colorectal cancer cell line DKO-1 is also mediated by a PKA-dependent phosphorylation, 
but of Ser
 299
 (Chinery et al., 1997).  
Under certain conditions a potential role of phosphorylation in the regulation of 
C/EBP isoforms α, -δ has been shown. For example, PKC can phosphorylate C/EBPα at 
several sites (Ser
248
, Ser
277
 and Ser
299 
), and leads to a weakening of its DNA-binding 
activity (Mahoney et al., 1992). In addition, insulin can reduce the expression of genes in 
adipocytes, in part, due to a dephosphorylation-mediated degradation of C/EBPα (Ross et 
al., 1999). Studies on the a1-acid glycoprotein regulation and the serum amyloid A genes 
during the APR have shown that dephosphorylation of C/EBPδ results in an inhibition of its 
DNA binding activity (Ray and Ray, 1994). Additionally, the transactivation potential of 
C/EBPδ was also found to be increased when hepatocytes were treated with cellular 
phosphatase inhibitors, such as okadiac acid and sodium orthovanadate (Ray and Ray, 
1994; Lekstrom-Himes and Xanthopoulos, 1998). 
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1.7.1.4 Protein–protein interactions 
Protein-protein interactions are important for the regulation of the C/EBP family since the 
different members can form heterodimers under all interfamilial conditions and such 
interactions are likely to have a profound influence on the regulation of gene transcription. 
Furthermore, the C/EBPs can form protein–protein interactions with other bZIP and non-
bZIP factors. For example, C/EBPβ has been shown to interact with the p50 subunit of NF-
kB, CREB/ATF, AP-1, glucocorticoid receptor, hepatitis B virus X protein, and the 
retinoblastoma (Rb) protein (LeClair et al., 1992; Vallejo et al., 1993; Lekstrom-Himes and 
Xanthopoulos, 1998; Hsu et al., 1994; Hsu et al., 1994; Wedel and Ziegler-Heitbrock, 
1995). Such heterodimers often have different transactivation potentials and/or DNA 
binding specificities or affinities compared with the corresponding homodimers. 
Additionally, the transactivation potential of the different C/EBP members differs; for 
example, C/EBPα is a stronger transcriptional activator than C/EBPβ.  
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Table 3 Regulators of the C/EBP family. Level abbreviations: DBA, DNA-binding 
activity; NL, nuclear localization; AP, activation potential.  
Gene Level Activator Repressor         
C/EBPα  mRNA  Thyroid hormone, thiazolinediones 
EGF, glucocorticoid, growth 
hormone, Interferon-gamma(IFN-g) 
, IL-1, IL-6, insulin, LPS, TNF-a 
  DBA   EGF, PKC activators         
C/EBPβ mRNA  
cAMP, glucagon, glucocorticoid, growth hormone, 
IFN-g, IL-1, IL-6, LPS, noradrenaline, NGF, VIP           
  NL cAMP, LPS, TNF-a, TPA TNF-a      
  AP Ca
2+
, IL-6, MAPK activators, PKC activators Insulin      
  DBA Transforming growth factor beta (TGF-b), EGF           
C/EBPδ mRNA  
Glucocorticoid, growth hormone, IFN-g, IL-1, IL-6, 
insulin, LPS, noradrenaline, PDGF, TNF-a, VIP           
  NL cAMP, TNF-a           
C/EBPε mRNA  Retinoic acid           
C/EBPδ mRNA  
Amino acid deprivation, agents that cause ER-, 
nutrient- and oxidative stress, Ca
2+
, nitric oxide, 
LPS, prostaglandin A2, UV light           
  AP Cellular stress           
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1.7.2 C/EBP in the nervous system 
Although it is known that C/EBPα, β and δ are expressed in the brain (Sterneck et al., 1998; 
Sterneck and Johnson, 1998) and methodical analysis on the function and properties of 
C/EBP proteins has been performed in a variety of tissues such as liver and adipose, much 
less
 
is known about the role of these transcription factors in the nervous system, especially 
in nerve regeneration after adult nerve injury. Nevertheless, some evidence suggests a 
potential function and possible implication of C/EBPs in gene expression mechanisms that 
underlie neuronal functions such as neuronal repair. This is supported indirectly by recent 
studies showing that members of this family are involved in the control of biological 
processes critical to neuronal development and survival, including cell fate determination, 
apoptosis  (Paquin et al., 2005; Marshall et al., 2003; Menard et al., 2002), synthesis of 
trophic factors (Takeuchi et al., 2002; McCauslin et al., 2006),  response to neurotrophic 
factors (Sterneck and Johnson, 1998; Calella et al., 2007), response to brain injury and 
ischemia (Kapadia et al., 2006; Soga et al., 2003) and neural plasticity in the adult 
(Sterneck et al., 1998; Sterneck and Johnson, 1998).  
There are multiple approaches to enhance regeneration following nerve injury. For 
instance, by overcoming the MAG/myelin inhibition of regeneration through the 
upregulation of permissive factors like cAMP, CREB and Arg I. Also by the upregulation 
of several cytokines, neurotrophic factors and regeneration associated genes. Therefore, it 
wouldn‘t be unexpected to discover a pivotal role of the C/EBPs during nerve repair given 
the numerous signalling pathways and molecules involved in this event. In addition, the 
fact that computational predictions show over 30 million C/EBP binding sites in the rat 
genome (Falvey et al., 1996), which is not surprising given the accepted variation in the 
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C/EBP consensus sequence, leads to the hypothesis that functional C/EBP sites are defined 
not just by their sequence but also by adjacent binding sites for transcription factors that 
interact with and stabilize C/EBP binding (Friedman et al., 2004; Calella et al., 2007).  
Moreover, the variety of DNA binding and activation domains available through 
heterodimerization enables C/EBPs to interact with a broad range of DNA sequences, 
transcription factors, co-activators and chromatin remodelling complexes which 
presumably increases the number of genes that are regulated by C/EBPs  
 
1.7.3 Potential signalling pathways of C/EBPs 
Several genes and signalling mechanisms are known to be upregulated following nerve 
injury and have also been implicated in nerve repair. Although, much less is known about
 
the expression and function of C/EBPs after nerve injury and during nerve repair, some 
indirect evidence showing different interactions between C/EBPs and these signalling 
pathways associated with nerve repair, suggests a possible implication of C/EBPs during 
neuronal regeneration. Some of the interactions between C/EBPs and nerve regeneration 
associated genes and signalling pathways are discussed below.     
 
1.7.3.1 C/EBP interaction with cAMP and CREB 
Structure and function analysis of C/EBPs have shown that this family of transcription 
factors possesses constitutively active domains, suggesting that C/EBPs can be induced in 
response to cAMP (Pelletier et al., 1998; Wilson et al., 2001; Roesler et al., 1998). In non-
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neuronal tissue, it has been shown that cAMP responsiveness is mediated by a cAMP 
response unit (CRU) (Roesler, 2000). This CRU consists of five cis-elements, and includes 
a typical CRE to which CREB can bind. However, the CRE on its own has weak enhancer 
activity, and a strong response to cAMP is obtained only when all five cis-elements are in 
use. C/EBPs bind to several of the cis-elements that make up the CRU, and mutations in 
these sites which disrupt C/EBP binding also affect the fold-responsiveness to cAMP (Liu 
et al., 1991; Roesler et al., 1994). In addition, overexpression of a dominant negative 
C/EBP inhibits cAMP responsiveness in liver-derived cells (Roesler et al., 1996). In the 
nervous system, cAMP elevation, has also been shown to regulate the expression of 
C/EBPs. In hippocampal neuron cAMP stimulation enhances mRNA expressions
 
and DNA 
binding activities of C/EBPβ and -δ (Yukawa et al., 1998). In pheochromocytoma PC12 
cell line cAMP elevation, following forskolin treatment, phosphorylates and translocates 
C/EBPβ to the nucleus (Metz and Ziff, 1991). In rat cerebral cortex, the activation of β-
adrenergic receptors (BAR) increases cAMP levels leading to an increase of C/EBPδ-
binding activity resulting in the upregulation of NGF (Colangelo et al., 1998). 
Furthermore, C/EBPs are also known for having a role in transcriptional programs 
underlying more complex brain functions, such as learning and memory. The first evidence 
that C/EBPs are expressed in neurons and
 
involved in long-term synaptic plasticity 
underlying memory
 
formation came from studies of the invertebrate Aplysia californica,  
which is used for in vitro
 
modelling of the short- and long-term synaptic responses that
 
occur during simple formation of memory. Experiments in coculture
 
systems were 
instrumental in determining the fundamental role
 
of C/EBP in long-term synaptic plasticity. 
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Indeed, this in vitro
 
system pioneered the identification and characterization of
 
several 
molecules and molecular mechanisms underlying memory
 
formation. 
C/EBPβ and C/EBPδ were co-localized with phosphorylated CREB in synaptic 
plasticity for long term memory (LTM) consolidation in Aplysia models (Guan et al., 2002) 
and in mice (Taubenfeld et al., 2001). The Aplysia C/EBP (ApC/EBP) is found to be 
increasingly induced in response to cAMP
 
and CREB signals (Alberini et al., 1994). 
Over the past 20 years, several studies have demonstrated that CREB holds an 
essential role in LTM formation (Dash et al., 1990; Yin et al., 1994; Bartsch et al., 1995; 
Bartsch et al., 1998; Guzowski and McGaugh, 1997; Taubenfeld et al., 2001). 
Phosphorylation of CREB can in turn regulate the transcription of more downstream target 
genes required for LTM formation such as the expression of late response genes and other 
inducible transcription factors (e.g., Arc, c-Fos, C/EBP) (Lonze et al., 2002; Alberini et al., 
1994). Additionally, it has been shown in Aplysia and Drosophila models and in different 
areas of the rodent brain that cAMP and PKA signalling pathway, working upstream of 
CREB, are involved in synaptic plasticity or learning (Kandel and Pittenger, 1999). 
Similarly, as mentioned before, this signalling cascade is also involved in axonal 
regeneration. Formation of LTM requires mRNA and protein synthesis, (Davis and Squire, 
1984; DeZazzo and Tully, 1995) whereas inhibition of protein synthesis completely blocks 
LTM even after spaced training without affecting learning and early memory (Tully et al., 
1994; Davis and Squire, 1984). Enormous research efforts have been used to identify the 
regulatory mechanisms of learning-induced gene transcription and translation.  
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There are different groups of genes which contain CRE sites in their promoters, including 
growth factors, structural proteins, cellular metabolism, transcription, and signal 
transduction factors (Lonze et al., 2002). Among these elements in Aplysia models, it has 
been shown that ApC/EBPs become induced upon binding to the CRE element on its 
promoter, indicating a direct sequential interaction between C/EBP and CREB. 
Furthermore, studies in Aplysia indicate that following neural stimulation the activation of 
C/EBP is induced by the Aplysia LAPS18-like protein (ApLLP) through a direct binding to 
CRE (Kim et al., 2006) which in turn leads to the consolidation of long term facilitation 
(LTF) (Kim et al., 2006; Alberini et al., 1994). Interestingly, it has also been demonstrated 
in Aplysia that axotomy induces the ApC/EBP mRNA expression (Alberini et al., 1994). 
Analogous results were demonstrated in mice where C/EBPβ and C/EBPδ are 
induced in the hippocampus after learning, correlating with CREB activation (Taubenfeld 
et al., 2001). Conversely, disruption of CREB activation in the hippocampus blocks the 
induction of C/EBPβ and C/EBPδ (Taubenfeld et al., 2001).  
 
1.7.3.2 C/EBP and STAT-3 
After STAT-3 activation by cytokines, dimerised STAT-3 translocates to the nucleus where 
it binds to specific enhancer sequences and regulates the transcription of various target 
genes, including C/EBPδ (Yamada et al., 1997). STAT-3 binding sites are often located 
proximal to binding sites for other transcription factors including C/EBPβ (Schumann et al., 
1996), suggesting that these factors cooperate in gene regulation. Additionally, in epithelial 
cells, co-immunoprecipitation and chromatin immunoprecipitation (ChIP) assays 
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demonstrated that pSTAT3 and Sp1 interact and bind to the transcriptionally active C/EBP
 promoter (Zhang et al., 2007) and in hepatocytes DNA binding experiments and 
transactivation
 
assays demonstrated that STAT-3 binds to C/EBPβ and-δ promoter 
sequence. Moreover, the suggested CNTF-mediated neuroprotective response through the 
activation of STAT-3 signalling led to an upregulation of C/EBPβ and C/EBPδ which was 
detected in microarrays of MS patient‘s cortex (Dutta et al., 2007). 
 
1.7.3.3 C/EBP and Arginase I  
Previously, it has been demonstrated that Arg I has neuroprotective
 
properties in cortical 
neuronal cultures (Esch et al., 1998). Other studies conducted by Filbin and colleagues have 
shown that Arg I overcomes MAG/myelin inhibition and it is involved in the cAMP 
regeneration pathway (Spencer and Filbin, 2004; Filbin, 2003; Filbin, 1996; Filbin, 1995). 
Additionally, polyamines, a group of arginase downstream products
 
with widespread 
biological effects, are also involved in neuronal growth
 
and development (Slotkin and 
Bartolome, 1986; Slotkin et al., 1982), axonal regeneration after injury (Gilad and Gilad, 
1988; Gilad et al., 1996) and in wound healing outside of the CNS (Witte and Barbul, 
2003). Several studies also implicate a protective
 
role for polyamines. For instance, all
 
3 
polyamines (putrescine, spermine, and spermidine) prevent
 
apoptotic cell death induced by 
high potassium chloride concentrations in cultured cerebellar granule neurons (Harada and 
Sugimoto, 1997).
 
Furthermore, the neuroprotective role
 
of spermine has been demonstrated 
in several models of neurodegeneration by Morris and colleagues (2002) who showed
 
that 
L-arginyl-3,4-spermidine significantly reduced cell death in the hippocampal
 
subregion 
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CA1 when administered prior to, or immediately after,
 
global ischemia in vivo. L-arginyl-
3,4-spermidine also reduced cell death in
 
excitoxicity models, as well as in superoxide-
mediated cell injury (Morrison, III et al., 2002). 
C/EBPs are known to regulate the expression of Arg I by binding to Arg I promoter 
region –90 to –55 relative to the transcription start site (Lange et al., 2008; Takiguchi and 
Mori, 1991; Morris, Jr., 2002). In the Arg I promoter region there are 2 binding
 
sites for 
C/EBPs, 1 at position
 
around –90 bp and the other around –55 bp (Gotoh et al., 1994; 
Chowdhury et al., 1996). Binding of C/EBP family members to the region around –55 bp 
stimulates the promoter activity. Hepatocyte nuclear factor-4
 
(HNF-4) represses the 
promoter activity without directly binding
 
the promoter region and the region overlapping 
with the C/EBP
 
binding site at 55 bp is responsible for the HNF-4 repression. Other 
studies linking C/EBPs with the regulation of ArgI have shown that the transcription of the 
rat Arg I gene is induced by glucocorticoids. The glucocorticoid
 
response of the Arg I gene 
appears to be mediated by C/EBPβ. In C/EBPα-deficient mice, mRNA and protein levels 
for arginase
 
I decrease markedly (Kimura et al., 1998). Additional evidence indicates that 
Arg I expression is induced in
 
macrophages by cytokines such as IL-4 which require a 
responsive element containing
 
STAT6 and C/EBPβ sites located 3 kb upstream of the 
transcription start site (Gray et al., 2005). 
 
1.7.3.4 C/EBP and Neurotrophic factors 
C/EBP-binding elements have been found to be present in the proximal region of the mouse 
BDNF gene which is conserved in the rat and it is suggested that C/EBPs might regulate 
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BDNF expression (Hayes et al., 1997). Moreover, in neuronal cells NeuroD a basic helix 
loop helix transcription factor, forms a complex with C/EBPα and β to modulate the 
signalling response of BDNF/Trk receptor, which regulates the expression of the immediate 
early genes Fos, Egr1 and Egr2 (Calella et al., 2007).  Additional evidence suggesting that 
C/EBP has a potential role in neuronal plasticity and in nerve repair has been proposed 
previously. Sterneck and colleagues identified the C/EBPβ protein and gene as direct 
downstream targets of the NGF receptor, proposing a role for C/EBPβ in neurotrophin 
signalling in the brain (Sterneck and Johnson, 1998). It has been reported that C/EBPδ 
interacts with a sequence spanning nucleotides –90 to –59 of the NGF promoter (Colangelo 
et al., 1998). Recent evidence indicated that C/EBPδ, in combination with CREB, 
contributes to NGF gene regulation in the glioma cell line and in rat brain (McCauslin et 
al., 2006; Colangelo et al., 1998). 
 
1.7.3.5 Others 
During regeneration several cytoskeletal proteins become involved. One particular member 
of this group is Tα1 tubulin, which is vigorously expressed in neurons during early 
differentiation (Miller et al., 1987) and following axonal injury (Miller et al., 1989) where it 
is likely to function as building blocks for the formation of nascent and regenerating axons.   
Another important cytoskeletal protein is mitogen activated protein (MAP) which in 
contrast to Tα1 tubulin does not recapitulate the embryonic pattern of expression after 
nerve injury in the adult (Fawcett et al., 1994). MAPs are important for the stabilization of 
the structure of growing axons, preventing their depolymerisation. It is possible that the 
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failure of adult neurons to mimic embryonic MAP expression after nerve injury could be an 
important factor leading to slower and less robust regenerative axon growth in the adult 
than axon growth in embryos. 
C/EBPβ has been shown to regulate the growth-associated gene Tα1 α-tubulin 
following axonal injury (Nadeau et al., 2005). In the same study it was also demonstrated 
that the injury-induced upregulation of the endogenous mouse Tα1 α-tubulin mRNA and 
GAP-43, was inhibited in C/EBPβ -/- animals (Nadeau et al., 2005). Further support of the 
involvement of C/EBPβ in the nervous system was showed by (Cortes-Canteli et al., 2002) 
who found that C/EBPβ induces neuronal differentiation in the nervous system. It still 
remains unknown whether any other member of C/EBP are associated with neuronal repair 
in the PNS. 
As previously mentioned, C/EBPs are involved in the response to inflammatory 
insults in non-neuronal systems and in the brain (Cortes-Canteli et al., 2004; Lekstrom-
Himes and Xanthopoulos, 1998). This regulation is induced through a wide range of 
different cytokines in the same way that peripheral nerve injury elicits cellular and 
molecular inflammatory signals, some components of which might contribute to axonal 
regeneration (Lu and Richardson, 1991). Inflammatory cytokines, such as TNF-α and 
interlukin-1 (IL-1β), appear to constitute at least some of the injury-signals in DRG 
(Murphy et al., 2003). All these data indicates that C/EBPs might also be involved in the 
regulation of an inflammatory response upon axonal injury in the nervous system, 
suggesting a potential role in neuronal regeneration analogous to its role in regeneration of 
other tissues. 
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1.8 Knockout mice 
 
A knockout mouse is derived from embryonic stem (ES) cells that have integrated a 
knockout construct by homologous recombination. This construct is cloned by using 
recombinant DNA technology. The targeting construct specifically replaces a segment of 
genomic DNA in the ES cell. The knockout ES cells are then microinjected into normal 
mouse blastocysts where they mix with cells from the normal embryo to form a chimeric 
mouse which contains cells derived from both the host embryo and knockout ES cells. Up 
to 100% of the resulting mouse chimera can be formed from cells derived from knockout 
ES cells. The chimeric mice are bred to produce mice that are heterozygous for the 
knockout gene. Thereafter the knockout allele can be transmitted in a Mendelian fashion. 
 
1.8.1 Mice breeding 
 
Breeding laboratory mice is never as simple as placing male and female together and 
waiting for the pups to be born. The genetic background of the mice selected for breeding is 
always important, and for many purposes it is critical, especially in the case of knockout 
and transgenic mice. For genetic experiments, the criteria for selection of breeders are quite 
specific and may vary from one generation to the next. Even for more general purposes, 
however, failure to choose breeders of the appropriate genetic background will eventually 
result in unwanted although often subtle changes in the characteristics of the mice.  
A strain is defined as inbred if it was produced by sibling matings for more than 20 
generations, after which all mice are considered genetically identical. To remain inbred, a 
strain must be maintained by sibling matings or, if necessary, by parent-off spring matings. 
The main pedigree line should be derived from a single sister-brother breeding pair at each 
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generation. With inbred mice, the goal is to preserve genetic uniformity in the colony. With 
most strains, this involves nothing more than mating males and females of the same strain. 
The only precaution is to avoid creation of a substrain or genetic drift, which occurs when a 
closed colony of inbred mice is isolated for many generations. A substrain may differ 
genetically from the original inbred strain and may yield different results when used in 
research. To avoid this, it is important to introduce outside animals from the same inbred 
strain on a regular basis.  
C57BL/6 is the most widely used inbred strain. It is commonly used as a general 
purpose strain and background strain for the generation of knockouts mice. Although this 
strain is refractory to many tumours, it is a permissive background for maximal expression 
of most mutations. C57BL/6 mice breed well, are long-lived and are used in a wide variety 
of research areas including cardiovascular biology, developmental biology, diabetes and 
obesity, genetics, immunology, neurobiology, and sensorineural research. For all the 
reasons previously mentioned C57BL/6 mice were used for the production of C/EBPδ -/- 
by Esta Sterneck‘s group and the production of C/EBP luciferase transgenic mice. These 
two strains were used in this thesis.   
 
1.8.1.2 Breeding strategies 
Heterozygous mutant (-/+) x homozygous mutant (-/-) 
This breeding scheme is normally used when only one gender of a mutant is a viable and 
fertile homozygote. The other gender may be infertile or have reduced fertility, embryonic 
lethal, die in utero, or die before reaching sexual maturity. Unless they can be recognized 
by a visible phenotype, all mutant mice must be genotyped to differentiate homozygotes 
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and heterozygotes. If the mutants are on a mixed genetic background, the off spring should 
be backcross to F1 hybrids about every 10 generations, to avoid producing recombinant 
inbred lines. If the mutants are on an inbred background, genetic drift must be avoided by 
backcrossing them to the appropriate inbred strain every 10 generations (for example, 
backcross a mutant on a C57BL/6 background to the standard C57BL/6 strain). 
Suitable controls if a knockout‘s genetic background is inbred would be either the 
inbred strain (C57BL/6) or heterozygous siblings with normal phenotypes.  
 
Heterozygous mutant (-/+) x heterozygous mutant (-/+) 
This breeding scheme is used when homozygous mutant mice are severely impaired, 
infertile, embryonic lethal, die in utero, or die before reaching sexual maturity. This 
breeding strategy is ideal for studies of knockouts and for experimental comparison with 
their respective +/+ littermates to ensure that the differences between them are limited to 
their differences in genotype and not other factors such as how the dams interact with their 
pups or potential in utero differences between knockout and wildtype dams. Thus, it is ideal 
to be comparing littermates to one another that are raised as similarly as possible. However, 
since this breeding scheme produces off spring of multiple genotypes: 25% wildtype, 50% 
heterozygous and 25% homozygous, a lot of effort and resources are used for genetic 
testing to distinguish those that carry the mutation from those that do not, as all of the pups 
may look the same. Additionally, most of the heterozygous progeny must be discarded.  
Suitable controls for the homozygous are the inbred strain and either wildtype or 
heterozygous siblings. 
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Homozygous mutant (-/-) x homozygous mutant (-/-) 
This breeding strategy is used when homozygous mutants of both sexes are viable and 
fertile. Cost-efficacy is one main advantage of this breeding scheme since only 
homozygous knockouts are generated. No heterozygous are generated and less time and 
money is used for genotyping. Although all off spring produced are homozygous mutants, 
breeder genotypes should be verified at least every two generations.  
If the knockouts are inbred, genetic drift must be avoided by backcrossing them to 
the appropriate parental inbred strain every 10 generations (for example like in my case, 
backcross a knockout on a C57BL/6 background to a standard C57BL/6 inbred mouse). 
Alternatively, if the mutants are on a mixed genetic background, backcross the off spring to 
appropriate F1 hybrids about every 10 generations, to avoid producing recombinant inbred 
lines.  
If a mutant‘s genetic background is an inbred strain, a suitable control for the 
homozygous knockout would be the inbred strain used to generate the knockout (In this 
thesis C57BL/6). However, a disadvantage is the risk for subtle genetic differences that 
might have arisen between knockouts (e.g. C/EBPδ -/-) and the wildtype inbred strain (e.g. 
C57BL/6).   
 
1.9 Hypothesis  
The C/EBP family of transcription factors has six different members and multiple isoforms, 
they can form homo and heterodimers and they can bind to other transcription factors and 
proteins. Due to the C/EBPs molecular versatility it
 
is not surprising that they have the 
ability to regulate the expression
 
of a
 
broad variety of genes with seemingly unrelated 
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biological function. By taking into account these properties and the C/EBP studies 
mentioned above, we hypothesised that C/EBPs are involved in the neuronal response after 
axonal nerve damage. Moreover, we suggest that C/EBPs may be a possible downstream 
target of regeneration within signalling pathways such as cAMP. This regeneration 
signalling cascade might work in a similar way to the memory formation pathway, which 
has several signalling molecules in common with the up to date known axonal regeneration 
signalling cascade, including cAMP, PKA and CREB (See Fig. 13, a proposed model in 
long term facilitation and nerve repair). C/EBP, are activated downstream of the cAMP-
CREB pathway indicating a possible involvement of the C/EBP, in the synaptic plasticity 
events of axonal regeneration and LTM formation. 
 
1.10 Aims 
 To determine whether injury in the peripheral nervous system elicits a response in 
the expression of the C/EBP family of transcription factors. 
 To assess the effect of C/EBPs in axonal regeneration by modifying their expression 
in vitro and in vivo.  
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Fig. 13 Signalling pathway in axonal nerve repair in a mammalian model and long term facilitation and 
memory formation in Aplysia: cAMP elevation leads to PKA activation which phosphorylates CREB. 
CREB upregulates the expression of certain genes, involved in axonal growth/regeneration in mammals. In a 
similar signalling cascade in Aplysia, CREB and Aplysia LAPS18-like protein (ApLLP) induce the 
expression of C/EBP which in turn leads to the consolidation of long term facilitation. The LTF model 
involving ApC/EBP as a downstream regulator is based on studies by (Kim et al., 2006).  
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Chapter 2: Materials and methods 
 
Experimental design.  Animal care and procedures were carried out in accordance with 
guidelines and protocols approved by the United Kingdom Home Office. The room was 
kept at 24°C, with controlled humidity. Small animal rat chow and water were available ad 
libitum. For the detection of C/EBP isoforms following nerve injury, experiments were 
performed on 27 adult male Wistar rats weighing 260–320 g. The animals were randomly 
divided into three main groups representing three different time points, 9 animals into each 
group. For each one of the three groups, the experiment was repeated 3 times and in each 
experiment 3 animals were pooled together. Therefore, n=3. Three different early time 
points were selected following sciatic nerve injury, 4, 24 and 72 hrs.  
The animals were
 
anesthetized by halothane inhalation and the left sciatic nerve at 
level of the sciatic notch was crushed by compression for 30 seconds with fine Dumon No. 
5 forceps (World Precision Instruments Stevenage, UK). Rats were sacrificed by 
decapitation and dissection of ipsilateral and contralateral L4 and L5 DRGs which were 
frozen in dry ice and stored at -80°C until used. Contralateral
 
DRGs from the same animals 
served as control samples.  Similarly, 1 cm of the axonal injury site, on the ipsilateral site 
and the corresponding non-injured area on the contralateral site were collected and stored 
72 hrs following sciatic nerve injury. 
For functional analysis studies, 8 C/EBPδ -/- mice adult female mice (2-4 months) 
and 8 C57BL/6 wildtype mice (controls) were used. A left sciatic crush injury was 
performed on all the animals. Function of the sciatic nerve of experimental animals was 
97 
 
evaluated a week before nerve injury and every 4 days until signs of function recovery was 
observed by day 28 following surgery.  
LPS-induced inflammation model. Adult male Wistar rats (400-500 g) were injected 
intraperitoneally with bacterial lipopolysaccharide (LPS) injection from Escherichia coli 
055:B5 (2 mg/kg body weight). For control experiments saline was
 
injected 
intraperitoneally. 24 hours after LPS injection the animals were sacrificed by decapitation 
and different tissue were carefully harvested, snap frozen in dry ice and stored at −80 °C 
before processing them. n = 3.  
RNA extraction and cDNA synthesis. Frozen tissue such as brain, spleen, L4-L5 DRGs or 
crush injured sciatic nerve were homogenized independently in Trizol® Reagent 
(Invitrogen, Paisley, UK) with a mortar and pestle and the samples were incubated for 5 
minutes at room temperature (RT) to permit a complete dissociation of nucleoprotein 
complexes. Subsequently 0.2ml of chloroform was added per 1ml of Trizol reagent. After 
vigorous shaking for 15 seconds the samples were incubated at RT for 3 minutes and 
centrifuged at 12,000 x g for 5 minutes. Following centrifugation the colourless upper 
aqueous phase was transferred into a new tube which was mixed with 0.5ml of Isopropyl 
alcohol per 1ml of Trizol reagent and 1µl of glycerol. Then after incubation at RT for 10 
minutes the RNA samples were centrifuged for 10 minutes at 13,000 x g at RT.  Following 
the phenol-chloroform RNA extraction, isopropanol precipitation and the RNA pellet 
formation by centrifugation, the RNA samples were washed using 300 ml of 75% ethanol 
and dissolved in RNase-free water. The RNA concentration was determined 
spectrophotometrically at 260 nm, and the quality of RNA was assessed based on the ratio 
of absorbance at 260 and 280 nm with a NanoDrop (ND-1000, NanoDrop Technologies, 
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USA). 1-2 µg of RNA were treated with RQ1 RNase-free DNase (1µl/µg of RNA) 
(Promega, Madison, Wisconsin) for 30 minutes at 37°C. After DNase treatment, RNA
 
samples were heated to 75°C for exactly 10 minutes in order to inactivate added DNase and
 
to denature RNA. Reverse-transcription of RNA into cDNA was carried out by firstly 
adding 1µl of random primers (150 ng/µl) to 1µg of RNA, subsequently the sample were 
incubated at 70ºC for 5 minutes and then on ice for 3 minutes. Thereafter it was added to 
each sample a mixture consisting of 4µl 5X reaction buffer, 2 µl of 25 mM MgCl2, 1µl of 
10mM dNTP mix, 0.5µl recombinant RNasin ribonuclease inhibitor (40U/µl) and 1µl 
ImProm-II™ Reverse Transcriptase (Promega, Madison, Wisconsin) followed by double 
distilled H2O up to a total of 15µl. The samples were incubated at 25 ºC for 5 minutes, 
thereafter at 55 ºC for 60 minutes and finally at 70 ºC for 15 minutes. As a negative control 
the samples were treated similarly but without any addition of 1µl ImProm-II™ Reverse 
Transcriptase. 
Real time PCR. Real-time PCR was performed with TaqMan chemistry (ABgene, Epsom, 
UK) and with SYBR Green (ABgene, Epsom, UK), only in the LPS-induced inflammation 
study. The real time PCR analysis was performed on a Rotor-Gene 3000 system (Corbett 
Research, Sydney, Australia). Gene-specific primers (Invitrogen, Paisley, UK) and probes 
(MWG, Berlin, Germany) were used, (Table 4). Amplification conditions were as follows:  
95 °C for15 min followed by 40 cycles of 95 °C for 10 s; 60 °C for 15 s; 72 °C 20 s. Each 
Real Time-PCR quantitation experiment was performed thrice using triplicate samples from 
independently generated cDNA templates originated from 1-2 µg of RNA. Expression of 
genes of interest between different conditions was determined following normalization to 
the level of a housekeeping gene, ribosomal 18S, in each sample. Due to 18S abundance in 
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tissues, the 18S cDNAs were diluted 100-fold before measurement of 18S mRNA. A 
standard curve was generated by real-time PCR analysis from triplicates of five ten-fold 
dilutions of cDNA generated from 1 ng of spleen RNA. As a negative control mRNA 
measurements were performed on samples treated with DNase (Invitrogen, Paisley, UK) 
but not with reverse transcriptase enzyme on each single run. Real time PCR runs showing 
mRNA expression signals for the negative control samples were discarded and completely 
new cDNA was generated for a re-run. The relative expression level of the gene of interest 
was computed from each experimental sample by calculating the ratio between the gene of 
interest (ng/reaction) and the 18S gene (ng/reaction), and multiplying the result by a 10000. 
C/EBP fold increase shows the ratio between ipsilateral and contralateral mRNA values.  
Cell Culture and neurite outgrowth assay. The ND7/23 cell line was maintained in 
Dulbecco‘s modification of Eagle‘s medium (DMEM) (PAA, Yeovil, UK) complemented 
with 2 mM glutamine, 100 i.u. ml-1 penicillin, 0.1 mg ml-1 streptomycin and 10% fetal 
bovine serum (FBS) (PAA, Yeovil, UK) at 37°C, 5% CO2. Stimulation of neurite 
outgrowth and differentiation towards a neuronal phenotype was induced by reducing the 
serum concentration to 0.5% and additionally by supplementing the medium with 1 mM 
dibutyryl cAMP (Sigma, Poole, UK). For epigenetic studies on C/EBPδ activity, ND7/23 
cells were treated with 1mM dibutyryl cAMP and with 5 M Trichostatin A (TSA) (Sigma, 
Poole, UK) for 24 hrs.  
For quantification analysis of the neurite length following TSA treatment and 
transfection with conditional C/EBP inhibitors, the length of the longest neurite for each 
neuron for TSA experiments and only neurons expressing GFP for conditional inhibitory 
experiments were measured. Neurons with neurites longer than once cell diameter were 
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counted as neurite-bearing cells. Image J software (NIH, Bethesda, USA) was used to 
measure the length of neurites. Culture for each group was performed in triplicate and 
repeated 3 times.  
For RNA extraction cells were grown for 3 days in 6-well plates (Corning, NY) and 
harvested by adding Trizol® Reagent (Invitrogen, Paisley, UK) directly to the cells. 
Primary DRG neuronal cultures and treatments. Dorsal root ganglia dissected from the 
spinal cord of adult mice were processed for primary cultures basically as previously 
described by Holmes et al (2000). DRG were placed in Hanks balanced salt solution 
(HBSS) containing 0.125% of collagenase (Sigma, Poole, UK) for 1h and 30min at 37ºC. 
Then ganglia were rinsed and placed in fresh Hanks medium containing 0.25% of trypsin 
(PAA, Yeovil, UK), for 15 min at 37ºC. Medium was then removed and ganglia were 
placed in F-12 medium (PAA, Yeovil, UK) containing 10% foetal calf serum (FCS) (PAA, 
Yeovil, UK). Afterwards, ganglia mechanically dissociate into a single cell suspension by 
trituration with a pipette and syringe in growth medium which was F-12/DMEM medium 
supplemented with N2, 1% Albumin (Fraction V) (Sigma, Poole, UK) and 1% penicillin-
streptomycin. The cell suspension was centrifuged on a 15 % bovine serum albumin 
cushion for 10 min at RCF of 200g (900 rpm). The supernatant was discarded and the cells 
were re-suspended in growth medium and plated onto Lab-Tek II 8-well chamber slides 
(Nunc, Naperville, IL) at a cell density of approximately 1000 cells/well on coverslips 
coated with 5µg/ml of poly-lysine (Sigma, Poole, UK) overnight and then with 1µg/ml of 
laminin (Sigma, Poole, UK) for 4h. Cells were incubated in growth medium in a humidified 
atmosphere at 37°C and 5% CO2. 48 hrs after plating the neurons were fixed with 4% PFA, 
washed with phosphate buffered saline (PBS) (PAA, Yeovil, UK) 3 times blocked in 10% 
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normal goat serum (Jackson Labs, Suffolk, U.K.) for 1 hr at room temperature and 
immunostained with anti-β(III) tubulin 1:1000 (Sigma, Poole, UK). Neurite/axonal length 
was measured as previously described in ND7/23 cells. For the quantification analysis, the 
length of the longest neurite of each neuron was measured with ImageJ software (NHS, 
USA). Neurons with neurites longer than one cell diameter were counted. Culture for each 
group was repeated 3 times and the length of approximately 400 neurons per culture was 
measured.  
Reporter system and transgenic animal. The C/EBP-Luciferase plasmid (Stratagene, 
Amsterdam, Holland) was digested with BamHI (New England Biolabs, Herts, UK) 
between bp 2670-5361 and the resulting C/EBP-Luc fragment yielded a 2.7-kb product that 
included
 
the C/EBP enhancer element, the luciferase gene and poly- A tail. The purified 
2.7-kb C/EBP-Luc constructs was quantified
 
and microinjected into oocytes and surgically
 
transferred into ovariduct of mice pseudopregnant foster
 
dams previously mated with 
vasectomised males. Oocyte injection was done by Mr. William Mansfield.  Ear
 
biopsies 
were obtained 5 wk after microinjection of
 
the eggs and analyzed for
 
the presence of the 
transgenic constructs. 
Genotyping of transgenic founders.  The screening of transgenic mice was performed with 
PCR. The primers sense 5'-GATGGAACCGCTGGAGAGC -3', antisense 5'-
CATACTGTTGAGCAATTCACGTTC-3' (Invitrogen, Paisley, UK) with a thermal
 
cycler 
profile of 95°C for 15 min, 95°C for 30 seconds, 58°C for 30 seconds, 72°C for 1 minute, 
35 cycles, generated a 300-bp product of the luciferase gene. 
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Luciferase assay in transgenic animals. Animals injected with LPS (2 mg/kg body weight) 
were sacrificed after 4 hrs. Selected tissue was collected and frozen on dry ice. Thereafter 
the tissue was homogenized on ice with a tissue grinder. For each volume of tissue 3 x Glo 
Lysis buffer ( Promega, Madison WI, USA) was added, mixed and incubated for 10 min at 
room temperature for cell lysis to occur. Subsequently, the solution was centrifuged and the 
supernatant was transferred to a new tube. 100 l of the supernatant was transferred to a 
well in a 96-well plate (Nunc, New Jersey, USA), thereafter 100 l luciferin substrate 
(Promega, Madison WI, USA) was added to the well and the luciferase signal was 
measured in a 1420 VICTOR
2 
luminometer (Wallac Co., Turku, Finland).  
Generation of conditional constructs. For the conditional C/EBP dominant inhibitor, the A-
C/EBP construct a generous gift from Dr. Charles Vinson (National Institutes of. Health) 
previously described in (Olive et al., 1996) was amplified with primers sense 5‘ 
CAGCTGACGCGTGGCTAACTAGAGAACCCACT 3‘ and primer antisense 5‘ 
CAGCTGGCTAGCTGGCTGGCAACTAGAAGGC 3‘ (Invitrogen, Paisley, UK) and 
cloned into the tetracycline conditional pBI-EGFP vector backbone (Clontech, Palo Alto, 
CA, USA) previously digested with MluI and NheI (New England Biolabs, Herts, UK). For 
the C/EBPδ antisense conditional construct, the IMAGE clone ID: 1528128 was amplified 
with primers sense.  
5‘ CGCCGCGCTAGCCGCGCGTTACCGGCAGT 3‘ and antisense 5‘ 
CAGCTGACGCGTTTTTCTCGGACTGTGCCGG 3‘ (Invitrogen, Paisley, UK) 
engineered with restriction sites MluI and NheI and cloned into the conditional pBI-EGFP 
vector previously digested with MluI and NheI. 
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Ligation and transformation. In a 0.5ml Eppendorf tube, vector DNA and insert fragments 
in a molar ratio of 1:6, 1 μl 10X ligase buffer, 1 u T4 DNA ligase (Promega, Madison WI, 
USA) and nuclease-free water to a final volume of 10 μl were mixed and incubated 
overnight at 16°C. Competent cells (Novablue Singles, Darmstadt, Germany) were thawed 
on ice and mixed gently to ensure suspension. 1 μl of ligation mixture was gently mixed 
with 30 μl cells in an ice-cold 1.5ml eppendorf tube, kept on ice for 30 minutes, then 
incubated for 30 seconds in a 42°C water bath, transferred immediately to ice were it was 
kept for 3 minutes. Immediately after 500 μl of room temperature SOC medium was added 
to the tube. If selecting for ampicillin-resistant colonies, 100-200 μl cells were spread 
directly on selective agar plates; if selecting for kanamycin-resistant colonies, cells were 
incubated at 37°C with shaking at 250 rpm for 30 minutes prior plating on selective agar 
plates. After air-dry, the plates were inverted and incubated overnight at 37°C. 
Plasmid DNA extraction with QIAprep Miniprep. Single colony from a freshly streaked 
selective agar plates was inoculated in 4 ml LB (Luria-Bertani; Sigma, St. Louis, MO, 
USA) medium containing selective antibiotic (ampicillin 100 μg/ml or kanamycin 50 
μg/ml) and incubated overnight at 37°C with shaking at 250 rpm. 1.5 ml cells were 
centrifuged at 10000 rpm for 1 min. To extract DNA from the pellet, the QIAprep miniprep 
kit was used (Qiagen, Crawley, UK). Briefly, the pellet was resuspended in 250 μl buffer 
P1 (50 mM Tris-HCL, pH 8.0; 10 mM Ethylene disodium tetra acetate (EDTA); 100 μg/ml 
RNase A) and gently mixed after adding 250 μl buffer P2 (200 mM NaOH, 1% SDS), then 
350 μl buffer N3 (guanidine hydrochloride, acetic acid) was added and mixed again by 
inverting the tube a few times. After centrifugation for 10 min at 13000 rpm, the 
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supernatant was collected to a QIAprep Spin Column, followed by spin for 1 min. The 
flow-through was discarded and the column was washed with 0.75 ml buffer PE (High-salt, 
Ethanol) and spun for 1 min. The plasmid DNA was obtained by centrifugation of the 
column for 1 min after incubation the column with 50 μl buffer EB (10 mM Tris-HCL, pH 
8.5) at room temperature for 1 min.  
Transfection. One day before transfection, 0.25-1.0 X 10
6
 cells were plated onto Lab-Tek 
II 8-well chamber slides (Nunc, Napperville, IL, USA) with 500 μl of growth medium so 
that the cells will be 50-80% confluent at the time of transfection. 150 ng of conditional 
construct and 150 ng of rtTA plasmid vector were diluted into 50 μl Opti-MEM® I 
Reduced Serum Medium (Invitrogen Paisley, UK). Thereafter 0.5 μl of Lipofectamine™ 
LTX Reagent (Invitrogen, Paisley, UK) was added to the diluted DNA and incubated at 
room temperature for at least 30 min. ND7/23 cells were washed with fresh medium 
without serum and antibiotics, lipofectamine complex was added to the cells and 300 μl 
new media without antibiotics was added to each well. The transfection medium was 
changed after 16 hrs and replaced with fresh culture medium containing antibiotics. The 
experiment was performed 3 times and the neurite length of 250-300 GFP positive cells 
was measured every time for each group.  
Generation of C/EBPδ null mice. The C/EBPδ null animals were obtained from Dr. Esta 
Sterneck (National Institutes of. Health) and its generation was previously described 
(Sterneck et al., 1998) 
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Genotyping of C/EBPδ null mice. The screening of knock-out mice was performed with 
PCR. The C/EBPδ primers sense 5‘ ACG ACT CCT GCC ATG TAC G 3‘ and antisense 5‘ 
GCT TTG TGG TTG CTG TTG AA 3‘ (Invitrogen, Paisley, UK) yielding a 133 bp 
fragment were used in combination with the sense 5‘ AAC AAG ATG GAT TGC ACG 
CAG 3‘ and antisense 5‘ GAA GGC GAT GCG CTG CGA A 3‘ primers (Invitrogen, 
Paisley, UK) for the neomycin cassette present in mutant animals yielding a 750bp 
fragment.  
Fixation. The animals were sacrificed by CO2 asphyxiation until breathing ceased and 
responsiveness to toe pinch was not detectable. The skin over the sternum was gripped with 
forceps and incisions made in the abdomen until the diaphragm was fully exposed. The 
xiphoid process of the sternum was clamped and held up so the diaphragm could be cut. 
The ribcage was cut bi-laterally and xiphoid process clamped back in a position so as to 
expose the whole thoracic cavity, with the heart accessible and still beating. A small 
incision to the left ventricle was made with fine micro scissors and a perfusion-drip needle 
inserted and clamped into place. The right atrium was identified and an incision made with 
fine micro scissors, and 0.9% saline was flushed through the hepatic circulation. After 40ml 
of saline had passed through the circulation, and the exiting fluid from the right atrium and 
liver was clear of blood, the animal was perfused with 4% paraformaldehyde (PFA) in 
0.1M PBS at pH 7.4, until the tissue and limbs were rigid. For morphometric analysis, the 
animals were perfused with 4% PFA and 1% gluteraldehyde in PBS. Dissection was carried 
out on the perfused mice extracting the ipsilateral and contralateral sciatic nerves. Nerves 
for morphometric analysis were sectioned at 6mm distal to the crush site (identified by the 
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suture) and subsequently stored in phosphate buffer solution (pH 7.4) and labelled 
appropriately ready for semi-thin sectioning. 
Preparation of semi-thin sections. After initial fixation, specimens were post-fixed in 1% 
Osmium tetroxide (Agar scientific, Stansted, UK) overnight. Subsequently specimens are 
dehydrated first in distilled water followed by gradual dehydration in alcohol (70%, 90% 
and 100%). Alcohol was removed from specimens by propylene oxide, followed by 
embedding sections in epoxy resin, prepared from Araldite (Agar Scientific, Stansted, UK). 
Sections were then cut using an ultramicrotome and glass knife.  
Toluidine staining. 1 µm thick semi thin sections were stained with 1% Toluidine blue 
while slides were placed on a hot-plate set at 70◦C for 30 seconds after which each slide 
was washed with distilled water and left for a few minutes to dry, followed by subsequent 
viewing by oil immersion light microscopy for morphometric analysis using an ocular grid 
with 50x zoom showing 30 x 30μm squares (900μm²). Semi-thin section preparation and 
Toluidine staining was performed by Mr. Kawaljit Dhaliwal. 
Cryostat sectioning. Fixed nerve specimens and L4-L5 DRGs were prepared for cryostat 
sectioning, firstly by orientating the nerve longitudinally to identify the proximal and distal 
ends. After embedding the nerves in embedding medium, 6µm thick sections were cut at -
20ºC and subsequently mounted onto SuperFrost Ultra Plus® Slides (VWR, Lutterworth, 
UK) for warm drying at room temperature. The slides were labelled according to genotype 
and ipsilateral (injured) or contralateral (uninjured) nerve.  
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Immunohistochemistry. Nerve sections from 3 day and 2 weeks injured mice were used for 
analysis of the regeneration associated gene, anti-GAP-43 (Chemicon, Chandlers Ford, 
U.K.) or  the neuronal marker protein gene product 9.5 (anti-PGP9.5). Slides were washed 
in PBS several times, blocked in
 
10% normal donkey serum (Chemicon, Chandlers Ford, 
U.K.) for 1 hour at room temperature and incubated with rabbit anti-GAP-43 antibody 
(1:2000) overnight or rabbit anti-PGP9.5 antibody (1:1000) (Abcam, Cambridge, UK) 
overnight. The secondary antibody, donkey anti-rabbit specific tetramethylrhodamine-5 
isothyocyanate (1:400 TRITC) (Jackson Labs, Suffolk, U.K.) was applied for 
approximately 2 hours. After several rinses with PBS, the slides were incubated with a 
1:15000 diluted solution of 4,6-Diamino-2-phenylindole dye (DAPI) (Jackson Labs, 
Suffolk, U.K.) for 10 minutes. Finally, slides were rinsed with PBS and coverslips applied 
using PBS glycerol (1:8). Immunoreactivity was quantitated using computerized image 
analysis, Leica Qwin Image Processing and Analysis System, (Leica, Wetzlar, Germany). 
For L4-L5 DRGs 4 hrs, 1 day and 3 days following sciatic nerve injury, anti-C/EBPδ 
(Santa Cruz, CA, USA), anti-SPRR1A a generous gift from Professor Stephen Strittmatter 
and anti-GAP-43 were used at a concentration of 1:500, 1:1000 and 1:2000 respectively. 
For all experiments negative controls were carried out by omitting the primary antibody 
from the staining procedure, and incubating with secondary. 
C/EBP  3,3'-Diaminobenzidine (DAB) staining. Following TSA treatment ND7/23 cells, 
were incubated with C/EBPδ (1:500) (Santa Cruz, CA, USA) overnight at room 
temperature, the slides were washed with PBST and then directly incubated in ABC 
reagents (1:200) (Vector Labs, UK) for 2 h. Sections were then washed in 0.1 M Tris-
buffered saline, pH 7.4 and finally developed in DAB solution containing 0.01% H2O2 and 
0.25% nickel sulfate. For all experiments negative controls were carried out by omitting the 
primary antibody from the staining procedure, and incubating with secondary. 
Imaging. All fluorescence microscopy was undertaken soon after the immunohistochemical 
incubation, to prevent loss of fluorescence from the fluorochromes. Photographs were taken 
with a digital camera (Hamamatsu Photonics, Welwyn Garden City, U.K.) connected to the 
microscope, at a constant exposure time to prevent false variation in staining intensity. For 
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quantification of immuno reactivity Leica Qwin software was used. For each animal, a 
fluorescent image of the sciatic nerve section extending 3mm distally from the crush site 
was captured. Each image was grey-scaled through Adobe Photoshop CS2. The image was 
subdivided into three different segments, 0-1, 1-2 and 2-3mm distal to the crush site.  Three 
measuring frames (200 x 200 mm) were placed on each segment. A binary image of GAP-
43 or PGP9.5 immunoreactive cells was then created within each frame. Both the upper and 
the lower gray level thresholds for creating the binary image were kept constant across all 
sections analyzed. The percentage of frame occupied by the binary image was then 
calculated.  
Functional testing. Functional behaviour was tested to compare phenotypic differences 
between C/EBPδ knockout and C57BL/6 mice before and after sciatic nerve crush injury. 
The mice were tested at regular intervals for 2 weeks preceding crush injury after which 
they were tested again at regular periods for a further 4 weeks. Experiments were 
performed on adult, female mice n=8.  
Mechanical sensory test. The baseline withdrawal thresholds of each of the hind paws using 
von Frey hairs were determined for each mouse prior to surgical manipulation (day 0). A 
platform containing 1.5 mm diameter holes in a 5 mm grid of perpendicular rows 
throughout the entire area of the platform was used. This platform is also opaque in 
appearance so that von Frey hairs are applied from underneath without distracting the 
mouse. Although objects distal to the surface of the customized platform were not visible, 
the plantar surface of a hind paw was visible as it was in direct contact with the platform 
surface. Two different hairs of 1.0g and 1.66g were applied from below the platform in 
ascending order. Application of the hair was to the central region of the plantar surface 
109 
 
avoiding foot pads of injured compared to uninjured hindlimbs. The hair was applied only 
when the mouse was stationary and standing on all four paws. A withdrawal response was 
considered valid only if the animal reacted by lifting the hindlimb from the platform. 
Although infrequent, if a mouse walked immediately after application of a hair instead of 
simply lifting the paw, the hair was reapplied. If the animals did not respond with the 
lightest hair after 5 attempts the next heavier hair (1.66g) was tested.  
Gripping and Grip test. Mice were allowed to grasp a rectangular metal bar. Subsequently, 
the bar was inverted and the number of grasps was measured for each hindlimb before 
sciatic crush injury. The number of failed attempts to grasp the individual metal bars was 
recorded out of 10 attempts. Following injury the ability to grasp on the injured side was 
measured and recorded at regular intervals until 22 days after injury. Before injury a Grip 
test was also performed using a grip strength meter. The grip strength meter was positioned 
horizontally and mice were held by the tail and lowered toward the apparatus. Mice were 
allowed to grasp the smooth, metal, pull bar with all four limbs and then pulled backwards 
in the horizontal plane. The force applied to the bar at the moment the grasp was released 
was recorded as the peak tension (g). The test was repeated 5 consecutive times within the 
same session and the highest value from the 5 trials was recorded as the grip strength for 
that animal. 
Sciatic functional index analysis. Functional motor recovery in mice was quantified by 
measuring the sciatic static index (SSI). Mice were placed in a transparent acrylic box and 
pictures were taken from underneath of box while the mice were standing still. Animals 
were assessed during the testing period from before injury and regularly after injury using a 
digital camera. They were then analysed with the computer software program Adobe 
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Photoshop CS3 and the toe spread TS and paw length were measured and computed into 
the following formula developed by Baptista et al (2007). 
SSI = 101.3 (ETS-NTS)/NTS – 54.03 (EPL-NPL)/NPL) -9.5 
 
 
Statistics. Detection of C/EBP mRNA levels after sciatic nerve injury included three 
measures taken at single time points by 4, 24 and 72 hrs following surgery. These measures 
of interest represent early time points in the initiation of the regeneration process. Although 
9 animals were used on each time point, the sample size was 3, since 3 animals were pooled 
for each experiment. This sample size was sufficient to find a statistically significant 
difference between contralateral and ipsilateral DRGs since the results were consistent and 
the standard error of the mean was fairly small. 
 Behavioural measures were taken in C/EBPδ -/- or wildtype animals. Such data is 
typically analyzed using t-tests when only two groups are being compared. Previous 
ETS: toe spread for the injured paw  
NTS: Toe spread for the uninjured contralateral paw 
EPL: length of injured paw 
NPL: length of contralateral uninjured paw 
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research in our lab has shown that the level of effect of most treatments (both for 
behavioural and anatomical parameters) along with the relatively small amount of variance 
of these measures within a group are such that small group sizes (i.e. 5 to 10) are generally 
sufficient to find a statistically significant effect. The animals were functionally tested  
Statistical analysis was performed using SPSS 15.0 software. Statistic significance 
was determined by Student's t-test, paired t-test. All results in the graphs and tables are 
indicated as the mean ± standard error of the mean (S.E.M.) where p<0.05 is considered as 
statistical significant. 
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Table 4 Primer and probe sequences designed to analyze mRNA expression of selected 
genes by real-time PCR 
Genes Sequence (5'-3')  Accession number 
C/EBP Alpha Forward: GAGTCGGCCGACTTCTAC   NM_012524 
 Reverse: GAAAGCCAAAGGCGGCGTT    
Probe CCCGATGAGCAGCCACCTCCAGA   
 
C/EBP Beta Forward: AGCGACGAGTACAAGATGCG  NM_024125 
 Reverse: GCTGCTCCACCTTCTTCTGC   
Probe TCTCCGCCGTCAGCTCCAGCACC   
C/EBP 
Gamma Forward: GCAAGCTGTCGCAGCCAG  XM_341842 
 Reverse: TGCTTGCTTGGAGGCACAG   
Probe ACTGCAGGAGTGAACGGGATCAGTGT   
C/EBP Delta Forward: CTGCCATGTATGACGACGAG  NM_013154 
 Reverse: TGATTGCTGTTGAAGAGGTCG   
Probe TGGCTGCCGTGCCCACCCTAGA   
C/EBP Epsilon Forward: TTGACCTCTCCGCCTACATC  NM_017095 
 Reverse: GGTAGTGAGGAAATGAAGGTG   
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Probe AACAGCTACTTTCTGACCTCTTGCCATGAA   
18S rRNA Forward: CGGCTACCACATCCAAGGAA      X01117 
 Reverse: TGG CAC CAG ACT TGC CCT C   
Probe CTTTCGAGGCCCTGTAATTGGAATGAGTC   
GAP-43                Forward: AGCCAAGGAGGAGCCTAAAC                                                     M16228 
                             Reverse: CTGTCGGGCACTTTCCTTAG  
SPRR1A   Forward: TCCATCACCATACCAGCAGA                                                       AA891911 
                             Reverse:  TAGCACAAGGCAATGGGACT                          
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Chapter 3: Expression of C/EBPs in the sciatic nerve after injury 
3.1 Generation of a C/EBP mRNA detection assay 
In order to develop a sensitive expression assay to detect and determine the changes in 
mRNA expression of the different members of the C/EBP family of transcription factors, 
SYBR Green and TaqMan Real Time- polymerase chain reaction (RT-PCR) analysis were 
performed 24 hours after LPS-induced inflammation in both brain and spleen of rats. LPS 
was used in these experiment since it was previously demonstrated that C/EBPs are 
upregulated following administration of LPS in vivo (Alam et al., 1992).  
 SYBR Green chemistry is a method used to perform RT- PCR analysis. SYBR 
Green is a dye that binds the Minor Groove of double stranded DNA. When SYBR Green 
dye binds to a double stranded DNA, the intensity of the fluorescent emissions increases. 
As more double stranded amplicons are produced, SYBR Green dye signal will increase. 
However, SYBR Green dye will bind to any double stranded DNA molecule in a reaction, 
including primer-dimers and other non-specific reaction products, which results in an 
overestimation of the target concentration. 
 TaqMan Probes are oligonucleotides that contain a fluorescent dye, typically on the 
5' base, and a quenching dye, typically located on the 3' base. When irradiated, the excited 
fluorescent dye transfers energy to the nearby quenching dye molecule rather than 
fluorescing, resulting in a non fluorescent substrate. TaqMan probes are designed to 
hybridize to an internal region of a PCR product. During PCR, when the polymerase 
replicates a template on which a TaqMan probe is bound, the 5' exonuclease activity of the 
polymerase cleaves the probe. This separates the fluorescent and quenching dyes and FRET 
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no longer occurs. Fluorescence increases in each cycle, proportional to the rate of probe 
cleavage. Therefore unlike SYBR Green chemistry, the TaqMan assay is specific to a pre-
determined target and it does not generate false positive signals.  
In this thesis I initially used SYBR Green RT-PCR, however, due to problems with 
false negative signals, I subsequently, replaced this method with the TaqMan RT-PCR. 
For the TaqMan RT-PCR analysis the mRNA levels of C/EBPα, β, γ, δ and ε were 
measured 24 hours after injection with LPS or saline as a control. The relative mRNA 
expression of five different members of the C/EBP family in the LPS versus saline 
condition was determined following normalization to the level of the ribosomal 18S, 
housekeeping gene, in each sample.  
Both SYBR Green and TaqMan RT-PCR analysis showed mRNA upregulation of 
the 5 different C/EBP members in the brain after LPS-induced inflammation in comparison 
to control groups (Fig. 14 and Fig. 15).  Similarly, SYBR Green and TaqMan RT-PCR 
showed mRNA upregulation of C/EBPβ and C/EBPδ and downregulation of C/EBPα, 
C/EBPγ and C/EBPε in the spleen after LPS treatment (Fig. 14 and Fig 15).   
However, these results showed that the magnitude of the C/EBP mRNA changes in 
the spleen and the brain after LPS treatment is different between the two Real Time-PCR 
methods (Fig. 14 and Fig. 15).  
The two RT-PCR methods indicated that transcriptional mRNA levels of C/EBPβ 
and C/EBPδ isoforms are upregulated in the brain and spleen after LPS-induced 
inflammation whereas C/EBPα mRNA is only upregulated in the brain but not in the spleen 
(Fig. 14 and Fig. 15). Furthermore, these results indicate that LPS treatment also increased 
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significantly C/EBPε mRNA expression in the brain (Fig 14A and Fig 15A). C/EBPγ 
mRNA showed a slight upregulation after LPS injection, however, this result was not 
statistically significant. 
         Additionally, C/EBPα, C/EBPγ, and C/EBPε mRNA expression was downregulated 
in the spleen, with the only exception of C/EBPβ and C/EBPδ, which were upregulated 
after LPS-induced inflammation (Fig 14B and Fig 15B). Notably by using TaqMan RT-
PCR, when compared to saline-injected control animals, the C/EBP expression in animals 
injected with LPS was significantly upregulated in the brain for isoforms alpha (p=0.009), 
beta (p=<0.001), delta (p=0.004) and epsilon (p=0.017). However, in the spleen only 
C/EBPδ was significantly upregulated (p=0.001). 
 In the brain, LPS injection upregulate C/EBPα, C/EBPβ, C/EBPδ and C/EBPε 
mRNA expression as compared to mRNA expression after control injections. TaqMan RT-
PCR indicated that these mRNA levels in the brain increased by 3-fold for C/EBPα, 3.5- 
fold for C/EBPβ, 4-fold for C/EBPδ and 5- fold for C/EBPε. Conversely, in the spleen, 
mRNA expression levels of C/EBPα, -γ and -ε measured by TaqMan RT-PCR, 24 hours 
after LPS treatment were significantly downregulated (Fig 15B). LPS injection raised 
dramatically the mRNA levels of C/EBPβ by 26-fold and to a less extent C/EBPδ by 2-fold 
when compared to control injections. However, SYBR Green RT-PCR indicated that 
C/EBPβ was increased 2 fold in the spleen after LPS treatment.   
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Fig. 14 SYBR Green real time-PCR measurement of C/EBPs mRNA expression 24 hours after LPS-
induce inflammation: (A) mRNA expression changes in the brain after LPS treatment. (B) mRNA 
expression changes in the spleen. Graph showing the normalized relative mRNA expression levels between 
LPS-injected versus saline-injected animals of five members of the C/EBP family (α-ε). Expression levels are 
showed as means of the ratio of C/EBPs mRNA to 18S mRNA. Saline injected animals were used as control.  
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Fig. 15 TaqMan real time-PCR measurement of C/EBPs mRNA expression 24 hours after LPS-induce 
inflammation: (A) mRNA expression changes in the brain after LPS treatment. (B) mRNA expression 
changes in the spleen. Graph showing the normalized relative mRNA expression levels between LPS-injected 
versus saline-injected animals of five members of the C/EBP family (α-ε). Expression levels are showed as 
means of the ratio of C/EBPs mRNA to 18S mRNA. Saline injected animals were used as control. (Mean ± 
S.E.M, n= 3 animals, *=P<0.05, **=P<0.01 and ***=P<0.001 by student‘s t-test). 
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3.2 C/EBP mRNA expression after crush axotomy of the sciatic nerve in vivo 
In order to study C/EBPs potential effect and involvement in nerve damage and subsequent 
axonal regeneration, the first objective was to screen five members of the C/EBP family 
and determine whether peripheral nerve injury elicits a regulatory response in the mRNA 
expression of the C/EBP family of transcription factors in vivo. The rat sciatic nerve injury 
model was used to compare the relative C/EBP mRNA expression, between the injured 
ipsilateral side and the uninjured contralateral side which was used as a control. C/EBP 
mRNA expression levels were measured in L4 and L5 DRGs. 
C/EBP mRNA expression analysis was performed by using a TaqMan RT-PCR 
assay, a more sensitive method than SYBR green RT-PCR method. In order to correct and 
compensate for intra-, inter-kinetic variations (sample-to-sample and run-to-run variations), 
cDNA sample loading variation and differences in the amount of starting material, all the 
samples were normalized against the housekeeping gene 18S ribosomal mRNA. mRNA 
expression was assessed in three different groups, in each group L4-L5 DRGs  from three 
animals were pooled together. Therefore, six different DRGs were used in each single 
experiment. Triplicates were measured in all the experiments.   
 
3.3 C/EBP mRNA expression after sciatic nerve injury in DRGs  
Following sciatic nerve crush, three different time points were selected for the in vivo 
analysis of the C/EBP mRNA expression between ipsilateral and contralateral DRGs. The 
first time point chosen was four hours after injury, representing early events in the neuronal 
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response to nerve damage, and the second time point was 24 hours after nerve injury and 
the last time point at a later stage of nerve damage, was 72 hours after injury. 
Analysis of the C/EBPs mRNA expression by TaqMan RT-PCR, following sciatic 
crush injury in vivo revealed that C/EBPβ, C/EBPγ and C/EBPδ were upregulated in 
ipsilateral L4-L5 DRGs compared to contralateral DRGs following sciatic nerve injury 
peaking at 4 hours (Fig. 16A).  
C/EBPβ, C/EBPγ and C/EBPδ mRNA levels increased significantly to 
approximately 3-fold within 4 hours after nerve injury (Fig. 16B). C/EBPβ mRNA 
expression resumed background levels by 24 hrs. C/EBPγ mRNA upregulation was 
maintained 24hrs after injury but returned to normal levels by 72 hrs after injury. C/EBPδ 
mRNA upregulation remained constant at 4, 24 and 72 hours following sciatic nerve crush 
in the ipsilateral side compared to the contralateral side (Fig. 16A). Relative mRNA 
expression shows that C/EBPα and C/EBPε were hardly detected in L4-L5 DRG neurons 
after sciatic crush (Fig. 16A).  
To demonstrate that the surgical procedure was carried out successfully and that the 
left sciatic nerve was properly crushed by compression, galanin was used as a control. The  
well known neuropeptide galanin is rapidly and highly upregulated after peripheral nerve 
injury in the adult (Wynick et al., 2001). Galanin mRNA expression was measured 72 
hours after nerve injury on L4-L5 DRG neurons from the ipsilateral and the contralateral 
side. Measurements of relative mRNA expression indicate that galanin was highly 
upregulated after nerve crush injury (Fig. 16A), demonstrating that the crush injury of the 
left sciatic nerve at the mid-thigh level was performed correctly.  
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Fig. 16  C/EBPs mRNA expression in DRGs following sciatic nerve injury crush: TaqMan RT-PCR 
measurements of mRNAs for C/EBPα, C/EBPβ, C/EBPγ, C/EBPδ and C/EBPε in rat L4 and L5 DRGs 
removed 4, 24 and 72 hours after sciatic nerve injury. Ratios of C/EBP mRNA are normalized to 18S mRNA. 
(A) Relative C/EBP mRNA expression levels between DRGs from the contralateral and ipsilateral side of the 
nerve crush. As control for the nerve crush galanin mRNA levels were measured 72 hours after nerve injury.  
(B) Fold increase indicates the ratio between C/EBP mRNA expression of DRGs from the ipsilateral and 
DRGs from the contralateral side after nerve crush. C/EBPα and C/EBPε display background levels, therefore 
no fold increase was calculated. (Mean ± S.E.M, n= 3, *=P<0.05 and **=P<0.01 vs. contralateral DRGs by 
student‘s t-test).   
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3.4 C/EBP mRNA expression in the lesion site of the sciatic nerve after crush 
Further analysis of the effect of nerve injury on the transcriptional expression of C/EBPs 
was carried out on the damaged area of the sciatic nerve (Fig. 17A). C/EBP mRNA 
expression were measured 72 hours following injury in the lesion site both ipsi- and 
contralaterally (Fig. 17B).  
Relative expression analysis indicated that C/EBPβ mRNA levels were significantly 
increased on the area were the nerve was crushed in comparison with the untouched 
contralateral side (Fig. 17B). C/EBPγ mRNA expression was slightly downregulated. 
However, this was not statistical significant. In contrast, C/EBPδ mRNA expression pattern 
was significantly downregulated (Fig. 17B). C/EBPα mRNA expression was close to 
background levels and C/EBPε was not detected. The C/EBPβ mRNA expression on the 
lesion site 72 hours after nerve injury was upregulated almost 1.4 fold in comparison with 
the uninjured contralateral side. In contrast, C/EBPδ mRNA concentration level on the 
ipsilateral side decreased almost 2.4 fold in comparison with the undamaged side (Fig. 
17B).  
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Fig. 17 C/EBP mRNA expression in the lesion site: (A) The left sciatic nerve was crushed by compression 
with forceps for 30 seconds at the mid-thigh level (L). Following injury L4 and L5 DRGs were taken from the 
ipsilateral side for mRNA expression analysis and compared to the uninjured contralateral side which was 
used as control. (B) Relative C/EBP mRNA expression levels between the contralateral and ipsilateral sciatic 
nerve lesion site 72 hours after nerve crush. (Mean ± S.E.M, n= 3, *=P<0.05 and **=P<0.01 vs. contralateral 
DRGs by student‘s t-test). 
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3.4 Discussion 
Generation of a C/EBP mRNA detection assay 
Initial experiments were designed to develop a sensitive quantitative RT-PCR assay that 
could be used in the analysis of small tissues such as DRGs and specifically to be used in 
the study of C/EBP expression upon different physiological responses. It was previously 
determined by Northern analysis that C/EBPs respond to inflammatory agents such as LPS 
(Alam et al., 1992). LPS is a major component of the outer membrane of gram-negative 
bacteria that contributes in great part to the induction of a strong immunological response 
upon stimulation. Consequently, the objective of these experiments was to develop a RT-
PCR assay by using the known study of the differential expression of C/EBP mRNAs in the 
LPS-induce inflammatory model. 
In order to validate the RT-PCR methodology, comparative results from northern 
analysis studies provided by Alam et al. (1992) were used. In that study, C/EBPβ and 
C/EBPδ were upregulated in brain and spleen following LPS treatment. C/EBPα mRNA 
expression was only upregulated in the brain and not in the spleen after LPS treatment. Our  
results validate the specificity and sensitivity of the TaqMan RT-PCR assay to measure the 
mRNA expression levels of different members of the C/EBP family, which can be further 
used for the assessment of the C/EBP transcriptional changes during different physiological 
states such as after nerve injury and during nerve repair.  
The results of this work indicated that LPS-induce inflammation regulates the 
transcriptional levels of the members of the C/EBP family of transcription factors which 
exhibit a degree of difference in their expression pattern in diverse tissues. The increase in 
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mRNA expression levels of C/EBPβ and C/EBPδ correlates with similar results in other 
studies showing a differential regulation of C/EBP isoforms in response to LPS and 
different cytokines. This has been shown by RT-PCR analysis of macrophages, where in 
general, the expression of C/EBPα was reduced and that of C/EBPβ and C/EBPδ was 
induced in the presence of LPS (Tengku-Muhammad et al., 2000; Bradley et al., 2003). An 
additional RT-PCR study indicates that C/EBPα, C/EBPβ and C/EBPδ mRNA expression 
is upregulated in rat glomerular mesangial cells after LPS treatment (Granger et al., 2000a).   
Another northern analysis study in mouse primary cortical astrocytes showed that 
C/EBPβ and C/EBPδ mRNA expression was induced after LPS and other pro-inflammatory 
cytokines in vitro (Cardinaux et al., 2000). However, none of the mentioned studies above 
examined the mRNA expression levels of C/EBPγ and C/EBPε, which is unique in this 
study. Furthermore, nuclear factor interleukin 6 (NFIL-6), a human homologue of C/EBP , 
has been shown to be highly upregulated by interleukins and LPS (Akira et al., 1990). In 
contrast C/EBPα is inhibited in most tissues and cell types (Akira et al., 1990; Poli et al., 
1990; Kinoshita et al., 1992; Ramji et al., 1994; Poli, 1998; Tengku-Muhammad et al., 
2000; Alam et al., 1992). 
In this study, TaqMan RT-PCR results indicated C/EBPα, C/EBPβ, C/EBPδ and 
C/EBPε were upregulated 3-5 fold in the brain 24 hours after LPS-induced inflammation. 
C/EBPβ and C/EBPδ were also seen to be upregulated in the spleen by 25 and 2 fold 
respectively following LPS treatment. In contrast, C/EBPα was downregulated in the 
spleen. Unique for this study was the analysis of the mRNA expression profile of C/EBPγ 
and C/EBPε which was also altered after LPS-induced inflammation. Similar results were 
obtained initially 24 hours after LPS-induced inflammation by SYBR Green RT-PCR 
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analysis. However, differences in the magnitude of the mRNA response were observed 
between the SYBR Green and the TaqMan RT-PCR analysis.  
Variations between SYBR Green and TaqMan RT-PCR results could be an effect of 
the different chemistries behind these two methods. SYBR Green assay uses a florescent 
dye that can bind to any double-stranded DNA even unspecific products. Amplified non-
specific products can modify the amplification efficiency for the specific products. 
Consequently, the amplification of non-specific products, such as primer dimers, results in 
a systematic error for the quantification independently of whether the non-specific products 
are detected or not. Additionally, if aggregations of primer dimmer formation take place in 
the late cycles, they will mask the signal resulting from the target amplification. The 
sensitivity can be restored by increasing the temperature at which the primer dimers are 
melted and hence do not contribute to the target signal measured. However, in this case, 
accurate quantification may be impaired. One major obstacle in the analysis of C/EBP 
mRNA expression is the fact that most of the C/EBP members are intronless. This makes it 
troublesome to develop primers for their detection due to the lack of an exon-intron 
boundary, giving rise in some cases to an unspecific amplification of genomic DNA 
resulting in high background levels. Additionally, all the members of the C/EBP family 
have over 90% homology on their basic leucine zipper region at the carboxyl-terminus, 
making it complicated to discriminate between the different isoforms. Furthermore, a great 
portion of the N-terminal DNA sequence of the C/EBPs does not fulfil the requirements for 
the design of an appropriate primer.  These technical difficulties gave rise to increased 
background levels and false positive results observed on negative control samples and on 
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unspecific bands in a 0.9% agarose gel (data not shown). Therefore, this approach was 
substituted by the TaqMan assay, which doesn‘t suffer from the same specificity problems. 
The TaqMan assay helps to detect and discriminate between the different C/EBP 
isoforms by adding an extra stringent factor to the reaction, a probe which is a single 
stranded oligonucleotide designed to bind only to the target DNA sequence between the 
two PCR primers. The TaqMan probe has two fluorescent tags attached to it. One is the 
reporter dye FAM and the other is the quencher TAMRA. The close distance between the 
reporter dye and the quencher inhibits the fluorescence signal. Therefore, intact probes do 
not fluoresce since they are quenched. Degradation of the TaqMan probe, by the Taq DNA 
polymerase, liberates the reporter dye from the quenching activity of TAMRA increasing 
the fluorescent activity, which is proportional to the amount of PCR product formed. 
Therefore in contrast to SYBR Green RT-PCR only specific PCR product can generate 
fluorescent signal in TaqMan RT-PCR. 
Another obstacle in the analysis of C/EBP gene expression after nerve injury is the 
limited amount of tissue which is even more aggravated due to the numerous isoforms 
present in this family of transcription factors. Therefore, L4-L5 DRGs from three different 
animals have been pooled together for each single experiment in order to compensate for 
the restricted amount of RNA extracted from single DRGs.  
Importantly, these results helped us to demonstrate that the TaqMan real time PCR 
assay is a sensitive assay for mRNA measurement of C/EBPs after different physiological 
conditions. Additionally, TaqMan real time PCR is a convenient method for assaying gene 
expression in small amounts of tissue such as the DRG. 
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C/EBP mRNA expression after sciatic nerve injury 
Several reports have shown that nerve injury to the CNS and PNS generate different 
molecular changes in the neuronal cell body (Broude, McAtee et al. 1997; Herdegen, Skene 
et al. 1997; Herdegen and Leah 1998; Schwaiger, Hager et al. 2000; Sheu, Kulhanek et al. 
2000), which is to some degree responsible for diverse regeneration outcomes in the 
respective nervous system. Peripheral nerve damage alters the expression of a series of 
genes including regeneration associated genes, in the DRG cell bodies, following with an 
increased production of several proteins necessary for regeneration (Plunet, Kwon et al. 
2002).  
One of the aims of my work is to study whether the C/EBP family of transcription 
factors have a potential role and involvement in axonal regeneration. In order to answer this 
question I first studied the C/EBPs expression profile following peripheral nerve damage, 
since upregulation after nerve injury is a prerequisite for involvement in axonal repair.  The 
results showed that the mRNA expression of C/EBPs is regulated after sciatic nerve injury 
in L4-L5 DRGs. C/EBP , C/EBP  and C/EBP  mRNA expression levels were upregulated 
3-fold, four hours after sciatic nerve injury. In agreement with these results, Nadeau et al. 
(2005) showed that C/EBPβ mRNA levels are increased in facial motor neurons following 
axonal injury, suggesting a potential role in neuronal regeneration analogous to its role in 
regeneration of other tissues. Additionally, they demonstrated that C/EBPβ is necessary for 
transcriptional induction of the Tα1 α-tubulin promoter following axonal injury and that its 
lack inhibits regular nerve-injury-induced upregulation of α-tubulin and GAP-43 mRNA, 
both essential for nerve repair.  
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On the other hand, it has been shown that C/EBPδ activation by  the receptor gp130 in 
cultures of dissociated Schwann cells of embryonic rat DRG affects the differential mRNA 
expression of the glial fibrillary acid protein, protein zero and myelin basic protein, 
suggesting that C/EBPδ might play a role in the switch to a myelinating phenotype, a 
switch functioning not only in the embryo during development but recapitulated after 
axonal injury during nerve regeneration (Kamaraju et al., 2004). Furthermore, gp130 
receptor has been involved in the activation of STAT-3 which becomes induced in 
axotomized DRG neurons (Qiu et al., 2005). STAT-3 activation can induce transcription of 
cytokine-responsive genes (Ihle, 2001; Heinrich et al., 2003) and it has been suggested to 
be involved in supporting survival of injured neurons by conditional knockout studies 
(Schweizer et al., 2002). It was unexpected to see an upregulation of C/EBPγ immediately 
after injury considering that C/EBPγ has an inhibitory effect on other C/EBP members.  
C/EBPγ can heterodimerize with other C/EBPs, it has a DNA binding domain but it lacks 
an activation domain.     
The results obtained 24 and 72 hrs after sciatic nerve injury indicate that the mRNA 
upregulation of C/EBP  and C/EBP  originally seen during the early events after axonal 
injury response is a transient effect, since only C/EBPδ mRNA upregulation is maintained 
72 hours after injury.  
Consistently, previous studies by microarray analysis have shown  that C/EBPδ is 
upregulated 2-3 fold in DRGs 12 and 24 hours after injury (Nilsson et al., 2005) although a 
4-fold upregulation has been found in sympathetic ganglia already 6 hours after axotomy 
and also after 48 hours (Boeshore et al., 2004). However, one study shows that C/EBPδ is 
upregulated transiently immediately after nerve lesion (5–8 h) (Bosse et al., 2006). 
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A main disadvantage with the RT-PCR method is the incapability to allow localization of 
transcripts to specific cells within a tissue. Therefore, it is unclear whether the detected 
C/EBP mRNA signals come from neuronal or non-neuronal cells within DRGs.  This 
problem could be circumvented by in situ hybridization. However, this technique is more 
complex and comparatively less sensitive than RT-PCR.  
 RT-PCR analysis showed a significant increase in the C/EBPβ mRNA levels and a 
significant decrease in the C/EBPδ mRNA levels in the ipsilateral side of the lesion site. 
These differences in the C/EBP mRNA expression between ipsilateral and contralateral 
side of the injury could suggest that C/EBP expression might be induced not only in 
neuronal cells but also in associated glial cells and macrophages surrounding the damaged 
axons which are normally recruited from the circulation and present in the degenerating 
sciatic nerve by 72 hrs after nerve injury. Therefore, future studies should include in situ 
hybridization experiments to analyze the C/EBP expression in non neuronal cells.  
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Chapter 4: C/EBP axonal outgrowth in cultured neurons 
4.1 C/EBP transcriptional activity during neurite outgrowth in vitro 
In order to determine whether C/EBPs are transcriptionally active during neurite sprouting 
the ND7/23 cell line was used for this experiment due to its ability to differentiate into a 
neuronal phenotype and induce neurite outgrowth upon stimulation with cAMP (Fig. 18A-
C). Undifferentiated ND7/23 cells (Fig. 18A) were treated with dbcAMP, a permeable 
analogue of cAMP. Cells untreated with dbcAMP did not differentiate and did not give rise 
to neurite outgrowth (Fig. 18A). Initial neurite sprouting was first noticed by day 1 
following dbcAMP treatment (Fig. 18B) and by three days after dbcAMP addition, fully 
differentiated ND7/23 cells with extended neurite outgrowth were observed under the 
microscope (Fig. 18C). Moreover, to assess C/EBP transcriptional activity, a commercial 
C/EBP luciferase reporter construct was used (Fig. 18D). Expression of the Photinus 
pyralis (firefly) luciferase gene in the reporter plasmid is controlled by a synthetic promoter 
that contains direct repeats of the transcription recognition sequences for C/EBP. C/EBP 
activation comprises the dimerization and binding of C/EBP to DNA, in this case, binding 
to the construct‘s recognition site in the promoter region. C/EBP binding to the promoter 
stimulates the luciferase reporter expression which can be measured and used as a direct 
approach to monitor the C/EBP transcriptional activity. 
C/EBP activity was assessed in ND7/23 cultures 1 and 3 days following dbcAMP 
addition. C/EBP activation levels were compared to cells untreated with dbcAMP which 
showed no neurite outgrowth. Initial neurite sprouting in ND7/23 cells, 1 day after 
dbcAMP addition (Fig. 18B), gave rise to a dramatic 157-fold increase in C/EBP protein 
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activation (Fig. 18E). A 24-fold increase of C/EBP protein activity was observed in fully 
differentiated ND7/23 cells, 3 days after dbcAMP treatment (Fig. 18E). As a control cells 
transfected with the C/EBP luciferase reporter construct but untreated with dbcAMP were 
used. Control cells showed similar luciferase expression levels as dbcAMP untreated cells 
(Fig. 18E). Altogether these results indicate that neurite outgrowth as a result of dbcAMP 
treatment increases the C/EBP protein activity. 
 
4.2 C/EBP mRNA expression during neurite outgrow 
In order to determine which members of the C/EBPs are upregulated during neurite 
outgrowth, their relative mRNA expression was measured. mRNA expression levels for 
C/EBP different members were measured on ND7/23 cells treated with cAMP for 1 day, 
during differentiation, and 3 days which were fully differentiated cells. C/EBP mRNA 
expression levels after cAMP were compared to a control group consisting of 
undifferentiated cells, untreated with cAMP, which did not show neurite outgrowth. As a 
control for development of neurites, GAP-43 was measured in fully differentiated ND7/23 
neuronal cells and also in undifferentiated cells (Fig. 18F). Relative expression studies were 
performed by TaqMan RT-PCR as described before, during and post differentiation. Cells 
during differentiation treated with cAMP for 1 day showed mRNA upregulation compared 
to   cAMP untreated/undifferentiated cells. This upregulation was significant for both 
C/EBPβ (p=0.02) and C/EBPδ (P=<0.0001). Furthermore, in differentiated cells with long 
neurites on day 3 following cAMP treatment compared to cAMP untreated/undifferentiated 
cells, RT-PCR analysis indicates that the mRNA expression was significantly upregulated 
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for C/EBPβ and C/EBPδ as well as for GAP-43 (Fig 18F). C/EBPα, C/EBPγ and C/EBPε 
mRNA were not detected in cells during and after differentiation or in the cAMP untreated 
group. Furthermore, C/EBPβ mRNA level was increased almost 5 fold 1 day after cAMP 
treatment when the cells were still differentiating and 15 fold after neurite outgrowth 
whereas C/EBPδ mRNA concentration was increased approximately 35 fold during 
differentiation and 26 fold after neurite outgrowth. These results indicate that C/EBPβ and 
C/EBPδ expression is highly upregulated during neurite elongation in ND7/23 cells and it 
appears to be responsive to cAMP in this particular neuronal system.  
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Fig. 18 Neurite outgrowth on ND7/23 cells induced by cAMP exhibits increased C/EBP expression: (A) 
Normal undifferentiated ND7/23 cells where treated with 1 mM dibutyryl cAMP in order to induce neurite 
outgrowth. (B) Differentiation of ND7/23 cells by means of neurite elongation was initially observed 1 day 
following cAMP. (C) Further neurite elongation was seen three days after treatment on fully differentiated 
cells. (D) Characterisation of the reporter construct transfected into ND7/23 cells and used to monitor the 
activation of C/EBPs. The components of the construct include a recognition site (C/EBP), a basic promoter 
element (TATA box) and a reporter gene (luciferase). (E) C/EBP-luciferase activity (counts/second) 1 and 3 
days following cAMP addition to ND7/23 cultures compared to cAMP untreated cells. As a control 
untransfected cells treated with cAMP were used. (F) Relative C/EBPβ and C/EBPδ mRNA expression in 
ND7/23 cells untreated with cAMP (undifferentiated), treated with cAMP for 1 day (during differentiation) 
and treated with cAMP for 3 days (differentiated). Expression levels are showed as means of the ratio of 
C/EBP mRNA normalized to 18S mRNA. As a control for neurite outgrowth GAP-43 was used (Mean + 
S.E.M., n= 3, *=P<0.05 and ***=P<0.001 by student‘s t-test).  
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4.3 Conditional downregulation of C/EBPs in ND7/23 cells 
To assess the involvement of C/EBPs on neurite outgrowth in differentiated cells; two 
conditionally regulated constructs were engineered by using the TetON system to inhibit 
the expression of the C/EBPs once the ND7/23 cells have acquired a neuronal phenotype.
 The constructs were transfected into ND7/23 cells and after induced differentiation 
with cAMP; the constructs were conditionally activated by addition of doxycycline, a 
tetracycline derivative. Due to the bidirectional promoter of the constructs, capable of also 
expressing green fluorescent protein (GFP), transfected cells were readily detected (Fig. 
19A). Construct expression was assessed in culture before (Fig. 19B) and after addition of 
doxycycline (Fig. 19C). Transfected ND7/23 cells without doxycycline did not show GFP 
expression (Fig. 19B) whereas transfected cell treated with doxycycline displayed GFP 
expression indicating construct activation (Fig. 19C). 
  A total dominant inhibitor construct, was designed to target all the C/EBP 
members (Fig. 20B) whereas a C/EBPδ antisense construct downregulates only the 
expression of C/EBPδ (Fig. 20C).  
Three days after transfection, the ND7/23 cells were fixed and stained with the 
neuronal marker PGP9.5 to indicate neuronal differentiation (Fig. 20A-C). The longest 
neurite of green GFP positive cells for each group (Fig. 20A-C) were measured and 
compared with a control group consisting of cells transfected with a construct expressing 
only GFP (Fig. 20A). 
Total inhibition of all the C/EBPs by using a dominant negative construct showed a 
statistically significant decrease in the average neurite length of neuronal ND7/23 cells by 
136 
 
41%, in comparison with GFP control group (Fig. 21A). Cells transfected with C/EBPδ 
antisense showed a similar effect, reducing the average neurite length by 33% in 
comparison with GFP control group (Fig. 21A). In cells transfected with GFP alone, the 
percentage for the longest neurites <30 μm, 30-100 μm, or >100 μm was 60%, 36% or 4% 
respectively (Fig. 21B). C/EBP dominant inhibitor resulted in increased percentage of cells 
with neurites <30 μm (87%) and decreased percentage of cells with neurites 30-100 μm and 
>100 μm (11% and 2% respectively). Similarly, after transfection with C/EBPδ antisense, 
the percentage of cells with neurites <30 μm increased to 75% and the cells with neurites 
30-100 μm, or >100 decreased to 23% and 2% respectively. These results indicate that total 
inhibition of all the C/EBPs and downregulation of C/EBPδ in ND7/23 cells decreases 
overall neurite growth and specifically increases the percentage of cells with small neurites 
<30 μm and decreases the percentage of cells with medium and long neurites 30-100 μm 
and >100 μm. 
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Fig. 19. The bidirectional conditional TetON system: Tetracycline conditional backbone plasmid (A) used 
to generate C/EBP conditional inhibitory constructs (Fig. 17). The pBI-EGFP bidirectional Tet expression 
vector allows the simultaneous expression of gene of interest (in our case C/EBP inhibitory constructs) and 
enhanced green fluorescent protein (EGFP) under the control of a bidirectional tetracycline-responsive 
promoter (Pbi-1) which is responsive to rtTA regulatory proteins.  Pbi-1 contains the tetracycline responsive 
element (TRE), which consists of seven copies of the 42bp tetracycline operator sequence (tetO). The TRE 
element is in between two identical minimal CMV promoters (PminCMV), which lacks the enhancer that is part 
of the complete CMV promoter. Consequently, Pbi-1 is silent in the absence of binding of rtTA to the tetO 
sequences. PminCMV-1 controls the expression of EGFP and PminCMV-2 controls the expression of the gene of 
interest. The vector backbone of the vector contains an ampicillin resistance gene and a Col E1 origin of 
replication to allow selection and propagation in E. coli. (B) Plasmid transfected into ND7/23 cells (C) was 
conditionally activated with doxycycline.  
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Fig. 20 Neurite elongation on ND7/23 cells transfected with conditionally-regulated constructs: ND7/23 
cells treated with cAMP and induced into a neuronal phenotype were thereafter transfected with three 
different constructs and stained with the neuronal marker PGP9.5 (red) and GFP (green). Tetracycline 
conditionally regulated C/EBP inhibitory constructs transfected into ND7/23 cells were designed by using the 
pBI-EGFP vector backbone (Fig. 18A). Control construct expressing only GFP (A), construct expressing a 
C/EBP dominant inhibitor and GFP (B) construct expressing C/EBPδ antisense and GFP(C). Compared to 
GFP control (A), total inhibition of C/EBP expression (B) and specific inhibition of C/EBPδ (C) decrease 
neurite elongation. Note the neurite length of the green fluorescent cells for each group. Scale bar, 100 µm.  
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Fig. 21 Suppression of C/EBPs and down-regulation of C/EBPδ impairs neurite outgrowth in 
differentiated neuronal ND7/23 cells: (A-B) The length of neurites of only green GFP positive cells was 
measured. (A) Inhibition of all the C/EBPs
 
reduced the neurite length of differentiated ND7/23 cells 
previously treated with cAMP by 41% and down-regulation of C/EBPδ reduced the neurite length outgrowth 
by 33% compared to cells transfected with GFP control. (n= 3 cultures, mean ± S.E.M; 
***
p < 0.001 Student's 
t test). (B) Frequency histogram shows the percentage of cells with neurites in each of the three length ranges.  
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4.4 TSA increases C/EBPδ activity in ND7/23 cells 
To further examine whether epigenetic modifications can influence the transcriptonal 
activity of C/EBPδ, ND7/23 cells were treated with cAMP followed by stimulation for 24 
hrs with the histone deacetylase inhibitor, Trichostatin A (TSA) and  compared with TSA 
untreated cells. Strinkingly, only 25% of the cells were immunostained for C/EBPδ after 24 
hrs in culture (Fig. 22A) whereas approximately 50% of the cells treated with TSA showed 
C/EBPδ staining (Fig. 22B).  This significant increase in the C/EBPδ expression after 
stimulation with TSA (Fig. 22C) did not show any increase in neurite length after 24 hrs 
compared with untreated cells (Fig. 22D). However, a statistically significant higher 
percentage of cells treated with TSA displayed neurite processes compared to TSA 
unstimulated cells (Fig. 22E). 
These results indicate that  histone deacetylase inhibition by TSA augments  
C/EBPδ expression in vitro.  
 
 
 
 
 
 
141 
 
 
 
     
Fig. 22 ND7/23 cells stimulated with TSA showed an increase C/EBPδ activity: ND7/23 cells 
immunostained for C/EBPδ after cAMP treatment (A) followed by stimulation with TSA for 24 hrs (B). After 
TSA treatment, a higher percentage of cells express C/EBPδ in comparison with TSA unstimulated cells (C). 
TSA treatment does not increase the neurite length in cultured cells (D). Nevertheless, 24 hrs after TSA 
treatment, a higher percentage of ND7/23 cells show neurite processes (E). (Mean ± S.E.M., n= 3 cultures, 
**=p<0.005 ***=P<0.001 by student‘s t-test). Scale bar = 100 um. 
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4.5 Lack of C/EBP delta affects the intrinsic growth capacity of DRG neurons 
To assess the influence of C/EBPδ on the intrinsic growth capacity of sensory neurons, 
DRG neurons from C/EBPδ null mice were cultured for 2 days. Neurons then were fixed, 
DAB immuno-stained for β(III) tubulin and the length of the longest neurite was recorded 
and compare to wildtype DRG neurons (Fig. 23A-B). DRG neurons from wildtype 
exhibited an average neurite length of 540 μm (Fig. 23A) whereas DRG neurons from 
C/EBPδ deficient animals failed to extend long neurites with an average of 167 μm (Fig 
23B). In DRG neurons from wildtype animals, the percentage of neurons with longest 
neurites <30 μm, 30-200 μm and >200 μm was 2%, 9% and 89% respectively (Fig. 23D). 
In DRG neurons from C/EBPδ null animals, the distribution of neurite lengths for <30 μm, 
30-200 μm and >200 μm was 41%, 29% and 29% respectively (Fig. 23D). These results 
show that C/EBPδ is required for initial DRG neurite outgrowth indicating that lack of 
C/EBPδ affects the intrinsic growth capacity of sensory neurons in vitro. 
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Fig. 23 The lack of C/EBPδ inhibits neurite outgrowth in DRG cultures: (A) DRG neurons from wildtype 
showing DAB staining for β(III) tubulin (B) Neurite elongation in DRG neurons from C/EBP delta -/- mice is 
significantly reduced compared with wildtype growth after 2 days in culture. Scale bar 100 μm. (C) 
Frequency histogram for wildtype and C/EBP delta -/- DRG neurons cultured for 2 days. n=3. (D) Mean± 
S.E.M. neurite lengths for wildtype (540 ± 34 μm) and C/EBP delta -/- (167 ± 19 μm) ***=P<0.001 by 
student‘s t-test. 
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4.6 Discussion 
cAMP induced neurite outgrowth and C/EBP activity  
Several signaling pathway cascades and intrinsic factors of the neuron have been implicated 
to have a role in neuronal outgrowth and regeneration. A line of investigation demonstrated 
that among these factors, the second messenger cAMP is a prominent and important one. 
Previously, it has been shown that cAMP is involved in the modulation of growth cone 
response to a variety of different diffusible and non-diffusible factors (Song et al., 1997), 
influencing guidance of growth cones towards chemoattractive signals (Ming et al., 1997), 
enhancing neurite outgrowth (Kao et al., 2002), overcoming the MAG inhibition effect on 
adult nerve cell extension of neurites (Cai et al.,2001) and promoting neuronal survival 
(Hanson, Jr. et al., 1998; Rydel and Greene, 1988). Importantly, some recent reports have 
indicated that elevation of cAMP promotes axonal regeneration in the central nervous 
system (Qiu et al., 2002; Pearse et al., 2004). 
To examine a possible involvement of the C/EBPs in neurite extension induced by 
cAMP, we used in this study, the sensory neuronal cell line, ND7/23, a neuroblastoma 
fused with a DRG cell line, which retains the same characteristics of normal DRG but not 
the properties from parental neuroblastoma and with the unique feature of not being post 
mitotic like regular DRG neurons. This specific hallmark makes the ND7/23 cell line ideal 
for in vitro experiments given that they can be kept in culture indefinitely. Due to the 
ability to divide and proliferate, they can be readily transfected which is another important 
feature that allows the study of the effect of gene manipulation.  
145 
 
Here I examined the C/EBP activity during neurite outgrowth in the ND7/23 in vitro model 
by using a generic C/EBP luciferase reporter construct. C/EBP luciferase activity was 
dramatically increased during the initial step of neuronal differentiation and neurite 
outgrowth 1 day after cAMP treatment. The C/EBP activity was also increased 3 days after 
cAMP treatment, in fully differentiated, ND7/23 cells, expressing long neurites. However, 
the increment in C/EBP activity observed 3 days after cAMP treatment was substantially 
less than the activity observed after 1 day, indicating that member of the C/EBP family are 
more active during the differentiation process distinguished by initial neurite sprouting than 
post differentiation, which could suggest that some C/EBPs are associated with certain 
growth cone elements.  
Previous studies have shown that C/EBPβ is active in neural precursor cells (NPC) 
following differentiation into neurons, but not following differentiation into astrocytes 
(Cheeran et al., 2005). C/EBPs have been shown to couple growth factor induced signal 
transduction to cellular differentiation in numerous tissues (Lekstrom-Himes and 
Xanthopoulos, 1998). Activation of an
 
MEK-C/EBP pathway in cortical precursors in vivo 
biases them
 
to become neurons and against becoming astrocytes, thereby acting
 
as a growth 
factor-regulated switch (Menard et al., 2002; Paquin et al., 2005). Additionally it has been 
shown that basic helix-loop helix (bHLH) transcription factors are important intrinsic 
regulators of neural fate determination and differentiation. Retroviral transduction of 
various neural bHLHs is sufficient to determine neuronal or glial fate in the developing 
mouse cortex (Cai et al., 2000). Furthermore, In vitro studies have shown that C/EBP 
luciferase is activated in Caco-2 cells after treatment with cAMP (Hershko et al., 2002) and 
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Neuro 2a cells during neurite outgrowth activate GADD153, which is a C/EBP homologous 
protein (Dikshit et al., 2006). 
In view of the fact that the C/EBP luciferase construct detects the activity of all the 
C/EBP members, further studies are required to determine which C/EBPs isoforms are 
active during neurite elongation. Perhaps by using luciferase constructs specifically 
designed for each C/EBP isoform.  
Following the detection of increased C/EBP luciferase activity during neurite 
outgrowth, I measured the C/EBPs mRNA expression in order to determine which 
members of the C/EBP family are upregulated during neurite elongation. Here we report 
that the cAMP-induced neurite outgrowth in ND7/23 cells gave rise to an increase in the 
mRNA expression levels of two of the most prominent members of this family of 
transcription factors, namely C/EBPβ and C/EBPδ. The upregulation of mRNA expression 
levels observed here were 5 to almost 35-fold during and after neuronal differentiation and 
neurite sprouting, 1 day and 3 days following cAMP treatment. This upregulation was 
almost as high as for the positive control GAP-43 which is an important growth associated 
proteins involved in axonal regeneration (Bomze et al., 2001; Frey et al., 2000). However 
no associative studies between GAP-43 and C/EBP role in neurite outgrowth were 
performed in this work. In previous studies on rat PC12 pheochromocytoma cell line, 4 
hours after treatment with the cAMP analogue, 8Br-cAMP, a 6-fold upregulation of 
C/EBPβ mRNA was seen, while levels of C/EBPδ mRNA were not significantly changed. 
The different responses of C/EBPβ and δ to cAMP in PC12 cells is surprising given that the 
promoters of both genes contain cAMP Regulatory Elements (CRE) and are inducible by 
cAMP in other cell types, including hippocampal neurons (Yukawa et al., 1998). However, 
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even though PC12 cells have been used for many years to model neuronal functions, these 
cells are certainly not neurons, unlike the sensory neural cell line ND7/23. 
 
Conditional downregulation of C/EBPs in ND7/23 cell 
My previous results indicated that C/EBP-Luciferase and C/EBP mRNA expression is 
upregulated during neurite elongation. To further address whether C/EBPs are important for 
neurite outgrowth in neuronal cells, conditional TetON inhibitory constructs were designed. 
The ND7/23 cells require cAMP in order to acquire a neuronal phenotype (Wood et al., 
1990), therefore the use of a conditional approach was necessary in order to activate the 
construct in post-differentiated cells and not immediately after transfection when the cells 
are undifferentiated.  
A conditional dominant negative C/EBP provides an effective tool for investigating 
the effect of repression of all the C/EBP members by overcoming the problem of functional 
redundancy among related gene products. In this case we used A-C/EBP as a dominant 
negative, which possesses a leucine zipper but lacks functional DNA-binding and 
transactivation domains and heterodimerizes specifically with C/EBPs. A-C/EBP 
specificity has been successfully tested and implemented previously by other groups 
(Greenwel et al., 2000; Olive et al., 1996; Zhang et al., 2004). My results shows that the 
general effect of a total C/EBP inhibition is unequivocal; it reduces the average neurite 
length by 41% and decreases the percentage of cells with medium (30-100 μm)  and long 
size neurites (>100 μm), from 36% to 11% and from 4% to 2% respectively when 
compared to GFP controls. Additionally, since my previous results indicated that C/EBPδ is 
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upregulated after peripheral injury and during neurite elongation, a C/EBPδ antisense 
conditional construct was also designed to inhibit C/EBPδ expression specifically during 
neurite outgrowth. Average neurite elongation is also affected by C/EBPδ downregulation 
which is reduced by 33% and the percentage of cells with medium (30-100 μm) and long 
size neurites (>100 μm) decreased from 36% to 23% and from 4% to 2% respectively. 
Although, the average neurite length was reduced in cells transfected with the 
conditional TetON inhibitory constructs, I failed to demonstrate whether the conditional 
constructs downregulated the expression of the different C/EBP members. Furthermore, the 
transfection efficiency could have been higher. Therefore, to demonstrate if the C/EBP 
expression has been successfully targeted, an improved transfection protocol should be 
developed by combining the co-transfection of the dominant negative conditional construct 
or the C/EBPδ antisense conditional construct with the C/EBP luciferase plasmid.   
Additionally, the transgenic inhibition of C/EBPs suggests that C/EBPs are 
important factors during neurite outgrowth; however, since C/EBPs can form protein–
protein interactions with other bZIP and non-bZIP factors, further studies are required to 
identify C/EBPs downstream target genes involved in neurite outgrowth. Additionally, 
overexpression studies should be conducted to elucidate whether the upregulation of 
C/EBPs gives rise to increased neurite elongation. It has been shown that C/EBPγ is an 
inhibitor of C/EBP transcriptional
 
activation since it lacks an activation domain and, 
therefore, represses gene transcription by forming inactive heterodimers with other C/EBP 
members (Ramji and Foka, 2002). Therefore, combinatorial experiments by inhibition of 
C/EBPγ and overexpression C/EBPδ could further increase neurite outgrowth.  
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TSA increases C/EBPδ activity in ND7/23 cells 
Here I showed that TSA upregulates the expression of C/EBPδ in vitro. However, this 
increase in the C/EBP activity does not have an evident phenotypic effect on the neurite 
length of the ND7/23 cells 24 hours after treatment. The average neurite length for the TSA 
treated and non-treated group was approximately 34 μm, which is similar to the neurite 
length observed previously in ND7/23 cells transfected with the conditional GFP control 
construct and cultured with cAMP for 3 days (Fig. 20A). For quantification analysis, the 
length of the longest neurite for each neuron was measured and this was done only in cells 
with neurites longer than one cell diameter. In comparison, the TSA treated group showed a 
higher number of cells with neurites compared to the TSA untreated group. Since both 
groups were treated with cAMP for 24 hrs, this difference can be only explained by the 
stimulation with TSA. It would be interesting to study the effect, especially on the neurite 
length, of TSA in culture cells 3 days after cAMP treatment since previous observation in 
the lab has shown that by that day most of the ND7/23 cells express long neurites. 
 Nuclear histone acetylation has an important role in transcriptional regulation. It is a 
reversible process regulated by a group of histone acetyltransferases (HATs), which 
promote acetylation, and histone deacetylases (HDACs), which promote deacetylation. 
HATs activate transcription by enhancing nucleosomal relaxation. On the other hand, 
HDACs can stabilize nucleosomal structures and repress transcription. Recent studies have 
shown that histone acetyltransferases can also acetylate a variety of non-histone proteins, 
such as transcriptional factors and signalling proteins (Greene and Chen, 2004). TSA 
induces acetylation of histones by neutralizing positive charges on their tail regions, 
reducing histones ability to bind to DNA and thus loosening the structure of chromatin, 
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resulting in a more ‗open‘ chromatin conformation. Therefore, highly acetylated regions are 
more accessible to transcription factors which are actively transcribed (Toth et al., 2004). 
There is emerging evidence indicating that TSA stimulation at various cellular and 
molecular levels is involved in the regulation of the C/EBPs transcriptional activity. 
Acetylation of histones by TSA inhibits the degradation of the C/EBP Homologous Protein 
(CHOP) in vitro (Ohoka et al., 2007). Additionally, it has been reported that TSA 
upregulates C/EBPδ expression in human breast cancer cell line (Tang et al., 2006).  
Interestingly, DiGiovanni‘s group previously reported at FENS 2008 (Gaub P, 2008), that 
the facilitation of HAT activity by using TSA switches the intrinsic neuronal genetic 
program from a non permissive to a permissive pattern leading to increased neurite 
outgrowth. Therefore future studies should investigate in detail the processes of histone 
acetylation/deacetylation on primary sensory neurones, their impact on neuronal repair and 
the possible participation of the C/EBPs.  
 
Lack of C/EBP delta affects the intrinsic growth capacity of DRG neurons 
My data so far indicate that C/EBPs, specially –β and –δ are expressed in response to 
peripheral nerve injury and neurite outgrowth. However, since previous studies have linked 
C/EBPβ with a potential role in the neuronal response to injury (Nadeau et al., 2005). I 
decided from this point to concentrate on the novel analysis of C/EBPδ.  
I initially, examined the effects of the lack of C/EBPδ on the intrinsic growth 
capacity of DRG neurons in culture by using C/EBPδ null animals generated by Sterneck 
and colleagues (Sterneck et al., 1998). DRG neurons from wildtype animals cultured for 2 
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days showed an average neurite length of 540 μm whereas DRG neurons from C/EBPδ null 
mice surprisingly displayed an average neurite length of 167 μm. Additionally, distribution 
of neurite lengths indicated that in knock-out DRGs the majority of the total number of 
neurons (41%) has small neurites of less than 30 μm. Simultaneously, only 29% of C/EBPδ 
null DRGs showed long size neurites of more than 200 μm. On the other hand in wildtype 
DRGs almost 90% of total number of neurons extended long neurites of more than 200 μm 
after 2 days in culture.  
These results in adult DRG cultures showed almost a 70% reduction of the neurite 
length from C/EBPδ null mice compared to wildtype. This reduction is much greater than 
the neurite length reduction oberserved in ND7/23 cells after transfection with a C/EBP 
dominant inhibitor or a C/EBPδ antisense construct (41% and 33% reduction respectively). 
A possible explanation could be the differences between the two cell type, one being a 
hybrid cell line and the other a primary cell line. Another possible explanation could be the 
fact that the adult DRGs came from knockout animals were the C/EBPδ gene has been 
totally removed from the whole animal whereas C/EBPδ expression in the ND7/23 cells 
was downregulated by using constructs which might have not been 100% efficient.   
These novel findings clearly indicate that C/EBPδ is an important factor in the 
intrinsic growth capacity displayed by DRG neurons in vitro and may provide an important 
target for inducing axon regeneration in vivo. 
It could be suggested that the lack of C/EBPδ affects the cAMP-PKA-CREB 
signalling pathway which is known to promote neurite outgrowth in DRG sensory neurons 
and motor neurons (Murray et al., 2009; Aglah et al., 2008; Chen et al., 2007). Activation 
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of cAMP and CREB is sufficient to overcome inhibition by myelin and to promote spinal 
axon regeneration in vivo (Gao et al., 2004). Therefore if C/EBPδ acts downstream of the 
cAMP-PKA-CREB, it would broaden the spectrum of possible targets for therapeutic 
intervention in vivo. Future studies should focus on the effect of C/EBPδ overexpression in 
CNS injuries and to elucidate whether C/EBPδ overcomes inhibition by myelin.  
 It was previously mentioned that in the nervous system cAMP elevation leads to 
C/EBPδ upregulation in hippocampal neuron (Yukawa et al., 1998), rat cerebral cortex 
(Colangelo et al., 1998) and during long term memory consolidation in Aplysia models 
(Guan et al., 2002) and in mice (Taubenfeld et al., 2001). cAMP is an important 
intracellular signalling molecule that among other things, leads to the transcriptional 
activation of a number of genes. cAMP generally exerts its effects in cells via the activation 
of PKA which catalyses the transfer of the terminal phosphate group of ATP to specific 
serine and threonine residues within select proteins, such as transcription factors. Within 
the regulatory region of certain genes exists a short DNA sequence called CRE. This DNA 
sequence is recognized by the gene regulatory protein CREB. When PKA phosphorylates 
CREB at a specific serine residue, the CREB protein becomes activated, leading to the 
transcriptional activation of CREB regulated genes (Alberts et. al., 1994). cAMP mediated 
regulation of C/EBPδ has been also reported by Cardinaux and Magistretti, (1996) and a 
CRE site has been identified in the promoter region of C/EBPδ (Cantwell et al., 1998). 
Therefore C/EBPδ expression may be regulated by cAMP via PKA and CREB proteins and 
their neurite outgrowth-promoting might be absent in DRG cultures lacking C/EBPδ. 
However, further studies are required to directly examine the expression of cAMP, PKA 
and CREB proteins in DRG neurons lacking C/EBPδ.  
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Chapter 5: Function of C/EBPδ in axonal regeneration 
5.1 Evaluation of sciatic nerve axons in C/EBPδ null mice 
My in vitro experiments have shown that C/EBPδ is upregulated following peripheral nerve 
injury and that C/EBPδ is required in DRG neurons to extend long neurites. Therefore in 
order to determine whether C/EBPδ is an important factor for nerve regeneration in vivo, 
we used the sciatic nerve crush model in wildtype and C/EBPδ -/- mice. The sciatic nerve 
crush model is a well-characterized model of peripheral nerve regeneration. After a crush 
lesion, nerve fibres in the distal stump degenerate. Myelin and axon debris are removed by 
the process of Wallerian degeneration. The endoneurial tubes remain intact, enabling fast 
and qualitatively good anatomical and functional recovery. 
First I examined whether the lack of C/EBPδ in C/EBPδ -/- mice had any 
phenotypic effect on the axons of the sciatic nerve under normal physiological conditions. 
Thus, semi-thin transverse sections of uninjured sciatic nerve from wildtype (Fig. 24A-B) 
and C/EBPδ -/- mice (Fig. 24C-D) were compared following staining with Toluidine blue. 
Initial observations on images taken with a 20X objective (Fig. 24 A and C), showing a 
transverse section of the entire sciatic nerve, indicated that similar density of axons were 
present in wildtype as in C/EBPδ -/- mice. Furthermore, axons were analysed quantitatively 
over a surface of 18,225 μm² area, using a calibrated grid was conducted on the sciatic 
nerve of wildtype and C/EBPδ -/- mice (Fig. 24 B-D). The sciatic nerve from wildtype 
animals (Fig. 24B) exhibited a similar axonal density 475 ± 59 vs. 470 ± 55 when 
compared to knockout animals (Fig. 24E). This finding shows that the lack of C/EBPδ does 
not affect the morphology of the sciatic nerve. 
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Fig. 24 C/EBPδ -/- animals display equal number of axons than wildtype: Cross-sections of uninjured sciatic 
nerves stained with Toluidine blue shows the number of axons in (A-B)  wildtype compared to (C-D) C/EBPδ -/- . 
Pictures were taken with 20X magnification A and C and with 100X magnification in B and D. Scale bar in A = 
100 μm and in B= 10 μm.  (E) Quantification of the data showing equal number of axons in the sciatic nerve of 
wildtype than in C/EBP δ -/- mice. n=3 animals. 
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5.2 Muscle strength assessment of C/EBPδ -/- mice 
In order to elucidate whether the lack of C/EBPδ affects the neuromuscular function, a grip 
strength test was performed on uninjured C/EBPδ -/- and wildtype animals. Mice are 
allowed to grasp a mesh pull bar with the fore and hind limbs and are then pulled backward 
in the horizontal plane. The force applied to the bar, at the moment the grasp is released, is 
recorded as the peak tension (force g). The test is repeated 5 consecutive times within the 
same session and the highest value from the 5 trials is recorded as the grip strength for that 
animal. Mice were not trained prior to testing and each mouse is tested once (5 trials equal 
one test session). 
The grip strength test shows no difference between wildtype and C/EBPδ null 
animals (Fig. 25). This indicates that the lack of C/EBPδ has no anatomical and no 
functional impact on the sciatic nerves.     
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Fig. 25 Grip strength test in wildtype vs. C/EBPδ -/- mice: Forelimb and hindlimb grip strength was 
assessed by measuring the force (g) applied to a mesh pull bar using a lateralized grip strength meter. No 
difference between wildtype and C/EBPδ -/- mice was observed in the grip strength test (Mean ± S.E.M., n= 8 
animals). 
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5.3 Sciatic nerve regeneration assessment in C/EBPδ null mice by 
immunohistochemistry. 
Nerve regeneration was assessed 3 days (Fig. 26) and 2 weeks (Fig. 27) following nerve 
crush by immunostaining with the regeneration associated gene GAP-43 and the neuronal 
marker PGP9.5. Immunohistochemistry for GAP-43 in wildtype animals identified 
continuous fibres that extend distally from the crush site for at least 3mm in sciatic nerves 3 
days (Fig. 26A) and 2 weeks (Fig. 27A) after injury. In contrast, GAP-43 staining was 
hardly detected in the sciatic nerve of C/EBPδ -/- mice after 3 days (Fig. 26B) and 2 weeks 
(Fig. 27B). A similar pattern was observed after staining with PGP9.5 3 days following 
injury. Sciatic nerve from wildtype animals showed strong PGP9.5 immunoreactivity (Fig. 
26C) whereas density of PGP9.5 immunoreactivity was reduced in C/EBPδ -/- mice (Fig. 
26D). However, 2 weeks after injury, image analysis indicated that there was no difference 
in the PGP9.5 staining between wildtype and C/EBPδ -/- null mice. Quantitative analysis of 
sections 1, 2 and 3mm distal from the injury site of the sciatic nerve, confirmed that GAP-
43 was significantly reduced 3 days and 2 weeks after injury in C/EBPδ knock-outs (Fig. 
26E and 27E) whereas PGP9.5 was significantly reduced in C/ EBPδ knock-outs after 3 
days (Fig. 26F) but not 2 weeks following injury (Fig. 27F).  
These data suggest that C/EBPδ is important for peripheral nerve regeneration and 
the lack of C/EBPδ reduces the expression of GAP-43 and delays the expression of PGP9.5 
in nerve regenerating axons.    
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Fig. 26 Regeneration of the sciatic nerve 3 days after injury is impaired in C/EBPδ null mice: 
Representative microphotographs showing the extent of nerve regrowth detected by the staining intensity of 
neuronal regeneration markers 3 days after nerve crush (A-D). (A) GAP-43 immunoreactivity in wildtype 
across the length of the sciatic nerve section (3mm) distal to the crush site (arrow) is much higher than in (B) 
C/EBPδ -/- mice (C) PGP9.5 immunoreactivity in wildtype is more abundant compared to (D) PGP9.5 
expression in C/EBPδ -/- mice. Scale bar = 1mm. (E-F). Quantitative analysis with Leica Qwin software in 
sections 1, 2 and 3 mm of the sciatic nerve distal from the crush site, expressed as percentage of area stained 
with (E) GAP-43 and (F) PGP9.5 (Mean + S.E.M., n=4 animals, *=P<0.05, **=P<0.01 ***=P<0.001 by 
student‘s t-test). 
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Fig. 27 Regeneration of sciatic nerve 2 weeks after injury: Representative microphotographs showing the 
extent of regrowth detected by the staining intensity of neuronal regeneration markers 2 weeks after nerve 
crush (A-D). (A) GAP-43 immunoreactivity in wildtype across the length of the sciatic nerve section (3mm) 
distal to the crush site (arrow) is much higher than in (B) C/EBPδ -/- mice (C). PGP9.5 immunoreactivity in 
wildtype is equally abundant compared to (D) PGP9.5 expression in C/EBPδ -/- mice. Scale bar = 1mm. (E-
F). Quantitative analysis with Leica Qwin software in sections 1, 2 and 3 mm of the sciatic nerve distal from 
the crush site, expressed as percentage of area stained with (E) GAP-43 and (F) PGP9.5 (Mean + S.E.M., n=4 
animals, *=P<0.05, **=P<0.01 by student‘s t-test). 
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5.4 Morphometric analysis of C/EBPδ null mice following sciatic nerve crush  
To further characterise the effect of the lack of C/EBPδ in vivo during nerve regeneration, 
morphometric analysis of sciatic nerve cross-sections 6mm distal to crush site (Fig. 28A) 
was performed to compare the number of regenerating axons in wildtype vs. C/EBPδ null 
mice. Four sections and ten microscopic fields in each section were randomly selected for 
quantitative analysis. The number of thinly myelinated regenerating axon were counted in 
each microscopic field of 30 x 30 μm2 and analyzed.  Two weeks after sciatic nerve injury, 
a significantly higher number of myelinated axons were observed in the cross sections of 
wildtype mice (Fig. 28B). A few myelinated axons were also seen in mutant mice (Fig. 
28C). The quantitative data showed fewer myelinated axons in the mutant mice 2 ± 0.05 
than in the wild-type mice (5 ± 0.05) (p < 0.001) (Fig. 28D). 
 
 
 
 
 
 
 
 
 
 
 
 
161 
 
 
 
 
 
 
Fig. 28 Regenerating axons 2 weeks following sciatic nerve crush: (A) Diagram illustrating sciatic nerve 
crush, sections were taken at 6mm distal to injury site. Toluidine blue staining of injured sciatic nerves 2 
weeks after crush. (B) Nerve section of wildtype animal showing regenerating axons (arrows). (C) Injured 
nerve section of C/EBPδ -/- showing high degree of myelin debris and damaged axons. Scale bar =20 um (D) 
Quantification of regenerating axons in injured sciatic nerves of four mice taken from nerve sections at 6mm 
distal to the crush site. (Mean ± S.E.M, n= 4 animals, ***=P<0.001 by student‘s t-test). B-C taken with a 50x 
objective.  
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5.5 Functional analysis in C/EBPδ null mice 
5.5.1 Mechanical sensory test 
Mice lacking the C/EBPδ gene have less regenerating axons than wildtype counterparts, as 
I showed by immunohistochemical and morphometric approaches in the sciatic nerve crush 
model. However, while much research has been undertaken to examine different forms to 
measure nerve repair, functional recovery remains the gold standard of successful 
reinnervation. Therefore, to determine whether the lack of C/EBPδ genuinely has a 
negative effect on nerve regeneration after sciatic nerve injury, several functional analyses 
were performed to test the sensor and motor recovery following a sciatic nerve crush injury. 
 Recovery of sensory function, as a measure of the rate and extent of regeneration of 
sensory axons in the injured sciatic nerve, was assessed in 8 wildtype and 8 C/EBPδ -/- 
mice by monitoring of the withdrawal reflex in response to stimulation of the hindpaw with 
Von Frey hairs from day 4 following nerve injury to day 22. Von Frey filaments 1g (Fig. 
29A) and 1.66g (Fig. 29B) were used.  
 A 100% response was detected in the uninjured contralateral side tested in all the 
animals before and after injury with 1g and 1.66g filaments (data not shown). No response 
was observed with any of the filaments up to day 9 in the tested animals. By day 14 no 
response was detected with the 1g filament (Fig. 29A). However, 14 days following nerve 
injury, flexion withdrawal responses were observed with the heavier 1.66g filament in 
87.5% of the wildtype and only 12.5% of C/EBPδ -/- animals (Fig. 29B). By day 18 a 
response was seen with the lighter 1g filament in 100% of the wildtype and in around 60% 
of C/EBPδ -/- animals (Fig. 29A). At the same time all the animals in the wildtype and 
knock-out group responded to the heavier 1.66 filament (Fig. 29B). By day 22 the 
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withdrawal response frequency with the 1g filament in wildtype was 100% whereas in 
C/EBPδ -/- animals was 87% (Fig 29A).  
These results show that even though C/EBPδ is not essential, it is important for 
sensory regeneration. This is illustrated by C/EBPδ -/- animals showing a delayed sensory 
regeneration in the sciatic nerve after a crush injury.  
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Fig. 29 Mechanical sensitivity test of mice after sciatic nerve crush injury: Responses to repeated 
mechanical stimuli with two different Von Frey filaments used 1g (A) and 1.66g (B). Each point represents 
the mean in percentage of the response frequency for wildtype and C/EBPδ -/- animals between 9 and 22 days 
following sciatic nerve crush. (n = 8) 
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5.5.2 Grid test 
Within a total of 16 mice subjected to unilateral sciatic nerve crush further behavioural 
testing was performed to evaluate recovery of hind-limb strength in 8 wildtype and 8 
C/EBPδ-/- animals. For that purpose we used the grid test which assesses the ability to 
accurately place the hindpaws during spontaneous exploration of an elevated and inverted 
grid by analysing the frequency with which the mice failed to accurately grasp the rungs in 
10 attempts. The animals were tested from 4 to 28 days following nerve crush.  
 Initially by day 4 and 8 all the animals in the wildtype and knock-out group failed to 
grasp the rungs in 10 out 10 attempts (Fig. 30). By day 12 the C/EBPδ -/- mice failed twice 
as many times as the wildtype group, 8 vs. 4 times out 10 attempts respectively (Fig. 30). 
This difference in grasping performance, between wildtype and C/EBPδ -/- animals, 
persisted throughout the testing period. However, the knock-out mice made significantly 
more footslips than wildtype only at day 12, 16 and 20 following injury, P<0.05, P<0.001 
and P<0.05 respectively.  Interestingly, at the end of the testing period by day 28, the 
animals of both groups show an improvement in the grasping ability indicating increased 
nerve regeneration. However, the average number of footslips was 0.6 fails for wildtype 
and 1.3 fails for C/EBPδ -/- mice. Even though this might seem like the knock-out group 
misses the grid twice as many times as the wildtype group, the difference is negligible and 
not significant.  
These data corroborates our previous immunohistochemistry findings indicating 
that C/EBPδ -/- animals subjected to a crush injury of the sciatic nerve, have delayed nerve 
regeneration.  
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Fig. 30 Grid test in mice after sciatic nerve crush: Mean number of gripping failures for every 10 attempts 
following sciatic nerve crush recorded in C/EBPδ -/- vs. wildtype mice. Fewer significant gripping failures 
are achieved by days 12, 16 and 20 after injury in the wildtype group. (M ± S.E.M, n= 8 animals, *=P<0.05, 
P<0.001***, by student‘s t-test). 
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5.5.3 The sciatic static index 
In order to assess the degree of functional loss and subsequent recovery after sciatic nerve 
crush in C/EBPδ -/- compared to wildtype mice, the sciatic static index (SSI) was used. The 
SSI measures functional loss on a scale from 0 to -100, where 0 corresponds to normal 
function and a value of −100 corresponds to complete loss of function. The SSI, which is a 
modified version of the sciatic functional index (SFI), uses the footprints, acquired when 
the animal is on a static position, and minimizes bias related to gait‘s velocity. Also, the 
SSI improves the acquisition of footprints, and is more repeatable and accurate then the 
SFI. The SSI was carried out by placing the animals in an acrylic cage with a digital camera 
placed underneath.  
Pictures were taken when the animals were static and the images were evaluated to 
obtain two footprint parameters, the toe spread (TS) which is the distance between the first 
and fifth toes and the paw length (PL) which is the distance between the tip of the third toe 
and the most posterior part of the foot in contact with the ground. The TS is defined as the 
most lateral edges of the proper toes, and the PL as the most anterior edge of the third toe 
and the most posterior portion in contact with the ground, where the limits of the paw 
became less clear, pale and discolored.  
Once the TS and the PL are measured the SSI can be calculated by using the 
following formula SFI = 101.3×TSF−54.03×PLF−9.5. The factors for each parameter (TS, 
and PL) were calculated with the formula: injured−uninjured/uninjured values (e.g. TSF 
(toe spread factor) = TS ipsilateral−TS contralateral/TS contralateral). The animals were 
evaluated before injury, shown as day 0 in (Fig. 31) and also on day 4,8,12,16,20,24 and 28 
after nerve crush. 
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Generally the SSI shows a higher loss of function for C/EBPδ -/- mice on each time point 
after injury except for day 28. By day 8 both groups showed a peak in functional loss with a 
SSI score of -62±2 for wildtype and -70±3 for C/EBPδ -/- mice. Even though the difference 
in the SSI score was noticeable by day 12 between wildtype (SSI: – 30±6) and C/EBPδ -/- 
(SSI: -41±5), this difference was not significant p = 0.09. Statistical significant differences 
in the regain of function displayed between wildtype and knock-out animals were observed 
following injury on day 16 (-13±4 vs. -31±5) and day 20 (-5±4 vs. -29±5) (Fig. 31). On day 
24 the SSI score for the wildtype group was -6±3 whereas the SSI for C/EBPδ -/- mice was 
-16±3, p=0.08. By the final evaluation day 28, the wildtype and C/EBPδ -/- groups 
displayed fully functional recovery demonstrated by resuming background levels (-0.8±3 
vs. -1.3±3).  
These results validates previous findings showing that animals lacking the C/EBPδ 
gene recover much slower after sciatic nerve crush than wildtype animals.   
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Fig. 31 Sciatic static index analysis shows a delayed recovery of function in C/EBPδ -/- mice: Following 
sciatic nerve crush, the sciatic static index was calculated by measuring the toe spread (TF) and paw length 
(PL). Note the differences of the foot posture and the particular footprint parameters between uninjured right 
and injured left hind limb. Images from wildtype and C/EBPδ -/- animals were taken before injury (0 day) and 
every 4 days after sciatic nerve crush injury. The knockout group of mice exhibit an initial deficit in recovery 
of loss function shown by a delayed return to baseline compared with the wildtype group. (Mean ± S.E.M, n= 
8, **=P<0.01, by student‘s t-test). 
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5.6 Lack of C/EBPδ and the expression of the regeneration associated genes 
To identify genes acting downstream of C/EBPδ and to establish whether the expression of 
genes known to be upregulated following sciatic nerve injury is affected in C/EBPδ -/- 
mice, the relative expression of GAP-43, galanin and SPRR1A mRNA were analyzed by 
RT-PCR in L4-L5 DRG neurons. GAP-43, galanin and SPRR1A have previously been 
shown to be upregulated following axotomy of sensory neurons in lumbar DRG (Benowitz 
and Routtenberg, 1997; Shadiack et al., 1998; Bonilla et al., 2002).  
The expression of GAP-43, galanin and SPRR1A was analyzed 3 days after nerve 
crush and compared to wildtype mice (Fig. 32). Additionally protein expression was 
assessed by immunohistochemistry for GAP-43 (Fig. 33) and SPRR1A (Fig. 34) in L4-L5 
DRG neurons 3 days after crush injury.   
 Following nerve crush injury the mRNA expression levels for GAP-43, galanin and 
SPRR1A were, as expected, upregulated in the wildtype DRG neurons from the injured site 
in comaparison to the uninjured site (Fig 32A-C). Relative GAP-43 mRNA expression in 
injured DRG neurons in wildtype and C/EBPδ -/- mice did not show any statistical 
difference (Fig 32A). A comparable pattern was obeserved in the mRNA expression of 
galanin which did not show any statistical difference between wildtype and C/EBPδ -/- 
mice in DRG neurons 3 days after nerve crush (Fig 33).  In contrast, the difference between 
ipsilateral DRG neurons from wildtype and C/EBPδ -/- animals in the SPRR1A realative 
mRNA expression was statisticly significant (Fig 34). SPRR1A mRNA expression was 
downregulated approximately 4-fold in knock-out L4-L5 DRG neurons in comparison to 
wildtypes (Fig. 35).  Interestingly, SPRR1A mRNA expression showed no significant 
difference in C/EBPδ -/- null mice  before and after nerve crush (p= 0,38).  
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Similar results following crush injury were observed by immunostaining of L4-L5 DRG 
neurons with GAP-43 and SPRR1A antibodies. GAP-43 immunostaining was hardly 
detected in uninjured DRG neurons in wildtype (Fig. 33A) and C/EBPδ null mice (Fig. 33 
C). GAP-43 intensity was greatly increased 3 days following nerve crush in injured DRG 
neurosn from wildtype (Fig. 33B) and C/EBPδ null mice (Fig. 33D). However, there was 
no difference in the percentage of GAP-43 positive DRG neurons stained after nerve crush 
between wildtype (48%±5) and C/EBPδ -/- (44%±2) mice (Fig. 33E). 
 SPRR1A immunostaining was not detected at all in uninjured DRG neurons from 
wildtype (Fig. 34A) and C/EBPδ null mice (Fig. 34C). Conversely, SPRR1A staining was 
detected in injured DRG neurons from wildtype and C/EBPδ -/- animals (Fig 34B and D).  
Although detected, the SPRR1A immunoreactivity observed in DRG neurons from C/EBPδ 
null mice was significantly lower than in wildtype animals. The percentage of DRG 
neurons stained with SPRR1A 3 days after nerve injury in wildtype animals was 67%±8 
whereas in knock-out it was 9%±2, this was statisticly significant P= 0.002 (Fig 34E). 
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Fig. 32 Relative mRNA expression of regeneration associated genes 3 days after nerve crush: Analysis 
of relative mRNA expression in L4-L5 DRG neurons of wildtype vs. C/EBPδ -/- mice, contralateral and 
ipsilateral to nerve crush. (A) GAP-43, (B) Galanin and (C) SPRR1A genes. Target mRNA expression was 
normalized with 18S rRNA and multiplied by a factor of 1000. (Mean ± S.E.M, n= 4 animals, ns= non 
significant, **=P<0.01 by student‘s t-test). 
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Fig. 33 GAP-43 expression in DRG neurons 3 days following sciatic nerve injury: Immunoreactivity for 
GAP-43 was analyzed in L4-L5 DRG neurons removed 3 days after sciatic nerve crush. Scale bar = 100 μm. 
GAP-43 staining detected in lumbar DRG neurons contralateral to nerve injury was barely detectable in 
wildtype mice (A) and in C/EBPδ -/- mice(C). GAP-43 immunoreactivity is seen in a high proportion of cells 
in injured DRG neurons of wildtype mice (B) and C/EBPδ -/- mice (D). (E) Percentage of GAP-43 positive 
DRG neurons from wildtype vs. C/EBPδ-/- mice (M ± S.E.M., n= 4 animals). 
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Fig. 34 SPRR1A expression in DRG neurons 3 days following sciatic nerve injury: Immunoreactivity for 
SPRR1A was analyzed in L4-L5 DRG neurons removed 3 days after sciatic nerve crush. Scale bar = 100 μm. 
(A) No positive SPRR1A staining is detected in lumbar DRG neurons contralateral to nerve injury in wildtype 
mice.  (B) SPRR1A immunofluorescence is seen in a high proportion of cells in the ipsilateral DRG neurons. 
(C) No positive immunofluorescence for SPRR1A is observed in DRG contralateral to nerve injury in 
C/EBPδ-/- mice (D) DRG neurons ipsilateral to nerve injury in C/EBPδ-/- mice show a low proportion of 
cells expressing SPRR1A. (E) Percentage of SPRR1A positive DRG neurons from wildtype vs. C/EBPδ-/- 
mice (M ± S.E.M., n= 4 animals, **=P<0.01 by student‘s t-test). 
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5.7 Discussion  
Evaluation of sciatic nerve function under normal conditions in C/EBPδ null mice 
To examine the role of C/EBPδ in vivo following the promising results from the in vitro 
experiments, we decided to use C/EBPδ null mice generated by Esta Sterneck‘s group at 
the National Institute of Health in the USA (Sterneck et al., 1998). Previously it has been 
shown that the disruption of other members of the C/EBP family of transcription factors 
interferes with normal embryonic and postnatal development. For instance, C/EBPα 
disruption results in perinatal death caused by impaired energy homeostasis (Wang et al., 
1995) as well as deficiencies of the hematopoietic system (Zhang et al., 1997). Deletion of 
C/EBPβ results in female infertility (Sterneck et al., 1997) and the health of C/EBPβ −/− 
mice deteriorates within weeks to months after birth. Consequently, in order to discern the 
specific effects of C/EBPδ in the sciatic nerve before addressing its involvement in nerve 
repair, I looked at transverse sections of uninjured sciatic nerves of wildtype and C/EBPδ - 
/- mice and compared them by morphometric analysis.  
No morphological changes and no differences in the number of axons in the sciatic 
nerve were observed. Subsequently, in order to determine whether the lack of C/EBPδ has a 
behavioural effect, a grip strength test was performed in wildtype and knock-out animals. 
The lack of C/EBPδ in mice does not affect the neuromuscular function since both groups 
applied the same amount of force to the mesh pull bar at the moment the grasp was 
released. Consistently, Sterneck and colleagues demonstrated that prenatal and postnatal 
development of C/EBPδ null mice was normal and the animals were healthy. C/EBPδ -/- 
mice only displayed significantly more contextual-conditioned fear after a 24-hr retention 
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interval. However, performance in a battery of behavioural tests indicated that basic 
neurological functions are normal.  
Sterneck‘s group assessed gross neurological functions in the C/EBPδ null mice by 
examining spontaneous behaviours in battery of tests, specifically, limb-extension reflexes 
in a moving cage, righting, eye-blink, ear-twitch reflexes, whisker-orienting response, wire-
suspension test, vertical pole test, motor coordination and sensorimotor behaviours 
(Sterneck et al., 1998). The C/EBPδ null mutation did not show any deleterious effect on 
sensory and motor functions or complex behaviours, concurring with our results where the 
lack of C/EBPδ did not have a negative functional effect. However, it cannot be ruled out 
that the potential behavioural phenotypes of the mutants could be caused by developmental 
defects that are not detected at the gross anatomical level.  
 
Sciatic nerve regeneration assessment in C/EBPδ null mice by immunohistochemistry 
To evaluate nerve regeneration in the sciatic nerve of C/EBPδ null mice after nerve crush I 
examined the expression of the regeneration associated gene GAP-43 and the general 
neuronal marker PGP9.5. I found that GAP-43 immunofluorescence was highly detectable 
in the sciatic nerve of wildtype animals 3 days and 2 weeks after nerve injury. Conversely, 
in the injured sciatic nerve from C/EBPδ null, GAP-43 general intensity of 
immunofluorescence was much lower 3 days and even 2 weeks after nerve crush. Other 
studies have shown that GAP-43 is present in the growth cones of developing and 
regenerating adult PNS (Chong et al., 1994; Meiri et al., 1986). Unfortunately, this could 
cause problems in differentiating between the axon and Schwann cell labeling, as well as in 
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discriminating between direct and indirect effects. However, it has been shown that GAP-
43 is expressed only by non myelin forming Schwann cells and dedifferentiated Schwann 
cells responding to the loss of axonal contact (Curtis, 1993). This suggests that the 
upregulation of GAP-43 observed in wildtype mice following nerve crush may be related to 
increasing Schwann cell density and that the abnormal GAP-43 expression seen in knock-
out animals could be due to a negative effect of the lack of C/EBPδ upon Schwann cells. 
Interestingly, Kamaraju and colleagues showed that silencing of C/EBPδ mRNA and 
protein expression by introduction of small interference RNA prevents the induction of 
myelin
 
protein zero (P0) and myelin basic protein (MBP) mRNAs in a Schwann cell 
myeloma culture model. Kamaraju also suggested that C/EBPδ may be relevant for the 
switch from embryonic and adult
 
non-myelinating Schwann cells, to the myelinating
 
phenotype expressing the myelin gene products (Kamaraju et al., 2004). Consequently, the 
difference in the GAP-43 immunoreactivity between wildtype and knock-out mice after 
nerve crush might not be entirely due to the presence of Schwann cells since according to 
Kamaraju et al. the lack of C/EBPδ only affects myelinating Schwann cells and according 
to Curtis GAP-43 is only expressed by non myelinating Schwann cells. It is also possible 
that other non-neuronal cells like macrophages and satellite cells might be affected in the 
knockout animals which might impair axonal regeneration.  
Therefore to elucidate whether the lack of C/EBPδ specifically affects axonal repair, 
we used PGP9.5 also another marker for nerve regeneration. PGP9.5 is a structural 
cytoplasmic protein present in all types of mammalian nerves (Thompson et al., 1983). 
PGP9.5 immunofluorescence was highly detected in the sciatic nerve from wildtype 
animals 3 days and 2 weeks following nerve injury. In the knock-out animals PGP 9.5 
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intensity of immunofluorescence was much lower than wildtype 3 days following nerve 
crush. However, after 2 weeks, PGP9.5 immunoreactivity was comparable to the levels 
observed in wildtype animals.  
These findings show that the lack of C/EBPδ specifically affects axonal 
regeneration which is not abolished but delayed in the C/EBPδ -/- mice. Further studies are 
required to assess whether Schwann cells and other non neuronal cells are affected by the 
lack of C/EBPδ and to clarify PGP9.5 but not GAP-43 high immunoreactivity in knock-out 
animals 2 weeks after nerve crush.  
Certain considerations need to be taken into account when analysing and discussing 
the results presented here. Variations in background levels might result due to inadequate 
sample fixation, hydrophobic interactions between tissue and reagent proteins, defective 
reagents or antibodies. Therefore, an adequate internal positive control should have been 
used. In this case only negative controls were performed by omitting primary antibodies.  
 
Functional analysis in C/EBPδ null mice: mechanical-sensory tests 
Von Frey sensitivity testing is regularly used to quantify the degree of neuropathic pain in 
various sciatic nerve injury models, such as the chronic constriction injury, the spinal nerve 
ligation and the partial sciatic ligation models. In this study we have used a modified Von 
Frey test to evaluate sensory nerve regeneration in C/EBPδ -/- compared to wildtype 
animals after nerve crush. However, it is erroneous to say that the Von Frey test is a pure 
sensory test. Since the animals cannot express sensory perception, this test relies on a motor 
response to a sensory stimulus. Thus, it becomes difficult to separate sensory and motor 
function. It should be noted that in this case even if the mice may be able to feel pain after 
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the applied stimulus, due to decreased axonal connections and decreased muscle strength 
they are unable to lift the foot in response to the stimulus. 
Initially I established that 1g and 1.66g Von Frey hair filaments invoke a response 
in non-injured hindlimbs. Therefore, in order to compare sensory regeneration I 
subsequently used these Von Frey filaments in injured animals. As axonal connections are 
re-established, sensory nerve regeneration increases and a decreased resistance to applied 
force is displayed.  
Our findings indicate that sensory nerve regeneration was delayed in C/EBPδ -/- 
mice. By day 14 only 1 out of 8 knock-out mice (12.5%) showed a response to the 1.66g 
filament whereas 87.5% of the wildtype mice responded to the same stimulus. Additionally 
by day 18 all the wildtype animals and only 5 out 8 (62.5%) in the knock-out group evoked 
a response to the 1g filament. However, the delayed sensory nerve regeneration seen in 
C/EBPδ -/- animals was not permanent given that all these animals were responding by day 
18 after stroke with the 1.66g filament and almost all of them (87.5%) were responding by 
day 22 after stroke with the lightest 1g Von Frey filament. These findings are consistent 
with our previous PGP9.5 immunohistochemistry results which showed delayed 
regeneration following nerve crush in the sciatic nerve of C/EBPδ -/- animals. In that 
experiment no PGP9.5 staining was detected by day 3, however, by day 14 the PGP9.5 
staining intensity in C/EBPδ -/- was as high, however more fragmented, as the wildtype 
group. 
 It is important to mention that although high PGP9.5 intensity staining was 
observed by day 14 in the knock-out animals, sensory regeneration was not properly 
observed in C/EBPδ -/- mice until day 18. The reason for this difference is that the sections 
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stained for PGP9.5 were approximately 3mm long distal from the injury site whereas the 
distance that the regenerating nerves need to cover in order to re-establish sensory 
connections is much further; therefore it requires longer time to show any response.    
Importantly, functional studies have non-linear correlation with reinnervation. 
Reinnervation and the response of the stimulated nerve can be due to collateral sprouting of 
uninjured axons. Therefore, functional studies should be combined with other techniques 
(e.g. anterograde and/or retrograde labelling) to circumvent this issue.  
  
The sciatic static index 
The SSI was used to evaluate the sciatic nerve function after injury and repair in C/EBPδ -/- 
mice. The SSI is a method that relies on the analysis of footprints to determine functional 
recovery and it has been adapted from the SFI which is one of the most commonly used 
forms of functional assessment of hindlimb performance by examining walking tracks. 
Walking track analysis is a direct measurement of function, whereas electrophysiological 
and histomorphometrical analyses are indirect methods that may not necessarily correlate 
with the return of motor and sensory nerve functions (Dellon and Mackinnon, 1989).  The 
SFI introduced by DeMedinaceli L et al., (1982) employed ink for staining the feet and 
allowed the animal to walk in a proper catwalk across white paper. Others used water on 
the feet and a special moisture-sensitive paper  (Lowdon et al., 1988), or developer and a 
radiographic film in a darkened catwalk (Bain et al., 1989). A serious improvement was the 
introduction of the video imaging technique to record the footprint (Lin et al., 1992). It 
allowed digital analysis of the video images and better repeatability. It significantly 
diminished the number of useless footprints and decreased printing errors.  
181 
 
The SFI adapted to the mouse model of sciatic nerve lesion relies only on the print length 
and the toe spread. Pawprints are recorded by moistening the hindpaws of each animal with 
water in combination with bromophenol blue-impregnated paper to allow clear 
identification of the footprint parameters which permits various gait cycles to choose 
(Inserra et al., 1998). However, this method may stress the animals and it is also time 
consuming. Furthermore, some other factors can bias the study, such as foot contractures, 
autotomy, excrements on the corridor and variations due to gait velocity (Walker et al., 
1994; Bain et al., 1989).  
The SSI on the other hand introduced by Bervar, (2000), and adapted to the mouse 
model by Baptista et al. (2007), is more practical to perform and is not so influenced by 
gait‘s velocity. The images are simpler to be acquired and analyzed since it only requires an 
acrylic cage, a digital camera and an image software. Compare to ink, photo methods are 
more accurate and reproducible. SSI doesn‘t suffer from poor variability due to difficulties 
with smeared footprints, contractures and variations on gait velocity. Additionally, due to 
the low quality of some prints the process to record footprints has sometimes to be repeated 
which stresses the animals contributing to greater variations on the measurements. The 
photos used on the SSI analysis eliminate most of these difficulties, since the researcher can 
wait for the moment where the animals are stopped to acquire the images. There is no bias 
due to smeared footprints, as the hindpaws are seen as they are, or to gait velocity 
variations, because the animals are not moving.  
To calculate the SSI score, the formula 101.3×TSF−54.03×PLF−9.5 was used. The 
formula developed by Baptista and colleagues, shows the big influence of the toes spread 
factor (TSF) as a measure of gait dysfunction due to sciatic nerve lesion (Baptista et al., 
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2007). The TSF parameter represents the main cause of changes and may be used alone as 
indicative of the lesion‘s status. The paw length factor (PLF) represents a small but 
significant contribution to the formula according to Baptista‘s group. This parameter 
expresses the ability of the soleous and gastrocnemious muscles to maintain the heel 
elevated during walking in rodents. Because these muscles are innervated by the sciatic 
nerve, when impaired they cannot maintain the normal ankle angle, letting a bigger portion 
of the paw to be in contact with the floor. Although the PL may be very variable, due to the 
difficulty to establish its posterior aspect, its significance has also been demonstrated in the 
ink track method, which generated the SFI formula for the mouse (Inserra et al., 1998).  
 The highest loss of function for the wildtype and C/EBPδ -/- mice was showed at 
day 8 after nerve crush (SSI= -62 vs. -70). This is in line with observations of others where 
the highest loss of function (SSI and SFI= -65) was observed after 1 week following sciatic 
nerve crush in mice (Baptista et al., 2007).  16 and 20 days after nerve crush a statistical 
significant difference was noticed in the recovery of function between wildtype (SFI: -16 
and -5) and C/EBPδ knock-out animals (SFI: -31 and -29). Previously it has been shown 
that upon full recovery animals achieved a SFI and SSI score between -10 and -5 (Baptista 
et al., 2007; Dijkstra et al., 2000; Dinh et al., 2009).  According to these results, our 
findings indicate that wildtype animals recovered normal gait function at the third week 
after nerve crush whereas C/EBPδ -/- animals achieved full recovery at the fourth week 
after crush. 
 The SSI results confirm our previous findings, from the motor-sensory analysis, 
grid test, morphometrical assessment and immunohistochemistry examination of 
regeneration markers that indicate an important delay of approximately 30% - 40% in the 
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functional recovery of C/EBPδ -/- animals following sciatic nerve injury. Similar delay in 
functional recovery after sciatic nerve crush
 
have been shown by mice lacking the cell cycle 
inhibitory protein p21
Cip1/WAF1
 (Tomita et al., 2006), mice lacking the genes for the key 
components of the plasminogen system, tissue plasminogen activator (tPA), urokinase 
(uPA), and plasminogen knockout mice (Siconolfi and Seeds, 2001). Comparably, deletion 
of the gene encoding the neuronal cell adhesion molecule alpha7 integrin subunit, causes a 
severe, almost 40% reduction in the speed of the motor axon regeneration after facial 
axotomy and a significant delay in the reinnervation of its peripheral target (Werner et al., 
2000). Additionally, several reports have shown the involvement of other transcription 
factors in nerve repair. Transcription factors such as c-Jun, ATF-3 are normally expressed 
at low levels in adult DRG neurons and rise significantly following peripheral axotomy, 
modulating adult injury responses (Lindwall et al., 2004; Tsujino et al., 2000; Raivich et 
al., 2004). Recently, it has also been shown that the transcription factor Sox-11 is required 
for a successful regeneration following peripheral nerve injury (Jankowski et al., 2009). 
 Furthermore, a recent report suggesting the importance of C/EBPs in the plasticity 
of the nervous system, identify 115 C/EBP target genes in PC12 cells that include 
transcription factors, neurotransmitter receptors, ion channels, protein kinases and synaptic 
vesicle proteins. C/EBPs binding sites were located primarily within introns, suggesting 
novel regulatory functions, and were associated with binding sites for other 
developmentally important transcription factors. Experiments using dominant negatives 
showed C/EBPβ to repress transcription of a subset of target genes. Target genes in rat 
brain were subsequently found to preferentially bind C/EBPα, β and δ. (Kfoury and 
Kapatos, 2009). 
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These previous results reveal the importance of the C/EBPδ gene in nerve repair after a 
sciatic nerve crush injury. However, two important details must be noticed: i) even though 
reinnervation and functional recovery are correlated, this correlation is not linear, since 
only 20–30% of the final reinnervation is required to detect recovery (Raivich et al., 2004). 
ii) The lack of C/EBPδ affects nerve regeneration but it is not essential for recovery of 
normal gait function since knock-out animals ultimately although belatedly regenerate. The 
C/EBP family is a large group of transcription factors with 6 different members and 
multiple isoforms that can interact with each other and with the members of other 
transcription factor families and proteins; therefore it wouldn‘t be surprising that another 
member, related transcription factor or protein compensates for the lack of C/EBPδ 
expression in the knock-out animals. Previously it has been shown that C/EBP family 
members can compensate for the lack of a specific subtype (Hu et al., 1998; Gery et al., 
2005; Chen et al., 2000b) and it has been suggested that C/EBPβ might compensate for the 
lack of C/EBPδ in vivo (Borrelli et al., 2007). Conversely it has also been suggested 
C/EBPδ as the most plausible candidate to compensate for the lack of C/EBPβ in C/EBPβ-
deficient animals upon
 
LPS treatment (Hu et al., 1998). A lack of C/EBPβ expression 
would be expected
 
to further reduce functional recovery in a regeneration model. Therefore, 
it should be interesting to study nerve regeneration in mice deficient in both C/EBPβ and 
C/EBPδ expression. However, it has been shown that approximately 85% of C/EBPβ (-/-) δ 
(-/-) mice died at early neonatal stage (Tanaka et al., 1997), so a conditional approach 
should be considered.  
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Lack of C/EBPδ and the expression of the regeneration associated genes 
We have shown that the C/EBPδ is upregulated following nerve crush injury and also that 
the lack of C/EBPδ delays functional recovery after peripheral injury. Because transcription 
factors which are upregulated early in
 
the regenerative process could be important for the 
expression
 
of multiple downstream genes, we investigated the expression
 
of several 
regeneration associated genes known to be upregulated after sciatic nerve injury in C/EBPδ 
-/- mice before and after nerve crush.  
The genes selected were galanin, GAP-43 and SPRR1A. Previously it has been 
shown by other groups that galanin (Boeshore et al., 2004; Shadiack et al., 1998), GAP-43, 
reviewed by (Benowitz and Routtenberg, 1997) and SPRR1A (Nilsson et al., 2005; Bonilla 
et al., 2002) are all upregulated after sciatic nerve injury.  
Here we report that the relative mRNA expression and also the protein expression 
of galanin and GAP-43 are equally upregulated in L4-L5 DRG neurons from wildtype and 
C/EBPδ -/- mice following sciatic nerve injury. On the other hand, in C/EBPδ -/- mice the 
mRNA and protein expression of SPRR1A was significantly reduced compared to wildtype 
animals. These results suggest that SPRR1A may act downstream of C/EBPδ in a neuronal 
regeneration cascade. To date, there is no direct connection between C/EBPδ and SPRR1A 
expression. However, several lines of experimental evidence indirectly suggest a possible 
association between the roles of SPRR1A as regeneration associated gene and the 
expression of C/EBPδ. For instance, SPRR1A induction by axotomy is upregulated during 
successful regeneration and blockade of SPRR1A decreases the outgrowth potential of 
regenerating adult neurons (Bonilla et al., 2002), two features which are also displayed by 
C/EBPδ. Furthermore, SPRR2A which is another member of the SPRR family and 
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normally expressed in the epidermis, is misexpressed in C/EBPβ -/- mice (Grimm et al., 
2002). Additionally, the
 
SPRR1A promoter contains functional AP-1 binding sites 
(Pradervand et al., 2004; Sark et al., 1998) which are recognized
 
by homodimers of Jun or 
heterodimers of Jun/Fos, ATF/CREB
 
bZIP transcription factors (Hai and Curran, 1991) and 
it is known that C/EBPs can bind to and regulate two AP-1 transcription factors, c-fos and 
c-jun, (Hsu et al., 1994). Furthermore, C/EBPβ has a binding site located on the SPRR1A 
promoter (Pradervand et al., 2004) which was discovered in a major pathway involved in 
cardiomyocyte protection that resembles a signalling pathway involved in nerve repair. In 
this pathway IL-6 cytokines bind to gp130/LIFR receptor which activates STAT3, PI-3K, 
and MAPK signalling cascade. Then MAPK activates C/EBPβ and AP-1. Thereafter, 
C/EBPβ binds to SPRR1A promoter inducing SPRR1A gene transcription (Pradervand et 
al., 2004). Interestingly, the induction of SPRR1A by C/EBPβ could explain the low 
although present mRNA and protein expression in C/EBPδ null mice before and after 
sciatic nerve injury. Recently it has been shown that SPRR1A induction is regeneration-
specific and distinct from developmental programs of gene expression (Starkey et al., 
2009). Therefore, these findings may be important for the future use of C/EBPδ as a 
regeneration-specific marker in CNS and PNS injury studies in mice. Further experiments 
are required to determine how C/EBPδ influences peripheral nerve repair and whether this 
occurs by controlling the expression of other regeneration associated genes following nerve 
injury. For that purpose microarray analysis could be used.   
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Chapter 6 - Summary and future studies 
Studies in the last two decades on the regulation of genes involved in cellular responses, 
such as cellular differentiation and neuronal repair, have led to the identification of key 
transcription factors that act as master regulators by interacting with regulatory sequences 
present in the promoter and enhancer regions of target genes. Transcription factors 
belonging to the C/EBP family, with many pathophysiological conditions associated with 
their defective function, fall in this category. Although C/EBPα, β and δ expression has 
been reported in the brain and systematic analysis on the function and properties of C/EBP 
proteins has been performed in a range of tissues such as liver and adipose, much less
 
is 
known about the role of C/EBPs in the nervous system, especially in nerve regeneration 
after nerve injury.  Indirect evidence documented in non-neuronal tissues have shown that 
C/EBPs can interact with well known genes present in the nerve regeneration signalling 
cascade such as ArgI, cAMP, CREB, NGF, SPRR1A and STAT-3, suggesting a possible 
involvement of the C/EBPs in neuronal repair. Consequently, the aim of my PhD project 
was to study the involvement of C/EBPs, especially C/EBPδ during neuronal repair in the 
PNS. 
A hallmark for the involvement of a transcription factor in neuronal repair would be 
the variation of its expression and activity after nerve injury, during axonal repair. This 
change in expression could regulate downstream target genes and account for the dramatic 
structural changes seen in axonal regrowth. Therefore our first goal was to determine if the 
expression of the members of the C/EBP family is altered following peripheral sciatic nerve 
crush.    
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In this thesis, I have shown that C/EBPβ –γ and –δ mRNA expression were upregulated in 
L4-L5 DRGs in vivo 4 hours after nerve crush. This increase was sustained up to 3days 
only for C/EBPδ, indicating that although all C/EBP isoforms share substantial sequence 
identity, they do have different functions and react differently to the same pathological 
condition in this case axonal injury.  
In this thesis, I also showed that in an in vitro model that the overall C/EBP 
transcriptional activity and specifically C/EBPβ and –δ mRNA expression are upregulated 
during neurite outgrowth induced by the addition of cAMP. Subsequently, in the same in 
vitro model, I showed that the use of a conditional dominant inhibitor of all the C/EBPs and 
the specific conditional C/EBPδ antisense construct decrease the neurite length. However, I 
have to admit the fact that the transfection efficiency was not very high and that I couldn‘t 
demonstrate the downregulation of the C/EBPs by the conditional constructs.  However, 
I‘m confident that the decrease in neurite length is affected by the downregulation of 
C/EBPs since I showed that axonal elongation was greatly reduced in DRG neuronal 
cultures from C/EBPδ null mice. These new lines of evidence, besides showing a direct role 
of C/EBPδ during neurite elongation, also indicate that C/EBPδ is an important factor of 
the neurons intrinsic growth capacity. 
 Moreover C/EBPs  might be a downstream effector of the second messenger 
cAMP, which is known to promote axonal outgrowth in vitro (Neumann et al., 2002; Qiu et 
al., 2002) and improve regeneration and functional recovery after spinal cord injury in vivo 
(Pearse et al., 2004). Therefore, C/EBPδ might be an interesting candidate to enhance 
axonal regeneration following an injury in the CNS. 
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Another interesting finding in my thesis was the increase of C/EBPδ after treatment of 
neuronal culture with the histone deacetyltransferase inhibitor, TSA. It has been reported 
that TSA switches the intrinsic neuronal genetic program from a non permissive to a 
permissive pattern leading to increased neurite outgrowth (Gaub P, 2008). Therefore future 
epigenetic studies should investigate in detail the processes of histone 
acetylation/deacetylation on primary sensory neurones, their impact on neuronal repair and 
the possible participation of the C/EBPs.  
The effect of the lack of C/EBPδ in axon regeneration after peripheral nerve injury 
had not been studied previously. Here I show that C/EBPδ null mice have equivalent 
amount of axons in the sciatic nerve compared to their wildtype counterparts. Additionally 
no difference was observed in the neuromuscular function indicating that the lack of 
C/EBPδ does not affect the anatomy or function of the sciatic nerve under normal 
conditions. These results confirm previous findings where no deleterious effects on sensory 
and motor functions or complex behaviours were observe in C/EBPδ null mice (Sterneck et 
al., 1998).  
More importantly, in my thesis I showed by immunohistochemistry, 
morphometrical studies and different functional analyses tests a direct detrimental effect of 
the lack of C/EBPδ after sciatic nerve crush and during axonal regeneration leading to 
delayed recovery of function.  Additionally, in my thesis I showed that after nerve crush the 
lack of C/EBPδ downregulates the expression of the regeneration associated gene SPRR1A 
which is normally highly upregulated by axotomized neurons and promotes axonal 
outgrowth (Nilsson et al., 2005; Bonilla et al., 2002). These results show that C/EBPδ 
affects the expression of a gene directly involved in nerve repair; it also shows that C/EBPδ 
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is important during nerve repair yet not indispensable for functional recovery. However, in 
this thesis it wasn‘t determined whether non neuronal cells (e.g. Schwann cells, 
macrophages and satellite cells) are affected in the C/EBPδ -/- mice which could influence 
the delay in regeneration observed after sciatic nerve injury. Therefore, future studies in 
C/EBPδ should include immunostaining of non neuronal cells following injury.   
 In future studies, it would also be valuable to use microarrays and proteomics to 
disclose gene expression profile at both translational and transcriptional levels in C/EBPδ-/- 
mice following injury to identify downstream targets and dissect the signalling cascade 
leading to this delay in nerve repair. Since nerve regeneration in C/EBPδ -/- mice is delayed 
and not completely impaired, it would be important to determine whether the lack of 
C/EBPδ becomes eventually redundant due to compensatory mechanism upregulating the 
expression of other C/EBP members. Therefore, in C/EBPδ -/- mice, the expression of the 
other C/EBP members should be measured at different time points following nerve injury.  
Additionally, since C/EBPβ has also been shown to be upregulated after nerve injury and 
during neurite sprouting, the concomitant lack of C/EBPδ and C/EBPβ should be 
investigated in a sciatic crush injury model.    
The findings of my thesis illustrate that peripheral axotomy provides several 
insights into axonal regeneration, showing the importance of the transcriptional factor 
C/EBPδ during neuronal repair in vivo. These results offers some hope for successful repair 
or at least enhanced regeneration after injury in the CNS, therefore, future studies should 
concentrate on the effect of C/EBPδ overexpression in the CNS after nerve injury. Since it 
is likely that the in vivo CNS regeneration depends on the concerted
 
action of multiple 
proteins to achieve robust axon growth, C/EBPδ should be overexpressed in combination 
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with other known genes involved in nerve repair, for instance GAP-43, CAP-23, c-jun, 
SPRR1A and STAT-3.  
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Appendix 
Generation of a C/EBP luciferase transgenic reporter mouse 
Here we report the generation of a C/EBP-luciferase transgenic mouse that can be used as a 
tool to assess the expression of the C/EBP family of transcription factors in vivo under 
different pathophysiological conditions such as inflammation or neuronal repair. 
The use of transgenic reporter mice to investigate regulation of genes in complex 
biological situations can be helpful to overcome the limitations of other techniques. For 
example, the effects of environmental factors on tissue culture cells cannot be correlated 
directly to the in vivo conditions, in part because the cell culture environment is artificial 
and cannot replicate all processes that occur in an intact animal. Thus it is required to use 
animal models both to validate in vitro data and to extend the knowledge relevant to the in 
vivo situation.  
The C/EBP-luciferase transgenic model that we generated can be used in 
combination with molecular imaging, allowing us to visualize and quantify C/EBP activity 
under biological processes at the cellular level within intact living animals. Furthermore, 
non-invasive imaging provides the possibility of repetitive assessments in the same animal 
allowing the animal to serve as its own control, thus reducing significance of differences 
between individuals. 
The production of transgenic C/EBP reporter mice was achieved by the use of pro-
nuclear microinjection where the transgene (see Fig. 18D) in multiple copies is injected into 
one of the nuclei of a fertilized mouse zygote. Because of the randomness of integration 
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and the variability of the transgene copy number, it was necessary to analyze several 
transgenic mouse lines to estimate the reliability of the expression.  
To image luciferase generated luminescence, the substrate luciferin is delivered 
intraperitoneally to ensure rapid distribution in the whole mouse, finally reaching the inside 
of the cells. Luciferin is oxidized to oxyluciferin by those cells that are producing 
luciferase, leading to the emission of light (Fig. 35). Detection and quantification of the 
photons generated by the luciferin-luciferase reaction requires that the mice destined for 
imaging must be placed in a light-tight chamber. To image the C/EBP mediated luciferase 
activity the mice are injected with 2 mg -luciferin ( 130 mg/kg). Five minutes later, the 
mice are placed in the light-tight chamber, where luminescence from these mice is collected 
for 5 min by using an IVIS-100 system from Xenogen.  
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Fig. 35 Schematic overview of non-invasive bioluminescent imaging of transgenic reporter mice: (A) D-
Luciferin (2 mg per mouse) is injected intraperitoneally. Shortly afterwards the mice are placed in a light 
sealed cabinet for a 5 min light collection. The light is amplified and finally processed digitally. (B) After the 
injection of luciferin, the substrate is taken up by the cells, where the intracellular amount of C/EBP mediated 
luciferase determines the light output from each cell. Modified from (Carlsen et al., 2004). 
 
 
 
A 
B 
Fig. 33 
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Validation of the model 
The C/EBP luciferase mice generated in our laboratory were the result of the screening of 
fifteen different founders by biochemical analyzes of the luciferase activity in various 
tissues following LPS injection. The mouse line selected reported faithfully the expected 
increases in C/EBPs activity after stimulation with LPS. However, this upregulation in the 
C/EBP expression was only observed in the brain (Fig. 36). C/EBP activity was not 
detected in transgenic animals not injected with LPS in vivo (Fig. 37A). The pronounced 
increase in luciferase activity in the brain, detected biochemically with the luciferase assay, 
was corroborated by in vivo imaging observations after injection with LPS (Fig. 37B). 
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Fig. 36 C/EBP upregulation in the brain of transgenic mice following LPS injection: The luciferase assay 
did not detect expression of C/EBPs in thymus or liver of transgenic animals injected with LPS. Increased 
C/EBP expression in the brain of transgenic animals was detected 4 hrs after LPS injection. As control 
transgenic animals without LPS injection were used.    
 
 
 
 
 
 
 
0
500
1000
1500
2000
2500
3000
THYMUS SPLEEN BRAIN
-LPS
+LPS
197 
 
 
 
 
Fig. 37 Molecular imaging of C/EBP activity in transgenic animals: Non-invasive imaging of induced 
C/EBP activity as seen in mice treated with or without LPS (2 mg/kg). The image was taken 4 hrs following 
LPS injection. 
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